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The osteochondral unit (OCU) comprises bone and cartilage, with a gradi-
ent interface between hard and soft tissues. Damage and diseases, such as
osteoarthritis (OA), cause irreversible changes to the cartilage matrix. Early,
clinically silent, matrix changes in OA were compared to healthy, post-mortem
cartilage using mechanical and physicochemical techniques. It was found that
degradation of matrix components leaves the superficial region susceptible to
mechanical damage. Strategies to repair cartilage damage have focused on
replication of the extracellular matrix using hydrogel sca↵olds. Alginate is
commonly used, and its positive e↵ects on chondrocyte phenotype have been
attributed to maintenance of a spherical cell morphology. Here, an alginate
fluid gel was formed to enable the non-invasive delivery of chondrocytes. It was
found, however, that a spherical morphology was insu cient for maintenance
of chondrocyte phenotype and geometric confinement of chondrocytes in algi-
nate played a significant role in phenotypic recovery and stability. Fluid gels
were then utilised as support matrices for bioprinting of bi-layered structures
to recapitulate the OCU. This support matrix could suspend low-viscosity
hydrocolloid solutions prior to crosslinking to co-culture chondrocyte and os-
teoblast populations in spatially defined regions. Distinct chemical and me-
chanical environments allowed the maintenance of primary cell phenotypes
and function.
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CHAPTER 1
INTRODUCTION
The osteochondral unit (OCU) encompasses bone, cartilage and their interface; it is struc-
turally and chemically adapted to transfer loads associated with the weight of the body
and the changing loads in joint locomotion. Physical, biological and chemical changes to
the OCU, as a result of trauma, disease or ageing reduce its ability to function properly.
One of the most prevalent diseases that a↵ects the OCU and surrounding joint tissues
is osteoarthritis (OA). Generally as a disease of older adults, and with increased body
mass index (BMI) as a key risk factor, OA is becoming more prevalent with the world’s
ageing and increasingly obese population [4]. In the Global Burden of Disease study there
was a 64% increase in the prevalence of OA between 1990 and 2010, and in 2012 it was
estimated that worldwide, 250 million people were a↵ected by knee OA [85, 140, 225].
Unlike rheumatoid arthritis (RA), which is an inflammatory multi-joint condition,
OA is a localised, non-systemic disease. The most researched and most easily diagnosable
pathology of OA is degeneration of the articular cartilage; however, the whole joint is
a↵ected and there are changes seen in the subchondral bone, synovial fluid, synovium
and meniscus [60, 113, 214]. While much research has been done into disease modifying
therapeutics, as yet, there are no therapeutics that can stop progression or reverse the
e↵ects of OA [166]. Current management strategies for OA are limited to pain relief and
intra-articular steroid injections.
When OA reaches ‘end-stage’ the only treatment option available is partial or to-
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tal joint replacement surgery. These procedures are highly invasive and the current gold
standard joint replacement options, particularly for the hip joint, have limited life-spans.
With high surgical precision, the best materials and low activity levels, a hip or knee
implant will last for up to 25 years; however, there is much variability and revision surg-
eries are common [210, 231]. Therefore, alternative strategies for the treatment of OA
are being sought, particularly via tissue engineering and regenerative medicine routes
[71, 239]. Preventative strategies and those which target early changes in OA may be the
most successful as severely degenerate cartilage has a drastically altered mechanical and
biochemical environment [59]. A key limitation to implementing early strategies is that
the first changes in OA are clinically silent as cartilage matrix is degraded without bulk
structural changes [5].
There remain unanswered questions surrounding the e↵ects of clinically silent changes
to the articular cartilage in OA. It is known that the mechanical properties are reduced,
but quantitative correlation of the changes in viscoelastic, mechanical properties with the
physicochemical changes has not yet been achieved. As such, the first aim of this thesis
is to investigate this correlation:
• Determine the viscoelastic properties of macroscopically undamaged OA cartilage
and healthy, age-matched cartilage.
• Undertake physicochemical and histological analysis of freshly isolated compared to
mechanically conditioned tissues.
• Investigate quantitative links between the di↵erence in mechanical properties with
matrix changes in disease.
The changing matrix properties in early OA alters the behaviour of chondrocytes
[61]. Similarly, in traumatic cartilage injuries, there are disruptions to the structure
and integrity of the matrix as well as damage to chondrocytes. These lesions in the
cartilage surface are often secondary to larger joint trauma, but left untreated can lead
to early-onset OA [200]. There are a number of clinical treatment strategies for cartilage
2
defects, however none of them are without limitations regarding overall joint function.
As a result, tissue engineering has been proposed as a promising solution for replacement
or regeneration of damaged cartilage. A common strategy for engineered cartilage is to
encapsulate chondrocytes in hydrogel matrices [172, 174, 222]. This can prevent and even
reverse dedi↵erentiation that is seen in monolayer culture of chondrocytes. Alginate is a
commonly used hydrogel for chondrocyte culture and the positive e↵ects have often been
attributed to maintenance of a spherical cell morphology [16, 95]. The delivery of a bulk
hydrogel matrix to a defect site, however, is challenging so novel methods of structuring
alginate hydrogels presents a way to deliver material and cells non-invasively. Therefore,
the second aim of this thesis is to investigate a deliverable alginate-chondrocyte system:
• Produce and characterise traditionally gelled ‘quiescent’ and sheared or ‘fluid’ algi-
nate matrices.
• Seed human chondrocytes into these matrices and determine the e↵ects of varied
levels of confinement (or entrapment) on cellular behaviour and phenotype.
• Investigate the use of factors that may help drive native chondrocyte phenotype in
these matrices.
As previously mentioned there are currently no disease-modifying therapeutics for
OA, and there is a high incidence of failure of candidate drugs in late stage clinical trials.
One factor may be the lack of appropriate models to test these therapeutics preclinically
[166]. In vitro testing is usually performed in monolayer cell cultures and the current in
vivo preclinical methods are poorly representative of the physiological situation in humans.
Animal models of OA are either chemically or mechanically induced by destabilisation
of the joint, which is unrepresentative of the chronic degenerative disease in humans.
The one animal that spontaneously develops OA is the Dunkin-Hartley guinea pig which
exhibits a severely obese OA phenotype so again, is unrepresentative of a lot of OA cohorts
[2, 103, 197]. To address this, a new in vitro model of the OCU will be developed using
3D printing technology:
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• Use and refine an embedded bioprinting technique to print low viscosity hydrocolloid
solutions prior to crosslinking.
• Develop a bi-layered sca↵old to represent bone and cartilage-like regions.
• Seed primary human chondrocytes and osteoblasts into this bi-layered sca↵old to de-
termine the capacity to produce region-specific mechanical, chemical and biological
environments.
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1.1 The Synovial Joint
This thesis focuses on the changes that occur in OA in the knee joint; therefore the focus
here is on the anatomy of this joint. The knee joint acts as a hinge allowing for flexion
and extension at the tibia, femur and patella, as well as allowing slight medial and lateral
rotation. It has both soft and mineralised tissues including the joint capsule, synovium,
the infrapatellar fat pad (IPFP), a number of ligaments and tendons, meniscus, hyaline
cartilage and bone. The joint is a relatively hypoxic environment as the only vascularised
tissues are the bone and synovium; oxygen and nutrients are delivered to many tissues
including the articular cartilage via the synovial fluid [215].
Meniscus, ligaments and tendons
Meniscus is a tough fibrocartilaginous tissue that forms a semi-circular wedge between the
femoral condyles and tibial plateau. The main functions of meniscus tissue are to stabilise
the knee joint in flexion, extension and rotation as well as transferring load across the
joint. The main stabilising structures in the knee joint are four large ligaments. The
anterior cruciate ligament and posterior cruciate ligament are intracapsular and restrict
medial/lateral joint rotation. The extracapsular ligaments include the medial and lateral
collateral ligaments which prevent valgus and varus bending. The patellar tendon connects
the patella to both the quadriceps and the tibial tuberosity without separation. It is a
critical bridge between the femur and tibia that enables flexion and extension of the joint.
Synovium and synovial fluid
The synovium is a vascularised tissue that lines the inner surface of the joint capsule,
encasing the joint. It has a small role in stabilising the joint but is mainly responsible for
the secretion of synovial fluid; a non-Newtonian fluid that fills the joint space, providing
lubrication, a supply of nutrients and also a waste removal system [5]. It has a high (3
mg/mL) hyaluronic acid content, which greatly enhances its viscosity, as well as other
proteins secreted by the surrounding joint tissues, some of which act to aid lubrication
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[34]. A combination of synovial fluid filling gaps in the cartilage surface and fluid being
released from the cartilage matrix allow for ‘weeping lubrication’ of the cartilage surface
[5].
1.2 Hyaline cartilage
Hyaline cartilage is so called because of its white-blueish glossy appearance; it comes from
the greek hyalos, meaning glass. It forms a 1-3 mm covering to the ends of long bones
in diarthrodial joints to allow for low friction joint gliding whilst also acting to distribute
compressive forces. It is an avascular and aneural tissue with a dense extracellular matrix
(ECM) primarily consisting of collagen type II (Col II) and proteoglycans [202]. Archi-
tecturally, cartilage can be sub-divided into regions which form a continuous gradient
structure. The distribution of the ECM constituents throughout the structure and their
interaction with water dictate its highly specialised mechanical properties [137].
1.2.1 Chondrocytes
Chondrocytes are cells from a mesenchymal lineage and are the only cell type found in
cartilage, albeit sparsely, making up less than 5% of the tissue volume [160]. During
development, mesenchymal stem cells (MSCs) are stimulated by TGF-  to di↵erentiate
into chondroprogenitors which start to express and produce Col II. They then di↵erentiate
into chondroblasts which additionally produce aggrecan, Collagen type IX and COMP
(cartilage oligomeric matrix protein). They then mature into chondrocytes. In healthy
adult cartilage, chondrocytes are very slow to proliferate and there is little turnover of
cartilage ECM. As an avascular tissue, delivery of nutrients is only possible via di↵usion
from the synovial fluid which is assisted by compression-driven fluid flow [137]. The exact
phenotype of chondrocytes varies throughout the di↵erent zonal regions of cartilage, but
the key markers are Col II, aggrecan and SRY (sex-determining region Y)-box-9 (Sox9)
[33].
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1.2.2 Cartilage pericellular matrix
There is a specific pericellular matrix (PCM) that immediately surrounds chondrocytes.
Here, there is little evidence of proteoglycan macromolecules and whilst many of the
constituent components are present, they are not co-localised. There are small Col II
fibres of 10-15 nm in diameter, as well as collagen types VI and IX, fibronectin, perlecan,
biglycan, decorin and laminin, at higher concentrations than in the main cartilage ECM
[96, 167–169, 209, 213]. It has been hypothesised that the PCM has a mechanosensing role
and a mechanoprotective role during compression to prevent damage to chondrocytes [167,
232, 233]. The combination of a chondrocyte and its PCM have been termed a chondron,
with the wider matrix between neighbouring chondrocytes referred to as the territorial
matrix [168]. Beyond this, the matrix is referred to as interterritorial or extracellular.
1.2.3 Cartilage extracellular matrix
Collagen
Fibrillar collagen types have a hierarchical assembly starting with individual polypeptide
monomers with the repeating sequence G-X-Y, most commonly glycine (G), proline and
hydroxyproline [93]. These 300 nm monomers form right-handed triple-helices in the
endoplasmic reticulum before being secreted from the cell. Extracellular enzymes are
then responsible for cleaving the propeptides that flank either end of the trimer, enabling
fibres to form that then assemble into fibrils (Figure 1.1) [5, 93].
Collagen makes up 15-20% of hyaline cartilage; Col II is the primary collagen type
in hyaline cartilage but collagen types I, VI, IX, X and XI are also present [213]. Col II
is a fibrillar homotrimer collagen which acts throughout the extracellular matrix to resist
tensile forces and prevent over-swelling of the matrix [104, 189]. Collagen type I (Col I)
is also a fibrillar collagen, found in small quantities in the superficial zone of cartilage but
in high quantities in fibrocartilage, a mechanically inferior form of cartilage often formed
following cartilage injuries. It is also highly expressed in chondrocytes following expansion
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Figure 1.1: Hierarchical collagen fibril assembly. Adapted from Athanasiou et al. [5]
in monolayer so is a key marker of dedi↵erentiation of chondrocytes in culture [32].
Collagen types IX and XI are involved in templating, crosslinking and diameter
control of Col II fibres [44, 213]. Collagen type VI is found in the pericellular matrix and
interacts with chondrocyte receptors, while collagen type X is found at the tidemark, in
calcified cartilage and is also expressed by hypertrophic chondrocytes [213].
Proteoglycans
Proteoglycans form as a core protein with glycosaminoglycans (GAGs) covalently bound
to them. The proteoglycans found in cartilage include biglycan, decorin and aggrecan
which is the most abundant. Aggrecan is a core protein which assembles into a bottle
brush structure with keratan sulphate (KS) and chondroitin sulphate (CS) groups cova-
lently bound to it (Figure 1.2) [219]. The aggrecan core is non-covalently bound to a
hyaluronic acid backbone, so a small glycoprotein (link protein) stabilises the interaction
to allow for the aggregation of aggrecan (Figure 1.2) [77, 219]. The carboxyl groups of
CS and sulphate groups of KS and CS give the proteoglycan network a highly negative
charge. This results in a repulsion between chains referred to as fixed charge density
(FCD) [189].
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Figure 1.2: Cartilage proteoglycan structure; aggrecan cores with sGAG chains are at-
tached to a hyaluronan back bone by a link protein.
Water
Hyaline cartilage consists of 70-80% water which fills the macropores between the collagen
and proteoglycan networks. FCD provided by KS and CS in combination with repulsion
between neighbouring negatively charged chains results in a high osmotic pressure [74,
122]. In healthy cartilage this pressure is compensated by the Col II network which
restricts over-swelling. Water is critical to cartilage’s longevity over repetitive loading in
a lifetime; compression results in a fast pressurisation of the confined fluid such that the
fluid bears the compressive loading, rather than the solid matrix components [74]. This
fluid is also important for the delivery of nutrients and removal of waste from chondrocytes
and any matrix breakdown products [87].
1.2.4 Regional organisation of cartilage
The articulating surface
The cartilage surface has a thin layer, the lamina splendens, that is around 300-1000 nm
thick [117]. It is an acellular region that facilitates the low friction properties of cartilage
by the mucinous glycoprotein lubricin which covers the articulating surface. It acts by
preventing cell and protein adhesion to the cartilage surface [89].
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Figure 1.3: Gradient structure of cartilage showing collagen fibril orientation (left) and
chondrocyte morphology (right). SZ: superficial zone, MZ: middle zone, DZ: deep zone,
TM: tidemark, CC: calcified cartilage, SCB: subchondral cortical bone, STB: subchondral
trabecular bone.
The superficial region
Just beneath the lamina splendens is the superficial zone (SZ), which comprises 10-20%
of the cartilage thickness [202]. Chondrocytes here are slightly flattened and secrete
superficial zone protein (SZP), also known as proteoglycan-4 (PRG4), which helps in
lubrication of the articular surface [193, 194]. Col II fibrils here have a small diameter
and are aligned parallel to the articulating surface to resist shear forces. There is a
relatively low proteoglycan content in this region.
The middle zone
This central region of cartilage makes up 40-60% of the thickness and has spherical chon-
drocytes that start to form columns towards the deep zone [202]. Cartilage intermediate
layer protein (CILP) is highly expressed by these chondrocytes [115]. Col II fibrils here are
randomly oriented and of larger diameter than in the superficial zone and proteoglycan
content is at its highest.
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The deep zone
The deep zone (DZ) of cartilage has large diameter collagen fibrils oriented perpendicular
to the articulating surface. These are anchored into the calcified region. Chondrocytes
here are organised into columns and are slightly elongated in the direction of the collagen
fibrils.
The tidemark and calcified zone
The tidemark (TM) is a distinction visible in histology that marks the region between
non-calcified and calcified regions. Beneath the tidemark, cartilage transitions to calcified
cartilage (CC) where collagen type X is present and the collagen fibril diameter is at its
largest. Beneath CC, is the subchondral cortical bone (SCB).
1.3 Bone
Bone is a highly mineralised tissue of two main types: cortical (or compact) and trabecular
(or spongy). Its main solid constituents are Col I and hydroxyapatite (HAp) which are
the basis of the commonly described hierarchical structure of bone [229]. The 206 bones
of the skeleton serve many functions in the body. The long bones allow for movement by
insertion and attachment points for tendons that are attached to muscles and ligaments
that prevent joint dislocation. They also have a large marrow cavity which is the major
site of production of blood cells and so the long bones are highly vascularised. Short bones
such as the carpus and tarsus allow for small amounts of movement and stability. The
flat bones such as the sternum and cranial bones provide protection to delicate organs
while irregular bones such as the vertebrae have varied functions. Finally the sesamoid
bones are those embedded in tendons such as the patella.
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1.3.1 Osteoblasts, osteoclasts and osteocytes
The cells involved in the formation and regulation of bone act synergistically resulting
in a dynamic tissue with high levels of turnover and remodelling. Disruption to the
biochemical balance can result in diseases of under or over-mineralisation of bone [203].
Osteoblasts
These are the matrix-forming cells of bone and make up around 5% of the cells present in
bone [52]. They are derived from a mesenchymal lineage, and key di↵erentiating osteoblast
markers include Runt-related transcription factor (RUNX2), osterix (OSX) and distal-less
homeobox 5 (DLX5). Fully di↵erentiated osteoblasts can be identified by the expression
of Col I (COL1A1 and COL1A2), alkaline phosphatase (ALP), bone sialoprotein (BSP)
and Bone Gamma-Carboxyglutamate Protein (BGLAP) [45]. As these cells produce high
levels of protein, they have large amounts of rough endoplasmic reticulum, free ribosomes,
large Golgi apparatus and mitochondria. Mature osteoblasts produce Col I, proteoglycans
and other proteins to form the non-mineralised osteoid [205].
Osteoclasts
Osteoclasts are responsible for bone resorption and are derived from a macrophage lin-
eage [205]. They are multinucleated and have a ru✏ed region of the cell membrane that
interacts with the bone matrix during resorption. The production of osteoclasts is de-
pendent on the expression of osteoprotegerin (OPG) from osteoblasts. Receptor activator
of nuclear factor kappa-B ligand (RANKL) is a key cytokine for osteoclastogenesis from
macrophage precursors in the bone marrow but interaction of precursors with OPG pre-
vents the binding of RANKL to the RANK receptor of the osteoclast. Therefore, the
relative levels of OPG and RANKL are important in the di↵erentiation of osteoclasts and
hence, the regulation of bone remodelling [52].
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Osteocytes
Prior to osteoid mineralisation, around 20% of osteoblasts become entrapped in the matrix
and are referred to as pre-osteocytes [205]. During mineralisation, these cells form long
processes (canaliculi) that allow communication between these deep embedded cells and
those on the bone surface. Osteocytes have an important role in mechanosensing to trigger
changes in bone remodelling [203].
Bone remodelling
Osteocytes have canaliculi in the range of tens of microns in length, which allow for both
sensing and communication of mechanical forces in bone [10]. The remodelling process is
driven by the local mechanical environment as stated by Wol↵’s law. The magnitude and
direction of loading determine the rate of bone formation and the architectural arrange-
ment of trabecular bone, followed by changes to the cortical bone. Together, osteoblasts
and osteoclasts make up bone multicellular units, which are responsible for bone remod-
elling [3]. Bone resorption by osteoclasts is followed by bone formation by osteoblasts. As
above, the RANK/OPG balance regulates the rate of bone remodelling and an imbalance
can cause over- or under-mineralisation [203].
1.3.2 Bone extracellular matrix
Organic matrix
Collagenous proteins make up 85-90% of the organic matrix of bone; Col I is the main
collagen type present alongside collagen types III, V and X. Col I is critical to the structure
of bone and is the basis of the hierarchical bone structure. It is a heterotrimer, with
two alpha-1 chains and one alpha-2 chain however these ratios can change with disease
[165]. Other non-collagenous proteins present in bone include glycoproteins, lipids and
glycosaminoglycans which make up the other 10-15% of the organic matrix [52].
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Inorganic matrix
Calcium, phosphate and carbonate were first identified as the major bone constituents
and then confirmed to be present in the form of HAp using x-ray di↵raction in 1930 [183].
HAp (Ca10(PO4)6(OH)2) is the main inorganic component of bone, making up 70% of
the inorganic matrix. However, HAp is often not completely pure; the most common
substitution is of a carbonate anion in place of a phosphate group or (less commonly) a
hydroxyl group [229]. There have also been trace amounts of Mg, Na, Si, Sr, Zn and Pb
found associated with bone mineral [86].
1.3.3 Hierarchical organisation of bone
Bone is hierarchical in nature; the collagen triple helix assembles as described in Figure
1.1 and in fibril assembly, very thin (3 nm), cuboidal HAp nanocrystals align in the gaps
between collagen fibres as in Figure 1.4 [227]. This forms mineralised fibrils which stack
into lamellae which then further align depending on whether they form in cortical or
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Figure 1.4: Hierarchical bone structure; adapted from Wegst et al. [227].
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Cortical bone
In cortical bone, the smallest functional unit is an osteon. These are cylindrical structures
formed of sheets of collagen fibrils. The sheets wrap concentrically at 90° to the previous
sheet with a central space referred to as a Haversian canal [3]. As can be seen in Figure
1.4, Haversian canals contain blood vessels that supply the length of the bone and are
connected to Haversian canals of neighbouring osteons by Volkmann’s canals [171]. These
are the other vessel-containing channels in long bones and they run perpendicular to the
Haversian canals. The tight packing of osteons makes cortical bone very dense with a
high fracture toughness (critical stress intensity factor, kc = 3.5-5 MPa) [146].
Trabecular bone
Trabecular (or spongy) bone is found in the medullary cavity. It is sponge-like in appear-
ance, with variable porosity. Regarding its hierarchical organisation, sheets of collagen
fibrils are aligned parallel longitudinally along trabeculae [176]. Trabecular bone is more
metabolically active than cortical bone, and its porosity and architecture are highly af-
fected by mechanical loading [229]. The orientation and porosity of trabeculae varies
between locations as a result of mechanical influences; this is clearly seen in the proxi-
mal femur (Figure 1.5) where the trabecular bone in the femoral head is less porous and
becomes more porous distally.
1.4 Osteoarthritis and cartilage lesions
OA is a chronic degenerative disease of the synovial joints; commonly seen in the knee
and hip, it is also found in the ankle, shoulder and hands [4]. It is historically associated
with wear and tear of articular cartilage, however it is more complex in that many of the
joint tissues are disrupted [113]. Repetitive cyclic loading of joints is thought to be the
key driver of OA, but age, obesity, joint trauma, genetic factors as well as changes to joint
alignment and shape can increase the likelihood of developing OA [58, 67, 156].
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Figure 1.5: Trabecular architecture in the proximal femur. Photo: Paul Crompton, Copy-
right University of Wales College of Medicine.
1.4.1 Cartilage in OA
In healthy cartilage, normal loading maintains matrix homeostasis [67]. In OA, cartilage
degradation is a gradual but irreversible sequence of events (Figure 1.6) [5]. The first
change to cartilage is its increased ability to hold water as a result of degradation of both
the proteoglycan and collagen networks [21, 179]. The proteoglycan matrix is primarily
broken down by aggrecanases that are members of the ADAMTS (a disintegrin and met-
alloproteinase with thrombospondin motifs) family alongside other proteins [53]. Multiple
sites in the aggrecan core protein are cleaved which has a large e↵ect on the mechanical
properties of the cartilage matrix, however, this first stage is clinically silent [5, 67].
At some stage during aggrecanolysis, the collagen matrix begins to be broken down
by both matrix metalloproteinases (MMPs) and physical, mechanical forces. This degrada-
tive process begins in the superficial zone and develops through to the deep zone [235].
Breakdown of the Col II matrix reduces the elastic restraint on the proteoglycan and wa-
ter components, allowing the tissue to swell [216]. Extensive collagenolysis is irreversible
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Figure 1.6: Sequence of events in OA-associated cartilage degradation, adapted from
Athanasiou et al. [5].
.
in vivo, therefore with normal loading, cracks and fissures start to appear in the cartilage
surface [59]. This is associated with increased pain as the aneural cartilage is removed and
the neural subchondral bone is exposed [61]. Cartilage calcification (chondrocalcinosis) is
often seen in older people with OA, and HAp-based deposits may be responsible for the
increased production of inflammatory mediators such as IL-1 and IL-18 [112, 141].
Chondrocytes
Alongside matrix changes, there are also distinct changes to chondrocytes in OA. Changes
in the mechanical signals that chondrocytes are exposed to can both change the function
of chondrocytes and cause apoptosis, as they are highly mechanosensitive through cell
surface mechanosensors [61, 67, 69]. In early stages of disease, chondrocytes become more
metabolically active in attempting to repair the matrix and undergo increased prolifer-
ation [5]. During this proliferative stage, chondrocytes show an increase in expression
of COL10A1, MMP13 and RUNX2; structurally, increased proliferation results in cell
clusters within a chondron [169]. As the disease develops chondrocytes produce increased
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levels of pro-inflammatory cytokines, MMPs and chemokines which have catabolic func-
tions and degrade cartilage [217]. The final process in OA chondrocytes is cell death;
increased cell numbers and insu cient levels of nutrients in the chondron causes cell
necrosis [5].
1.4.2 Bone in OA
There are changes to subchondral cortical and trabecular bone as well as formation of
bony spurs (osteophytes) in OA, all of which are specific to the stage of OA. Increased
loading leads to an increase in bone turnover as stated previously. In OA, there is region-
specific thickening of the subchondral cortical and trabecular bone as seen in Figure 1.7
[59, 111]. There is also thinning of the epiphyseal trabecular bone which is likely due to




Figure 1.7: Reconstructed µCT image of an OA tibial plateau (sagittal plane) showing
thickening of the subchondral cortical bone (SCB) where cartilage (C) is thinning or
completed degenerated. The subchondral trabecular bone (STB) architecture is also
irregularly thickened.
.
Excessive loading that occurs when cartilage is completely degraded can lead to
bone marrow lesions and bone cysts. These defects in the bone have been associated with
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increased pain in OA and may be initiated by local damage and subchondral bone necrosis
[20]. Another pathological bone condition in OA is the development of osteophytes at the
joint margin. Abnormal proliferation of periosteal cells causes the development of these
bony protrusions that are radiographic indicators of OA [14, 113].
1.4.3 Inflammation in OA
OA was historically considered as a simple ‘wear-and-tear’ disease, however it is now
well-known that inflammation is an important consideration in OA progression. The
commonly accepted series of events that occur during the inflammatory response are
summarised in Figure 1.8. Matrix fragments, which are a result of either traumatic dam-
age or degradation by catabolic enzymes, act as DAMPs (damage-associated molecular
patterns) [114]; DAMPs prompt an inflammatory response in the synovium, where syn-
ovial fibroblasts and macrophages produce catabolic enzymes, chemokines and cytokines
[217]. These cells also secrete a number of alarmins, including interleukin-1↵ (by the
macrophage inflammasome), adenosine triphosphate (ATP), heat shock proteins (HSPs),
and uric acid (UA). These alarmins induce a positive feedback loop where more catabolic
enzymes, chemokines and cytokines are produced in the synovium as well as the bone and
cartilage [217].
Overall, this results in a highly inflammatory environment in the joint space such
that even the menisci and ligaments are a↵ected, with increased vascularisation and min-
eral deposition in the menisci and collagen fibre disorganisation in ligaments [113]. In
overweight and obese subjects, there is the additional insult of inflammatory adipokines
that have been found in the synovial fluid [166, 170].
19
Figure 1.8: Schematic representation of inflammatory processes in OA progression,
adapted from van den Bosch [217].
.
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1.4.4 Current treatment strategies
Common clinical presenting symptoms of OA are single-joint pain in loading alongside
reduced mobility in people over the age of 50. Radiographic narrowing of the joint space
is the most common clinical diagnosis. There are currently no disease-modifying thera-
peutics available for the treatment of OA, however, pain relief and steroid injections are
commonly prescribed to alleviate symptoms [214]. When OA reaches ‘end-stage’, and
there is bone-bone contact in the joint, patients are referred for partial or total joint re-
placement surgery. This involves the removal of the joint surface, drilling a cavity in the
neighbouring long bone and inserting a prosthetic implant.
1.4.5 Cartilage lesions and clinical treatments
Traumatic damage to the cartilage surface is fairly common in joint injuries, particularly
in the knee joint. In a damaging loading event, the superficial region of cartilage can
be abraded resulting in a cartilage lesion. Due to its avascular nature, cartilage lacks
an inherent capacity for repair so left untreated, normal mechanical loading can cause
these lesions to become larger. As a result, people who experience cartilage lesions are
predisposed to the development of OA [200]. Clinically, these lesions are diagnosed by
MRI and arthroscopic investigations; lesions with the potential to develop further are
then treated, often using one of the following techniques.
Debridement
This is the simplest of the treatments and is carried out arthroscopically. Damaged
cartilage is excised from the joint to allow for new tissue to form. This technique has




This procedure was developed in the late 1990s by Steadman et al. [204]. Firstly, the
damaged cartilage is debrided down to the subchondral bone before small canals are drilled
through the cortical bone. Bone marrow is then able to flow into the debrided region to
form a blood clot, or haematoma [200, 204]. Pluripotent stem cells from the bone marrow
are then left to di↵erentiate into chondrocytes to form cartilage matrix. Unfortunately
the matrix that forms is not hyaline in nature, and is referred to as fibrocartilage. Whilst
visually similar to hyaline cartilage, the type and organisation of collagen fibrils is not the
same as hyaline cartilage. As a result, the mechanical properties of this tissue are inferior
to hyaline cartilage and it is prone to fragment [130].
Autologous chondrocyte implantation
The first stage in autologous chondrocyte implantation (ACI) involves taking a small
cartilage biopsy from a non-articulating region of the joint. The tissue is then digested
to isolate a population of chondrocytes which are expanded in vitro. When su cient
numbers of cells have been produced, they are re-implanted into the cartilage defect and
secured with a periosteal flap [37, 218]. An advantage of ACI over microfracture is the
use of cartilage-derived cells rather than bone-marrow cells so there is a better chance
of high quality hyaline cartilage formation. However, there is still high prevalence of
fibrocartilage formation as chondrocytes de-di↵erentiate during their monolayer culture
in vitro and start expressing Col I [180]. Further limitations include morbidity of the
tissue at the site where the initial biopsy is taken from (donor-site morbidity) and there
have been cases where the periosteal flap has delaminated from the soft tissue [37].
Mosaicplasty
This technique was first developed in 1993 and has had fairly good clinical uptake since
[123]. In mosaicplasty, cylindrical osteochondral cores are removed from a non-articulating
region of the joint. The defect site is then debrided and drilled similar to in microfracture
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surgery, before the cores are implanted into the defect site and secured [75]. A key
advantage of this technique is the transplantation of already mature, autologous hyaline
cartilage. Similar to ACI, there is the chance of donor site morbidity and there is limited
evidence of lateral integration with the existing cartilage [200].
1.4.6 Summary
The OCU is a complex, multifactorial tissue with distinct regions of precise biochemical
composition that give distinct mechanical properties. Self-repair of cartilage matrix is
intrinsically limited by its poor ability to regenerate. As a result, matrix alterations
due to trauma and degenerative changes in OA are largely irreversible. Increasing the
knowledge of the changes that occur in cartilage during OA that are not ‘wear and tear’
based is critical to developing and improving therapeutic tissue engineering strategies for
cartilage regeneration.
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1.5 Mechanical properties of materials
In the mechanical characterisation of materials, a force is applied to a test piece and its
displacement is measured (or vice versa). The conversion of force and displacement to
stress and strain respectively allows for the application of these parameters to di↵erent
test pieces and testing modalities.
1.5.1 Stress, strain and modulus
Stress ( ), measured in Pascals (Pa) refers to force per unit area as described in Equation
1.1. Strain (✏) is unitless but often described as a percentage and refers to the change in










The ratio of these two parameters, the stress experienced by a material as a result of
an applied strain, is referred to as the modulus and describes the resistance to deformation
of a material. There are many modalities of mechanical testing which result in di↵erent
modes of stress application and as such, di↵erent equations are required for calculation
of specific moduli. Young’s (or elastic) modulus (E) is the most commonly described and
is determined by compression and tensile testing of solid materials. It presumes that the
material obeys Hooke’s law which states that stress is proportional to strain (Equation
1.3). It describes perfectly linear elastic behaviour, as shown to the left of the dashed line
in Figure 1.9, where a material can be deformed and will immediately return to its original
dimensions when the stress is removed. Young’s modulus is calculated from this region as
a ratio of stress and strain (Equation 1.3). For most solids, this linear behaviour is only
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seen at low strains; above a threshold referred to as the yield stress, the deformation is
no longer recoverable. Solid materials then exhibit a phase of plastic deformation prior














Figure 1.9: Typical solid stress-strain behaviour. The elastic region left of the dashed
line shows linear, recoverable behaviour whereas the plastic region to the right shows
permanent deformation leading to failure.
1.5.2 Viscosity
Viscosity is a parameter traditionally associated with fluids rather than solids. It de-
scribes a material’s resistance to flow when subjected to a shear or tensile stress. Impor-
tantly, viscosity is not a material constant and may be dependent on other factors such
as temperature. Newtonian fluids are those whose viscosity is independent of stress and
exhibit linear shear stress/shear strain behaviour, such as water. Most polymer solutions
and biological fluids are non-Newtonian in that their viscosities are dependent on stress.
Shear-thickening materials, such as a mixture of cornstarch and water, show an increase
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in viscosity with an increased shear stress due to coalescence of colloids. Shear-thinning
materials such as paint show a decrease in viscosity with increasing shear stress but the
recovery of viscosity is very fast. Thixotropic materials such as ketchup also show shear-
thinning behaviour but exhibit more time dependent recovery of viscosity upon removal














Figure 1.10: Newtonian and non-Newtonian fluid behaviour.
1.5.3 Viscoelasticity
The term viscoelasticity refers to materials that exhibit both solid-like (elastic) and liquid-
like (viscous) properties. Purely elastic materials, such as metals, act like a spring in
that they strain when a stress is applied and then immediately return to their original
state when the stress is removed. Purely viscous materials, such as honey, show time
dependent stress-strain behaviour and act like a dashpot. These components are modelled
together by the Maxwell and Kelvin-Voigt models (Figure 1.11). In the Maxwell model,
the spring and dashpot are arranged in series (Figure 1.11A), such that the stresses in
each component are identical but the strains can vary. Contrastingly, in the Kelvin-Voigt
model, the two components are arranged in parallel (Figure 1.11B) to model identical
strains in each component and the stresses experienced can be di↵erent.
The separate elastic and viscous components are characterised by the storage mod-
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Figure 1.11: Maxwell (A) and Kelvin-Voigt (B) models of viscoelasticity where elastic
behaviour is modelled as a spring and viscous behaviour as a dashpot.
ulus (E’) and loss modulus (E”) respectively. The storage modulus describes the rigidity
of the material and its ability to store energy that is then used to recoil elastically when
a stress is removed. The loss modulus refers to the materials ability to dissipate energy
by polymer chain reorganisation and friction. The energy lost by a viscoelastic material
is seen in a hysteresis loop produced by loading and unloading cycles as in Figure 1.12.










Figure 1.12: Hysteretic stress-strain behaviour in viscoelastic materials.
Alongside the storage (E’) and loss (E”) moduli, complex modulus can be calculated
as Equation 1.4. Complex modulus (E⇤) at a certain frequency can be compared to
Young’s modulus at the same loading frequency, however Young’s only considers the
27
loading and not unloading of a material. This modulus can be calculated from loading





E 0 + E 00 (1.4)
Creep and stress relaxation
Viscoelastic materials exhibit creep and stress relaxation, which are time-dependent phe-
nomena. When held at a constant stress, viscoelastic materials show increasing strain,
which is referred to as creep. Stress relaxation explains how viscoelastic materials show
decreasing stress under a constant strain. This form of viscoelastic testing often has very
long time constants.
1.5.4 Mechanical analysis of cartilage
Cartilage has two mechanical functions: firstly, it provides a low friction gliding surface
for smooth joint articulation; secondly it acts to dissipate and transmit compressive forces
to the subchondral bone. The mechanical properties of cartilage vary between its regions
due to the collagen organisation and proteoglycan content, which give rise to their specific
functions [98]. For example, the surface region is strong in tension to resist shear defor-
mation, while the middle and deep zones are strong in compression to distribute loads.
In OA, matrix catabolism causes large reductions in the strength of the tissue [19, 67].
Further, the mechanical properties of articular cartilage vary between anatomical loca-
tion, species, disease and testing modality [98, 179]. Table 1.1 summarises some of the
investigations into the mechanical properties of human articular cartilage.
As Table 1.1 shows, there is variation in mechanical properties of cartilage between
joints and disease states. There is however, further variation within each joint. For ex-
ample, in the study by Peters et al., the shear modulus of cartilage was greater in the
femoral condyles than the tibial plateau [164]. Likewise, in the study by Burgin, the mod-
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Table 1.1: Values obtained for mechanical testing of human articular cartilage. FH:
femoral head; TP: tibial plateau; FC: femoral condyle. All units are MPa except for
creep, measured in %.




















































OA FC G 0.83-3.38 [221]
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ulus values were varied across the regions of the femoral heads investigated [19]. Further,
age plays an important role in the mechanical properties of cartilage, as was thoroughly
investigated by Kempson et al. [97, 98]. These studies have primarily investigated the
static properties of cartilage, however, the viscoelastic properties are more relevant to the
overall function of cartilage.
Cartilage viscoelastic theories
Cartilage is a viscoelastic material, with time dependent mechanical properties. The carti-
lage matrix can be considered as a biphasic material consisting of 1) a solid matrix and 2)
the interstitial fluid. The mechanical properties of these individual components and their
interaction give the unique viscoelastic properties of cartilage. Interactions between the
proteoglycan and collagen networks due to physical entanglements, friction, chemical and
electrostatic interactions are responsible for flow-independent behaviour. The intersti-
tial fluid flowing through the porous matrix is responsible for flow-dependent behaviour.
Biphasic theory, developed by Mow et al. in 1980 brings these components together,
assuming a linearly elastic solid matrix with viscous properties and an incompressible
viscous fluid. This determined that the frictional drag between the two phases was pri-
marily responsible for the viscoelastic properties of cartilage in tension, compression and
indentation [119, 136, 137].
In 1987, Mak then considered the e↵ects of matrix permeability and inherent vis-
coelasticity of the solid matrix in developing the biphasic poroviscoelastic (BVPE) theory
[119]. This theory was then tested experimentally by Setton et al. in 1993 including in-
vestigations of the role of the surface zone. Their findings showed that in intact cartilage,
the flow-dependent behaviour dominates the dissipation of energy. Contrastingly, with
increasing tissue permeability, seen following removal of the surface region that could rep-
resent fibrillation of the articular surface in OA, the viscoelasticity of the solid matrix was
found to significantly change the energy dissipation properties of the tissue [196]. This
also showed how the surface region of cartilage is critical to maintaining fluid pressurisa-
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tion in the bulk tissue. Thus far, the simple solid-fluid interactions and behaviours had
been considered but the e↵ects of swelling had not. Lai et al introduced a third, ionic,
phase to consider the fixed charge density of the proteoglycan network in various ionic
solutions which is referred to as triphasic theory [102].
The viscoelastic creep response in cartilage is governed by fluid exudation. As a load
is applied, fluid moves out of the tissue. Cartilage has been reported to take between 4-16 h
to reach creep equilibrium where no further fluid is removed, so strain no longer increases
with constant loading. As such, dynamic mechanical analysis is a useful technique to
determine the viscoelastic properties of cartilage, with much shorter time constants. It
also enables investigations into the frequency dependent properties of tissues.
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1.6 Hydrogels in cartilage tissue engineering
Due to their high water content, hydrogels have been used as 3D ECM mimics for decades
[70, 84]. They show great potential to improve the current treatments for cartilage de-
fects as they enable the replication of a 3D ECM that has been shown to be able to be
remodelled by embedded chondrocytes [71]. 3D sca↵olds have been shown to be of high
importance in chondrocyte culture as they can recover and maintain the native Col II
phenotype that is lost in monolayer or 2D culture.
Hydrogels can be produced from a number of materials. Polysaccharides used in
cartilage engineering include: agarose, alginate, chitosan, CS, gellan and hyaluronic acid
as well as blends of these [16, 101]. Proteins used include: collagen, fibrin and silk. Lastly,
synthetic hydrogels such as PEGDA have been used as sca↵olds for chondrocytes and for
MSCs to di↵erentiate into chondrocytes and to produce cartilage-like ECM. Of these
di↵erent hydrogels, and blends of multiple hydrogels, alginate has shown wide success in
maintaining chondrocyte phenotype and allowing the production of cartilage matrix.
1.6.1 Alginate
Alginate (or alginic acid) is a linear polysaccharide derived from brown algae, formed of
D-mannuronic acid (M) and L-guluronic acid (G) residues (Figure 1.13). Upon dissolution
in water alginate forms a hydrocolloid which can then be gelled upon the introduction of
multivalent cations such as Ca2+, Sr2+ and Ba2+ [108]. These cations form electrostatic
interactions with the carboxyl groups of G residues, to form an ‘egg-box’ structure as
shown in Figure 1.14. Therefore, the ratio and pattern of M and G residues has a large
impact on the properties of alginate gels, as does the type of multivalent cation used
[108]. The ratio and pattern of residues depends on the source of the raw material so
the simplest way to tailor the gel properties are with the concentration of alginate and
crosslinking cation used. Alginate has been investigated for use in cartilage engineering
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Figure 1.13: Chemical structure of a unit of an alginate chain showing guluronic acid (G)




















































































Figure 1.14: Chemical structures of the egg box structure formed between guluronic acid
groups upon crosslinking with divalent cations such as calcium (Ca2+).
1.6.2 Gellan gum
Gellan gum is a linear polysaccharide produced by the bacteria Sphingomonas elodea.
Its primary structure has tetrasaccharide repeating units containing  -D-glucose,  -D-
guluronic acid and ↵-L-rhamnose in a 2:1:1 ratio as shown in Figure 1.15. Gellan is
available, and will form gels, in both acetylated and deacetylated forms, as well as varying
degrees of acetylation. Highly acetylated gellan undergoes thermogelation at around 42￿,
which makes it suitable for cell culture applications. Upon dissolution in heated water,
gellan exists as a coiled polymer solution (Figure 1.16). Upon cooling, it forms coiled coils
and with the addition of divalent cations, ionic bonds can form between these coiled coils
to form a sti↵er, but no longer thermoreversible gel (Figure 1.16) [50]. Gellan gum is FDA
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approved for use as a food additive and has been investigated for both food and biomedical




















Figure 1.15: Chemical structure of the repeat unit of low acyl gellan gum showing
from left-right the structures of  -D-glucose,  -D-guluronic acid,  -D-glucose and ↵-
L-rhamnose.
Figure 1.16: Gellan gum structure upon thermal and ionic crosslinking.
1.6.3 Fluid gels
The properties of materials can be precisely controlled by the way in which they are
processed and also the way in which they are structured [26, 147]. Fluid gels have long
been used in the food and cosmetics industries but research into their use in biomedical
applications is relatively new [148].
Fluid gels are produced by introducing shearing forces during their gelation resulting
in a network of entangled polymer particles as shown in Figure 1.17B. The key property
of these materials is that they exhibit solid, weak-gel like properties at rest but upon
application of shear they exhibit liquid-like flowable properties. Depending on the polymer
used, the rate of shear applied and the method of inducing shear, the particle morphology
and size can be controlled as shown in Figure 1.18. These morphological di↵erences
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Figure 1.17: Schematic of polymer networks following A) quiescent gelation and B)
sheared gelation to produce a fluid gel, from Cooke et al. [26].
have been shown to infer di↵ering mechanical properties, particularly in the solid-like
behaviour of the gel [42]. In this instance, the fluid gel produced with a pin stirrer, with
a ‘hairy particle’ morphology (Figure 1.18B) showed a higher yield stress (defined as a
5% deviation from the LVR) than the one produced in a rheometer (Figure 1.18A) [147].
This is likely due to stronger interaction between the extensions of the hairy particles
compared to the more spherical ones. Tuning these parameters can give rise to unique
rheological properties for the potential delivery of therapeutics, cells and other material.
Figure 1.18: Morphology of agar fluid gel particles produced either in a) a rheometer or
b) a pin stirrer; reproduced from [42].
35
1.7 Bioprinting and biofabrication
Biofabrication is a term that has been loosely for many years since the start of 3D printing
of biological components but recently a consortium of leaders in the field developed the
following definition:
“ The automated generation of biologically functional products with struc-
tural organization from living cells, bioactive molecules, biomaterials, cell
aggregates such as micro-tissues, or hybrid cell-material constructs, through
Bioprinting or Bioassembly and subsequent tissue maturation processes.” [65]
This clarifies the process as a way to produce biologically relevant structures from
cell-biomaterial mixtures, deposited in a specific way that are then matured into tissues.
The material that is extruded or deposited during this process is commonly referred to as
a bioink. Again, there was a lot of discussion in the field surrounding the exact definition
of a bioink and as such the following has been developed:
“ Formulation of material(s) and biological molecules or cells processed using
bioprinting technologies.” [134]
There are many parameters to consider during the printing phase of biofabrication
that a↵ect the fidelity of the print and the capability of the seeded cells to behave as
intended. These are summarised in Figure 1.19.
1.7.1 Methods of bioprinting and bioassembly
There are a number techniques for the printing of soft materials to act as cell sca↵olds.
Some of these focus on the production of a rigid support for cells (or a cell-seeded hydrogel)
to adhere to [100]. While this is an appropriate solution for some applications, other
tissues are not suited to rigid sca↵olds, even when they are degradable. As such, di↵erent
techniques have been developed and adapted for printing of soft materials and some of
the common ones are detailed.
Electrospinning was originally used in the textile industry but now has been adopted
in the fields of tissue engineering and regenerative medicine as a support for 3D cell culture
36
Figure 1.19: Considerations for printing technique; reproduced from Malda et al. [120].
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[238]. It can be used to produce large sheets of fibres produced from soluble polymers,
with fibre diameters ranging from a few microns down to the nanoscale [64]. The two
main features are aligned and random fibres, with the former allowing for control over
cellular behaviour with alignment along fibres [240]. A key limitation in electrospinning
is production of thick sheets of material, however, the development of melt electrostatic
writing (MEW) bridges the gap between electrospinning and fused deposition modelling
(FDM). By matching or exceeding the speed of filament extrusion with the speed of
the collector, highly ordered single fibre deposition can be achieved [18, 31, 124]. These
structures are limited to 2-3mm in height, but by applying a voltage to the nozzle during
extrusion the polymer jet is stabilised such that the fibres can be stacked without large
deposits of material that are seen when the jet is not stable. Using this approach, MEW
can be used to print structures up to 7mm in height [237]. These fabricated structures
have been used to reinforce hydrogel cultures of human chondrocytes, giving them similar
compressive mechanical properties to human articular cartilage. They were then capable
of withstanding a physiologically relevant loading regime and a cartilage-like matrix was
produced [224].
Ink-jet, or drop-on-demand, printing acts by depositing very small (1-100 picoliter)
droplets of liquid onto a print bed, close enough for them to then coalesce to form fibres,
without forming bulges [36, 207]. This can be used to produce structures containing
proteins and live cells [35, 190]. To produce 3D cell-seeded constructs by inkjet deposition,
Boland et al. deposited cell-seeded CaCl2 into a sodium alginate bath to produce sheets
of crosslinked microspheres with endothelial cells encapsulated in the voids [15]. This
approach has also been used to print microvasculature-like networks from fibrin gels and
HMVECs [29]. Further, cylinders of 4 mm height were printed from PEGDA with human
chondrocytes, demonstrating the capability of this technique to produce distinct zones
by simultaneous printing and photo-polymerisation of the PEGDA droplets [30]. A key
limitation of this technique, is the number of bioinks available as they must have very low
viscosity to produce picoliter droplets.
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One technique that removes the need for hydrogel sca↵olds is the production of
organoids (or spheroids) that are then assembled to fuse into larger structures. Organoids
are grown using suspension culture, where a mass of cells is grown in a droplet of media.
They are then usually assembled on needle arrays and allowed to mature to form a larger
sca↵old [128]. This technique was been used in the fabrication of hollow constructs for
tracheal replacement and verified in a rat model [211]. Recently, the concept of truly
sca↵old-free, label-free and nozzle-free fabrication has been demonstrated by the fusion of
spheroids of chondrocytes (chondrospheres) into millimetre-scale tissue constructs using
magnetic levitation [157]. In this study, the needle array usually required for assembly is
removed and instead, a paramagnetic solution of cell culture media and 50 mM gadolinium
was used in conjunction with a heterogeneous magnetic field with a central void (the
levitation point) which allowed the clustering of tissue spheroids for fusion. The resulting
fused construct had imperfections and voids, but cell viability was very good [157]. Overall
this technique shows a fascinating technological development to overcome many of the
limitations in biofabrication.
To enable the production of larger constructs, FDM has been used to print ther-
molabile polymers. FDM has been used for a long time in rapid prototyping using spool
fed polymer filament. The extrusion nozzle is heated, such that the material is liquefied
for deposition but quickly cools and solidifies on the print bed [242]. Multi-layer struc-
tures that are large in the z-direction can be produced. FDM has been used to produce
PCL/CaP sca↵olds that were capable of allowing the culture and osteogenic di↵erenti-
ation of MSCs seeded onto them with a fibrin glue [191]. Many studies have employed
PCL to print biodegradable sca↵olds, with the intention that they can be implanted and
resorbed as newly regenerated tissue matrix is laid down. Atala et al. developed a system
to print rigid, but biodegradable, PCL lattices along with cell-seeded hydrogels for the
production of large-volume tissue constructs [94]. This system was used to print sca↵olds
for mandible and calvarial bone as well as cartilage and skeletal muscle [94].
Bioplotting, or direct-writing, uses a similar technique to FDM, but the rigid sca↵old
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Figure 1.20: A consideration of the biofabrication window regarding hydrogel sti↵ness
and geometry complexity. Softer gels which allow for cell migration and o↵er high cyto-
compatibility are of too low viscosity for traditional techniques and so novel techniques
are required to overcome this limitation. Reproduced from Malda et al. [120].
is no longer required as the cell-seeded hydrogel is printed directly [11]. This is becoming
a widely used technique and has led to the development of many novel hydrogels to
enable direct extrusion. Methacrylated gelatin (GelMA) is a commonly used bioink for
direct printing of structures for cartilage tissue engineering and has been modified with
HA, PEG, PEGDA and graphene oxide to enhance its print properties [144, 195, 244].
Another material that has been modified for printability is hyaluronic acid. Another
application of methacrylation of established hydrogels for tissue engineering was achieved
by Burdick’s group; using methacrylated (and further modified) hyaluronic acid, they
were able to produce multi-layer constructs by direct bioplotting [153]. They developed
a system to ‘in-situ’ crosslink these formulations such that they gelled upon arrival on
the collector so there was very well controlled deposition of fibres to produce a lattice
structure [154].
Many hydrocolloid solutions commonly utilised in 3D cell culture by casting into
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moulds are of low viscosity prior to crosslinking into rigid hydrogel structures. A key
challenge in printing intricate structures from these materials is avoiding the inherent
instabilities of liquids; surface tension forces sharp features towards spherical shapes and
gravity causes sagging and buckling of printed lines. To overcome this, some bioplotting
strategies have used co-extrusion, where the hydrocolloid solution and crosslinker are
printed simultaneously for rapid solidification. Other techniques with photocrosslinkable
bioinks can also be directly crosslinked upon extrusion. These strategies are not suitable
for all bioinks, particularly those with longer crosslinking times such as collagen. These
limitations are summarised in Figure 1.20, in that the softer, lower viscosity gels which
show very good cytocompatibility are generally challenging to print into large geometries
with high shape fidelity [120]. As many of these softer materials are well established
as tissue engineering sca↵olds, novel strategies are being developed to overcome these
limitations.
1.7.2 Embedded printing
Embedded printing describes a group of techniques that can be used to produce hydrogel
constructs of greater complexity or shape-specificity without limitation over build direc-
tion, supports or overhangs. Embedded techniques were first published in 2011 and all
have a similar theme in that they use 3D support matrices in place of the traditional 2D
print bed for bioplotting. These matrices vary from viscous liquids through particulate
gel systems to solid gels with embedded phases, and some of the published techniques are
summarised in Table 1.2. One of the first embedded printing methods was ‘EMB3D’, de-
veloped by Lewis et al. in 2011 to print perfusable vascular networks in blocks of Pluronic
F127 [236]. Using a fugitive, unmodified Pluronic F127, a vascular network was printed
inside a liquid reservoir of modified Pluronic F127 that was subsequently photocrosslinked.
Simple liquification at 4￿ under vacuum allowed removal of the fugitive phase leaving an
embedded perfusable network. This group then developed the technique to print strain
sensors within stretchable elastomers for wearable strain sensing devices [142] and soft
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autonomous robots [228]. More recently, this group has used PDMS as a viscoplastic
matrix to further characterise the e↵ects of the support matrix on the extruded material
around the nozzle [66]. The key features of EMB3D are the production of multi-phase
components by the embedding of one phase within another fixed one. In this technique
the support matrix forms the final part, whereas more commonly, the support matrix is
sacrificial.
An example of this is a method that uses a hydrophobic fluid bath, developed
by Fischer et al. in 2012. Perfluorotributylamine is, like many fluorocarbons, highly
hydrophobic and has a density of 1.9 g cm 1 so can mechanically support the printing of
a water-based hydrogel [40]. This technique has been used to support printed constructs
for 6 months, shows high levels of cell viability, and was also used to direct osteogenic and
adipogenic di↵erentiation by changing the mechanical and physicochemical properties of
the printed hydrogels [40, 41].
Table 1.2: A summary of embedded printing methods used for bioprinting. ‘Matrix’ refers
to the sacrificial or support phase whilst ‘Ink’ refers to the material used for printing.
Method Matrix Ink Ref.























FRESH Gelatin slurry Alginate, Collagen,
Fibrinogen
[79]
FRE Carbopol PDMS [80]
In 2015, three distinct methods for embedded printing based on di↵erent sacrifi-
cial matrices were published. Highley, Burdick et al. developed a Guest-Host (GHost)
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writing print system in which supramolecular hydrogels (modified hyaluronic acid) were
printed into a second a hydrogel matrix of the same material in di↵ering ratios [78]. The
hydrogels used for both the bioink and the support material have non-covalent reversible
bonds, which are broken during shearing and rapidly reform when the stress is removed.
The bioink and matrix materials were also modified by methacrylation to enable covalent
crosslinking using UV light. Using this system they were able to print freeform geome-
tries including helices and embedded, perfusable vascular networks whilst achieving cell
viability of over 90% [78].
In the same year, a study utilised Carbopol as a granular gel media for embedded
printing [12]. Carbopol is a highly hydrophilic polymer that enables high resolution
printing of hydrophobic inks such as PS, PVA and PDMS. In this study, the authors
showed the possibility of printing polystyrene microspheres with features as small as 100
µm as well as printing human aortic endothelial cells (HAECs) directly into the gel. In
order to retrieve printed constructs from the gel, they were produced in PVA before the
Carbopol was washed away with water.
Freeform reversible embedding of suspended hydrogels (FRESH) is a technique de-
veloped by Feinberg et al. where the support matrix is a gelatin slurry [79]. The slurry
support was produced by first thermogelling a solution of gelatin before adding further
liquid and blending the gel into small (around 55 µm) particles. This material behaved
like a Bingham plastic and enabled the printing of alginate, fibrinogen and collagen using
a modified desktop FDM printer. Using this technique, alginate filaments of between
160-250 µm were extruded and helical structures were produced to show that the process
was truly freeform. The reversible aspect of this printing technique exists in the way that
the gelatin slurry can be liquified by heating to 37￿ and the printed part removed before
washing to remove residual gelatin. In a further study by this group, carbopol was used as
the support matrix to print PDMS. Using this method, they were able to print perfusable
bifurcating structures. To release the printed structure, the carbopol was again washed
away with aqueous solution [80].
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1.8 Thesis overview
General methods and techniques are described in Chapter 2 while specific methods are
presented in each of the data chapters. As a result, Chapters 3, 4 and 5 can be inter-
preted as single chapters as they are based on three separate published papers. Finally, a
summary of the findings, limitations of the studies and directions for future investigations




This chapter presents and describes the techniques used, specific methodologies are in-
cluded in the relevant data chapters.
2.1 Ethical approval
Ethical approval for the use of human tissues was granted by the University of Birmingham
and the United Kingdom National Ethics Research Committees:
• Chapter 3: Nottingham Research Ethics Committee (05/Q2403/24) and Derby Re-
search Ethics Committee (11/H0405/2).
• Chapter 4: East of Scotland Research Ethics Service (11/ES/1044).
• Chapter 5: Hertfordshire Research Ethics Committee (12/ EE/0136).
All patients, their families or next of kin provided consent for the use of these tissues.
2.1.1 Tissue preparation
Human joint tissue samples were donated by OA patients following total hip replacement
(THR) or total knee replacement (TKR) and were transported to the laboratory immedi-
ately after surgery, immersed in unsupplemented culture media. They were then stored at
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4￿ overnight to enable replicable processing times between samples. Post-mortem sam-
ples, from patients with no history of joint disease, were retrieved by Kingsmill Hospital
pathology service before being transferred to the laboratory, and were stored in the same
way prior to processing.
Cartilage was excised from the subchondral bone using a scalpel; care was taken to
ensure that full thickness cartilage was obtained. Cylindrical explants of varying diameters
were prepared from cartilage pieces using cork borers. Bone chips of 3-4 mm3 were
removed from the subchondral trabecular bone using bone scissors, and care was taken




Alginate solutions were prepared by the addition of medium viscosity sodium alginate
(M/G ratio: 1.56, Mw: 80,000 - 120,000, Sigma Aldrich, UK) to dH2O and heating to
85￿ for 1 h. The solution was then allowed to cool to room temperature.
Gellan gum preparation
Gellan gum solutions were prepared similarly; low acyl gellan gum (Special Ingredients,
UK) was added to dH2O and stirred at 85￿ for 1 h whilst stirring. Solutions were stored
in a water bath at 50￿ until use.
All hydrogel solutions prepared for cell culture were sterilised by autoclaving for 30
min at 121￿ and 1 bar.
Fluid gel preparation
Fluid gels were produced by the introduction of shear during crosslinking which can be
achieved using a rheometer, magnetic stirring or overhead mixing. For alginate, a 1.5%
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w/v solution was prepared as above and then added to a cup geometry in an AR-G2
rheometer (TA Instruments, USA). The solution was sheared using a vane geometry at
a shear rate of 500 s 1, whilst 10% w/v 200 mM calcium chloride was added drop-wise
over a period of 3 min. The solution was then equilibrated for 30 min at 20￿.
Agarose solutions were prepared by heating a 0.5% w/v low EEO agarose (Sigma)
in dH2O to 90￿. To form a fluid gel, this solution was then allowed to cool to room
temperature (20￿) whilst constant shear was applied at 700 rpm on a magnetic stirrer.
2.2.2 Nanocrystalline hydroxyapatite preparation
Nanocrystalline hydroxyapatite (nanoHAp) was prepared by the precipitation method re-
ported by Mobasherpour et al. [133]. 350 mL of 290 mM calcium nitrate tetrahydrate
(Sigma) solution was raised to pH 10 by the drop-wise addition of ammonium hydrox-
ide (NH4OH, 28-30% NH3, Sigma). 250 mL of 240 mM ammonium phosphate dibasic
(Sigma) was then added to the stirring calcium nitrate drop-wise using a burette, whilst
maintaining a pH between 9-11 with the addition of NH4OH. The resulting solution was
left stirring overnight before being centrifuged at 2000 x g for 5 min. The supernatant
was removed and the precipitate was washed with dH2O with agitation before centrifug-
ing again. This was repeated a further four times to remove residual ammonium. The
mineral content in solution was found to be 12% w/v by drying in an oven at 65￿ for 6
h.
2.3 Mechanical
2.3.1 Dynamic mechanical analysis
Both the solid-like and liquid-like components of viscoelasticity in cartilage were deter-
mined at a range of frequencies using dynamic mechanical analysis (DMA). Unlike stress
relaxation and creep which have long time constants, DMA allowed for the investigation
of short term loading e↵ects using the phase lag ( ) between load and displacement.
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A sinusoidal load was applied to the material and the displacement response was
measured as in Figure 2.1. A Fourier analysis was then performed of the load and dis-
placement waves. From this analysis, the magnitudes of the load (F* ) and displacement
(d* ), were obtained as well as the angular frequency (!, by equation 2.1) and time lag
(T ) [105, 125]. The complex sti↵ness (k⇤) was then calculated as equation 2.2.







The phase lag ( ) was calculated from the fundamental frequency waves determined
in the Fourier analysis using equation 2.3. In perfectly elastic materials,   = 0° while in
perfectly viscous materials   = 90°.






Figure 2.1: Example trace of out-of-phase load and displacement behaviour during cyclic
testing of a viscoelastic material. d⇤ magnitude of displacement; T  time lag; F⇤ magni-
tude of force.
With these values of complex sti↵ness (k⇤) and phase lag ( ), storage (k’ ) and loss
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sti↵ness (k”) were calculated using equations 2.4 and 2.5. These were then be further
converted to storage (E’ ) and loss (E”) modulus by dividing by a shape factor (SF ),
determined by the dimensions of the sample (equation 2.6 refers to a cylindrical sample
of diameter, d, and thickness, t).
k
0 = k⇤cos  (2.4)
k


















The viscoelastic properties of healthy and OA cartilage specimens were quantified using
a Bose ElectroForce 3200 testing machine and the accompanying WinTest 4.1 DMA soft-
ware (TA Instruments, USA). Prior to testing, cartilage specimens were fully hydrated
in Ringer’s solution (720 mg NaCl, 37 mg KCl, 170 mg CaCl2 in 100 mL dH2O, filtered
through a 0.22 µm filter) for 30 min before being removed from the solution for testing.
Cartilage specimens were placed on an aluminium base plate mounted on a 200 N load
cell and were loaded using a 20 mm cylindrical compression platen that made contact
with the articulating surface (Figure 2.2). Similar to previous cartilage studies, a sinu-
soidal compressive force of 16 to 36 N was applied to each specimen [43, 55, 161, 212].
As the cartilage specimens were 5.2 mm in diameter, the peak load of 36 N induced a
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peak stress of 1.7 MPa which is similar to the estimated physiological peak stress during
walking [241]. Before applying a frequency sweep, each specimen was preloaded to 3 N to
avoid initial slipping and subjected to two preconditioning cycles. 1500 and 3000 cycles
at 25 and 50 Hz respectively were applied, with 60 s between them, to achieve a dynamic
‘steady-state’ which has been stated to occur after around 1200 to 4500 cycles for ex vivo
cartilage [55, 125, 220]. Following preconditioning, eight di↵erent physiologically-relevant
sinusoidal frequencies (1, 8, 10, 12, 29, 49, 71 and 88 Hz) were applied to each cartilage
specimen in order of increasing frequency [55].
Figure 2.2: Mechanical testing set up for cartilage. Left: Aluminium compression platen
mounted for DMA tests. Right: Sharp needle attached for thickness measurements.
Specimen thickness
The thickness of each cartilage specimen was measured, for conversion of DMA sti↵ness
data to moduli, using a needle thickness test. A sharp needle was attached to the ma-
chine’s displacement transducer (1 µm resolution, Figure 2.2 right) and the needle was
pushed through the full thickness of the cartilage specimen. The displacement of the
needle from initial contact with the cartilage (Figure 2.3 (a)) to contact with the base
plate (Figure 2.3 (c)) was calculated as the cartilage thickness.
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Figure 2.3: Thickness test displacement and load trace. a) initial contact between needle
and cartilage, b) point at which the needle overcomes the surface tension and breaks
through the surface, c) point at which the needle reaches the aluminium base plate.
Thickness is calculated as the displacement between points a and c.
2.3.2 Stress relaxation
Stress relaxation was measured using a Bose Electroforce 5500 (TA Instruments). Each
cylindrical hydrogel sample was displaced to 20% strain and the displacement was main-
tained for 5 min whilst the change in load (N) was measured using a 22 N load cell.
Sample dimensions (length, L) were measured using a vernier caliper (10 µm resolution).










Rheology is a branch of mechanical characterisation that considers the deformation and
flow of materials, especially the non-Newtonian flow of liquids and the plastic flow of solids.
Oscillation was applied at a range of shear rates and frequencies and the resistance to
flow of the material was measured. The shear storage modulus and loss modulus were
determined similarly to in DMA by calculating the out-of-phase displacement of the stress
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and strain amplitudes.
From the shear storage (G’ ) and shear loss (G”) modulus the complex shear modulus
(G⇤), phase angle ( ) and complex viscosity (⌘⇤) were determined using equations 2.11,
















All rheological characterisation was performed using an AR-G2 rheometer (TA in-
struments, USA). Fluid gels were tested using 40 mm sandblasted parallel plates with a
350 µm gap, while quiescent gels were tested using serrated plates with a 1000 µm gap.
In all rheological characterisation, an initial stress sweep was performed to determine the
region in which the viscoelastic behaviour was constant (linear viscoelastic region, LVR).
Frequency sweeps were then performed at a constant strain to determine the frequency
dependent moduli. Shear thinning behaviour was investigated by ramping the shear rate
and measuring the change in viscosity. Specific rheological methods are detailed in the
relevant chapters.
2.4 Physicochemical and Imaging
2.4.1 Thermogravimetric analysis
Thermogravimetric analysis (TGA) uses a very precise (1 µg resolution) balance to mea-
sure mass change in relation to temperature in order to collect information about physical
phenomena such as phase transitions. Due to its high measurement accuracy, it can be
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used to determine the specific temperatures at which these transitions occur.
The mass change relating to water loss in healthy and OA cartilage samples was
measured using TGA in air. Cartilage explants were heated from 25-250￿ at a rate of
1 K.min 1 and gas flow rate of 30 ml.min 1 using a TG209 F1 (Netzsch, Germany) in
aluminium oxide crucibles with lids (Netzsch, Germany). A background correction of the
crucible environment was performed prior to testing cartilage samples. The mass was
measured continually during heating and the change in mass plotted. The rate of mass
change was calculated by the accompanying Netzsh TA4 software (Netzsch, Germany).
2.4.2 Micro X-ray fluorescence spectrometry
X-ray fluorescence spectrometry (µXRF) provides information about the spatial distri-
bution of elements in a sample. X-rays produced by the instrument displace electrons of
the inner shells of an atom. This induces an instability in the atom which is immedi-
ately corrected by movement of an electron from the next outer shell to fill the valency.
Electrons closer to the nucleus have a lower binding energy than those further away, so
transition to fill a valency results in a loss of energy. This energy is emitted as a K↵ x-ray
which is then detected by the instrument. The energy of the emitted x-ray is unique to
the element as the distance between orbital shells is specific to each element.
Benchtop µXRF mapping was performed using an M4 Tornado and accompanying
software (Bruker, Nano Gmbh, Berlin, Germany). The x-ray tube voltage was set to 50
kV and the tube current set to 500 µA with a pressure of 200 mbar to enable the detection
of low K↵ elements. For cartilage, 30 µm sections (see 2.5.1) on glass slides were scanned
with a pixel size of 20 x 20 µm by the beam rastering across the sample at a scanning rate
of 100 ms/px. Following data acquisition the maximum pixel intensity for each element
was normalised across all sections.
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2.4.3 White light interferometry
White light interferometry (WLI) is used to measure surface profiles and is commonly
used to image electronic circuitry. An incident beam of white light is split to divide it
between a reference plane and the test object. The reflection of white light from the
reference and sample cause changes in the optical interference. This is detected by the
CCD of the interferometer and processed to build a 3D profile which can then be analysed.
A MicroXAM Interferometer (KLA Tencor, UK) was used to map and quantify
surface roughness (Sa) of healthy and OA cartilage explants both untested and after
DMA testing. For each 5.2 mm diameter cartilage explant, 9 216 x 198 µm regions were
imaged. The surface roughness (Sa) was then calculated using Scanning Probe Image
Processor software (Image Metrology, Denmark).
2.4.4 Scanning electron microscopy
Scanning electron microscopy (SEM) uses a focused beam of electrons to image a sample.
The interaction of electrons with atoms in the surface causes secondary electrons (SE)
to be emitted, which are then detected to produce topographical information about the
sample. The high focus of the beam gives a large depth of field resulting in an image with
a 3D appearance.
Hydrogel samples were frozen at -20￿ before being dried under vacuum at -56￿
for 48 h (Mini Lablyo, Frozen in Time, Ltd., York, UK). They were then mounted onto
conductive carbon tape for imaging. SEM was performed using a TM3030Plus benchtop
instrument and accompanying software (Hitatchi, USA) with a beam acceleration voltage
of 15 kV.
2.4.5 Micro computed tomography
Computed tomography uses x-rays and the relative attenuation of the sample is measured
by the detector. In µCT, the sample is mounted on a rotating stage that moves in steps
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of fractions of degrees to produce a series of images. These are then reconstructed to
produce a vertical stack that can be visualised as 3D volumes.
µCT was performed using a Skyscan 1172 and accompanying software (Bruker, Ger-
many). Scan parameters were specific for the material being analysed but all scanning
was performed as 180° scans with 3 frame averaging. Prior to scanning, a flat-field cor-
rection was done to remove background artefacts such as the container in which samples
were scanned. Following scanning, data was reconstructed in NRecon (Bruker) to build a
3D volume. Alignment adjustments and 2D measurements (e.g. cartilage thickness) were
performed in DataViewer (Bruker). Further 2D and 3D analyses of the reconstructed
data were performed in CTAn (Bruker). Regions of interest were defined and then data
was thresholded to remove non-sample objects before morphological operations, such as
despeckling, erosion and dilation as necessary before analysis. 3D volumes were visualised
in CTVox (Bruker).
2.4.6 Phase contrast microscopy
Phase contrast microscopy uses slight variations in refractive index to image transparent
samples. A phase ring blocks a large amount of light coming from the source, but when a
sample is inserted, it scatters part of the light which is then refocused on the detector so
that an image can be produced. Phase contrast microscopy for the visualisation of fluid
gel structures was performed using a Leica DM 6000B.
2.4.7 Confocal laser scanning microscopy
Confocal microscopy enables imaging of a single focal plane, by passing a laser beam
through a small aperture which is then reflected o↵ a dichromatic mirror and focused by
an objective lens. By rastering across the sample, a single plane image can be produced.
Z-stacks are produced by scanning sequential layers of a sample which can then be re-
constructed as a 3D image. Confocal microscopy of fluorescently labelled samples was
performed using an FV1000 (Olympus, Germany) and 3D z-stacks were produced using
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Imaris software (Bitplane, UK).
2.4.8 Cell tracking
Cell tracking was used to determine the level of entrapment provided by hydrogel matrices.
Chondrocytes seeded in fluid and quiescent alginate were imaged every 5 min at 3 z-
positions in each well over 20 h using a Cell-iQ and accompanying software Cell-iQ Imagen
and Cell-iQ Analyser (Chip-Man Technologies, Tampere, Finland).
Cell movement was quantified by tracking individual cells frame-by-frame using Cell-
iQ analyser (Chip-Man Technologies). The trajectories were mapped, and the movement




Cartilage tissue samples were snap-frozen in liquid nitrogen and embedded in TissueTek
OCT (optimal cutting temperature) compound (Sakura, Finetek, USA) for sectioning
using an OFT5000 cryostat (Bright Instruments Ltd, UK). Sections were prepared at
thicknesses suitable for the intended analysis, attached to glass slides (SuperFrost, Ther-
moFisher) and stored at -20￿ until staining or analysis.
2.5.2 Alcian blue staining
Alcian blue stains acidic polysaccharides so is suitable for the staining of glycosaminogly-
cans in cartilage. 10 µm thick sections were prepared as above. Firstly, residual OCT was
removed by washing in dH2O for 5 min before Alcian blue solution was added. After 30
min it was rinsed with running water. Sections were then dehydrated by the addition of
increasing concentrations of ethanol from 70-95% before sections were cleared with xylene
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and mounted with distyrene, plasticiser and xylene resin (DPX). A coverslip was added
and the DPX was allowed to cure for 30 min prior to imaging with an Eclipse E400 optical
microscope (Nikon, Japan).
2.5.3 Cell isolation and culture
Chondrocytes
For the isolation of primary human articular chondrocytes (hAC), cartilage was diced
into 1-2 mm3 pieces using a scalpel and digested in sterile-filtered 2 mg/ml collagenase
Clostridium Histolyticum, Type IA (0.5-3.0 FALGPA units/mg, Sigma Aldrich, USA)
for 3 h at 37￿ under agitation. Following digestion, the solution was passed through a
70 µm cell strainer to remove any remaining fragments of tissue. The filtrate was then
centrifuged at 400 x G for 7 min before removing the supernatant and resuspending the
cell pellet in basal chondrocyte media:
• Dulbecco’s Modified Eagle medium (DMEM) - high (4500 mg/L) glucose with L-
Glutamine (D5796, Sigma, USA)
• 10% Fetal Bovine Serum (FBS) - South American origin (Sigma)
• 100 units/mL Penicillin-Streptomycin (Gibco, UK)
• 1% Non-Essential Amino Acids (NEAA) (Sigma)
Following initial isolation, hACs were cultured in a humidified incubator at 37￿ and
5% CO2. Media was changed twice weekly. When cultures reached 70-80% confluence,
they were passaged. Chondrocytes were washed with sterile phosphate bu↵ered saline
(PBS) and then 2x Trypsin-EDTA (Sigma, in PBS) was added and incubated at 37￿ and
5% CO2 for 7-10 min to allow detachment of cells. Trypsin was inactivated by adding
chondrocyte growth media. The cell-trypsin-media solution was centrifuged at 400 x g for
7 min and then the supernatant removed. Cells were then either passaged further, used
experimentally or cryogenically stored. A human chondrocyte cell line, TC28 (gifted by
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AstraZeneca) was also used for some experiments. The culturing and passaging technique
for these cells was the same as hACs.
Osteoblasts
Bone chips isolated from joint tissue were washed 3 times in PBS and then 3-4 chips were
added to a T25 flask with osteogenic media:
• Dulbecco’s Modified Eagle medium (DMEM) - high (4500 mg/L) glucose with L-
Glutamine (D5796, Sigma)
• 10% Fetal Bovine Serum (FBS) - South American origin (Sigma)
• 100 units/mL Penicillin-Streptomycin (Gibco)
• 1% Non-Essential Amino Acids (NEAA) (Sigma)
• 2 mM  -glycerophosphate disodium salt hydrate (Sigma, USA)
• 50 µg/mL L-ascorbic acid (Sigma, USA)
• 10 nM dexamethasome (Sigma, USA)
Bone chips were cultured in a humidified incubator at 37￿ and 5% CO2. Initially,
media was changed after 5 days and then every 3 days. After 10-14 days, osteoblasts
reached around 30% confluence and bone chips were removed. When cultures reached
70-80% confluence, they were passaged. Osteoblasts were washed with sterile PBS and
then 0.05% Trypsin-EDTA (with phenol red, Gibco) was added and incubated at 37￿
and 5% CO2 for 7-10 min to allow detachment of cells. Trypsin was inactivated by adding
osteoblast growth media. The cell-trypsin-media solution was centrifuged at 300 x g for
5 min and then the supernatant removed. Cells were then either passaged further, used
experimentally or cryogenically stored.
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Cryogenic cell storage
Chondrocytes and osteoblasts were passaged and then resuspended at 1 x 106 cells/mL in
freezing media (FBS with 10% DMSO). They were then placed in a Mr Frosty (Nalgene,
Thermo Scientific, USA) and stored at -80￿ for 24 h before being transferred to liquid
nitrogen for longer storage.
Cell counting
Prior to seeding and experiments, cells were counted using a Countess II automated cell
counter (Thermo Fisher) with Trypan blue correction. Passaged cells were centrifuged and
the pellet resuspended in 1 mL growth media. 10 µL cell suspension was then mixed with
10 µL Trypan Blue solution. 10 µL solution was added to either side of a cell counting
slide and automatically counted. Parameters for counting of each cell type are shown in
Table 2.1. For encapsulation in hydrogel matrices a seeding density of 1 x 106 cells/mL
was used throughout.
Table 2.1: Parameters for automated cell counting using Countess II (Thermo Fisher)
Cell type Light Focus
TC28 7 2659
Primary chondrocyte 7 2650
Primary osteoblast 7 2660
2.5.4 Live/Dead staining
Cell viability and morphology in monolayer cultures as well as in hydrogel sca↵olds were
determined using a calcein AM/ethidium homodimer-1 LIVE/DEAD assay (Invitrogen,
USA). Calcein AM is cell-permeable and is hydrolysed to green fluorescent calcein by
interaction with intra-cellular enzymes; cell-impermeable ethidium homodimer-1 binds to
DNA and fluoresces red, and so, binds to the DNA of dead/dying cells with compromised
cell membranes.
59
Culture media was removed and cells in monolayer or hydrogel constructs were
washed with PBS. A solution of 2 µM calcein AM and 4 µM ethidium homodimer-1 was
prepared in PBS and added to the cell cultures. After 20 min incubation at 37￿ away
from direct light, cells were imaged using confocal microscopy (see 2.4.7). The images
were then overlaid to view both live and dead cell populations in a single image.
2.5.5 RNA isolation
RNA was isolated from monolayer and hydrogel sca↵old cultures using TRIzol reagent (In-
vitrogen). For cells in monolayer, culture media was removed before 1 mL TRIzol reagent
was added for 3 min to lyse the cells. For hydrogel cultures, 1 mL TRIzol was added and
the sca↵old was then mechanically homogenised using a TissueRuptor (Qiagen). TRIzol
and lysate from either preparation was then transferred to a lo-bind microtube (Eppen-
dorf, Sigma). 200 µL chloroform (Fisher Scientific, molecular biology grade, RNAse free)
was then added to each sample and they were shaken vigorously by hand for 15 s. Samples
were then left on ice for 3 min before centrifugation for 15 min at 12,000 x g at 4￿ for
the phase separation of RNA, DNA and protein. The aqueous, RNA-containing phase
was aspirated and transferred to a new microtube. The protein and DNA phase were
stored at -80￿ if required for further analysis or discarded. 500 µL isopropanol (Sigma,
molecular biology grade, RNAse-free) was added to the aspirated RNA phase and RNA
was left to precipitate at -20￿ overnight. The precipitate was isolated by centrifugation
for 10 min at 12,000 x g at 4￿ before the supernatant was removed and discarded. The
pellet was washed with 75% ethanol (Sigma, molecular biology grade, diluted RNAse-free
molecular grade water), shaken by hand, and then centrifuged again for 5 min at 7,600 x
g at 4￿. The supernatant was discarded and the pellet was dried in a vacuum desiccator
for 5-10 min. Finally, the pellet was resuspended in 50 µL RNAse-free H2O (HyClone,
Fisher Scientific). RNA was stored at -80￿ until use in qRT-PCR.
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RNA Quality and Concentration
RNA purity and concentration were determined using a NanoDrop 2000 UV-Vis spec-
trophotometer (Thermo Scientific, USA). 1 µL of RNA was added to the sample stage
and the absorbance read at A260 and A280. Only samples with A260/280 ratios of more
than 1.7 were used for qRT-PCR.
2.5.6 Quantitative real time polymerase chain reaction (qRT-
PCR)
SYBR green chemistry was used for all qRT-PCR; custom forward and reverse primer
sequences are listed in Table 2.2. These were used in combination with PrecisionPLUS
OneStep SYBR Green master mix (PrimerDesign, UK) and alongside a housekeeping
gene (PrimerDesign). The amplification protocol was performed using 5 µL reactions
in frosted 384-well plates on a BioRad CFX384 thermocycler. The first step was reverse
transcription for 10 min at 55￿ before enzyme activation at 95￿ for 2 min. Denaturation
was performed at 95￿ for 10 s followed by 60 s of data collection at 60￿; this was cycled
40 times. Finally, a melt curve was run by the thermocycler. Relative gene expression
was determined by ddCT, normalized to the housekeeping gene.
Table 2.2: Primer sequences used in qRT-PCR. Housekeeping primer sequences were not
made available by the manufacturers.
Gene Accession No. Forward Reverse

















2.5.7 1,9-Dimethyl-methylene blue (DMMB) assay
Sulphated glycosaminoglycan (sGAG) release into the supernatant from chondrocyte-
alginate cultures was measured using a 1,9-dimethyl-methylene blue (DMMB) assay [46].
DMMB binds to polyanionic substrates (such as sGAG) and undergoes a colour change
from blue to violet [243].
The assay colour reagent was prepared by adding 1.6 mg DMMB, 0.304 g glycine,
0.237 g sodium chloride and 9.5 mL 0.1 M hydrochloric acid (HCl) into dH2O to produce
a total volume of 100 mL. The pH was then adjusted to pH 3 using HCl. Supernatant
samples (50 µl) at 3, 7, 10, 14, 17, 21, 24, 27 and 30 days and standards of shark
chondroitin sulphate were added to 200 µl DMMB colour reagent at pH 3. Alginate alone
served as a control to remove the e↵ect of interference of uronic acid groups in alginate.
The absorbance was read immediately at A540 using a BioTek EL808 plate reader.
2.5.8 Immunohistochemistry
For immunohistochemistry, cell-seeded constructs were fixed with 4% paraformaldehyde
for 10 min before blocking in vehicle (0.1 M PBS, 10% goat serum, 0.3% Triton-X-100).
Aggrecan was detected using a mouse anti-aggrecan primary antibody (1:200, Ther-
moFisher, AHP0012) and incubated overnight at 4￿ under agitation. After washing in ice
cold vehicle, Alexa-488 goat anti-mouse secondary antibody (1:500, Invitrogen A-21121)
was used. Nuclei were counterstained with DAPI (1:5000, Sigma Aldrich). ProLong
diamond antifade mountant (Thermo Fisher) was then added to each section before a
coverslip was placed over the section and sealed using nail varnish.
2.5.9 Cytokine stimulation
Chondrocytes were seeded into gellan at 1x106 cells/mL and 100 µL volume constructs
were printed. Chondrocytes were also seeded into 48 well plates at 1 x 105 cells/well
to match the seeding density of the printed constructs. Cells were allowed to adhere
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overnight before the addition of recombinant IL-1  (from E. Coli, Sigma Aldrich) at 0.1,
0.3, 1, 3, 10 and 30 ng/mL in chondrocyte media. After 4 and 24 h, supernatants were
removed and stored at -20￿ prior to analysis by enzyme linked immunosorbent assay
(ELISA).
2.5.10 Enzyme-linked immunosorbent assay (ELISA)
Concentrations of IL-6 produced by chondrocytes were determined by solid-phase sand-
wich ELISA (DuoSet, R&D systems). Briefly, nunc plates (ThermoFisher) were coated
with capture antibody (diluted in PBS) and incubated overnight at room temperature
(RT) before being washed 3 times with wash bu↵er (0.05% Tween20 in PBS). Plates were
then blocked using 0.1% bovine serum albumin (BSA, Fisher Chemical) in PBS for 2 h at
RT. Samples were diluted 1:5 with culture media and IL-6 standards were serially diluted
in PBS. 50 µL of sample or standard was added to the plate and incubated for a further
2 h at RT. The plate was then washed again before the detection antibody was added.
After a further 2 h incubation and wash, 50 µL Strepdavin-HRP was added to each well
and incubated in the dark for 20 min. After a final wash, Tetramethylbenzidine (TMB)
solution was added and incubated for 20 min away from light. Stop solution was added




CHANGES TO THE VISCOELASTIC RESPONSE
IN OSTEOARTHRITIC CARTILAGE
Data in this chapter is also presented in the published article: Matrix degradation in
osteoarthritis primes the superficial region of cartilage for mechanical damage. Acta Bio-
materialia (2018)1 2
Osteoarthritis (OA) is a degenerative disease that a↵ects 25% of the world’s
population over fifty years of age. It is a chronic disease of the synovial
joints, primarily the hip and knee. The main pathologies are degradation of
the articular cartilage and changes to the subchondral bone, as a result of
both mechanical wear and a locally elevated inflammatory state. This study
compares the viscoelastic properties of cartilage that represents the biochem-
ical changes in OA and age-matched healthy tissue. Further, the mechanical
damage induced by this compressive loading cycle was characterised and the
mechanism for it was investigated. The storage modulus of OA cartilage was
shown to be significantly lower than that of healthy cartilage whilst having
a higher capacity to hold water. Following mechanical testing, there was a
significant increase in the surface roughness of OA cartilage. This change in
surface structure occurred following a reduction in sulphated glycosaminogly-
can content of the superficial region in OA, as seen by alcian blue staining
and quantified by micro x-ray fluorescence. These findings are important in
understanding how the chemical changes to cartilage matrix in OA influence
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3.1 Introduction
Mechanically, cartilage provides both a low-friction surface for articulation of the joint
and acts to transmit compressive loading forces to the underlying subchondral bone.
Similar to many other tissues in the body, it exhibits time-dependent viscous and elastic
behaviour in both compression and tension [159]. The superficial region consists of Col
II fibres oriented parallel to the articulating surface giving local tensile strength. This
collagen network becomes more disordered in the middle region and in the deep zone and
through the tidemark, fibres are aligned perpendicular to the articulating surface. In OA,
the Col II network deteriorates, starting from the articulating surface in early OA and
progressing through the tissue with increasing OA severity, as measured by Hollander et
al., using Mankin grading [81]. Aggrecan, the most common proteoglycan in cartilage,
is found at highest concentrations in the middle and deep zones. It is the second most
abundant protein in cartilage following Col II and it sits along a hyaluronic acid backbone.
Individual aggrecan molecules have sulphated glycosaminoglycan (sGAG) chains (keratan
and chondroitin sulphate) coming from the aggrecan core protein that form a bottle-brush
structure. These sGAG chains have a negative charge resulting in a high binding a nity
to water.
The binding of water to proteoglycans is partly responsible for the compressive
mechanical properties of cartilage. The carboxyl and sulphate groups of chondroitin sul-
phate and sulphate group of keratan sulphate provide fixed charge density (FCD) to the
tissue, which, in combination with repulsion between neighbouring negatively charged
chains results in a high osmotic pressure [74]. In healthy cartilage this pressure is com-
pensated by the Col II network which restricts over-swelling and allows the tissue to
resist compressive forces [74]. In OA an increase in matrix metalloproteins (MMPs)
and aggrecanases, particularly members of the ADAMTS (A Disintegrin and Metallopro-
teinase with Thrombospondin motifs) family, have been identified as primary factors in
the catabolism of articular cartilage matrix proteins including aggrecan and Col II [23, 81].
Changes in these matrix components have been shown to a↵ect the mechanical properties
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of human cartilage [181] and the dynamic mechanical properties of canine tissue with
destabilisation-induced OA [68].
The viscoelastic properties of a material can be quantified by numerous methods
including creep, stress relaxation and dynamic mechanical analysis (DMA). Unlike creep
and stress relaxation which usually have long time constants, DMA is a dynamic testing
method. By applying an oscillating force to a specimen and analysis of the out-of-phase
displacement response, the frequency-dependent storage and loss moduli can be calcu-
lated. The storage modulus (E’) describes a material’s ability to store energy for elastic
recoil while the loss modulus (E”) characterises the material’s ability to dissipate energy
[126]. Studies have examined articular cartilage at low strain rates [51, 92, 136, 137, 196]
and others have used DMA to assess frequency-dependency of the viscoelastic properties
of cartilage in bovine and human specimens [106]. From these investigations, biphasic
theory and BPVE theory were developed [119, 136]. However, the e↵ects of OA on the
dynamic, viscoelastic properties of human cartilage have so far been limited to the use of
femoral head cartilage, where the direction and magnitude of loading is harder to define,
or by indentation methods [178, 182, 196].
Changes to both the mechanical and physicochemical properties of cartilage are of
interest in OA, and physical techniques for tissue analysis are becoming more commonly
utilised. As such, quantitative mapping of chemical elements present in tissues is now
possible using micro x-ray fluorescence spectroscopy (µXRF). This gives good spatial
resolution of elements and has been used in a number of tissues including cartilage [83, 234,
245]. Other quantitative techniques that are traditionally used in materials science, but
not in biological contexts, such as thermogravimetric analysis, are also being transferred
to better understand the chemical structure of tissues and biomaterials. Cartilage is
interesting thermogravimetrically due to its high water content, which has implications
for its mechanical properties. As such, an accurate quantification of cartilage hydration
can be helpful in understanding matrix changes in di↵erent disease states [201]. In OA,
there is an observed change in the cartilage surface as it becomes fibrillated. White light
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interferometry (WLI) is a commonly used technique in the analysis of surface features
but as yet its use in characterising biological surfaces is infrequent. These techniques can
all be used to enhance the knowledge and understanding of biological tissues.
Varus knee alignment as measured by the femorotibial angle has been shown to be
a key factor for development and progression of OA [17]. In this position, the medial
aspect of the knee joint experiences more damaging mechanical loading, as seen by a
larger reduction in cartilage thickness [138]. However, the local inflammatory environment
a↵ects both aspects of the joint equally as the synovial fluid fills the joint space. In this
study we have used human cartilage from the lateral aspect of the femoral condyles
(Figure 3.1) of OA subjects. This tissue is exposed to the same chemical environment but
is macroscopically undamaged. As yet, no one has studied the association between the
early viscoelastic and chemical changes that occur in human OA cartilage. Therefore, the
aim of this study was to determine the dynamic mechanical properties at a wide range
of physiological frequencies and undertake a detailed chemical analysis to understand the
di↵erences observed in less structurally degraded, OA and healthy cartilage from the same
anatomical region.
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Figure 3.1: Representation of healthy (A) and OA (B,C) joint structures. Varus loading
in OA causes a reduced joint space in the medial aspect such that cartilage of the medial
aspect including the medial femoral condyle (MFC) undergoes severe mechanical degrada-
tion, revealing the underlying subchondral bone. The lateral aspect of the joint maintains
a wider joint spacing such that tissue of the lateral femoral condyle (LFC) experiences
less mechanical damage. The dashed region in C indicates where cartilage explants were
taken for this study.
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3.2 Methods
Tissue isolation and preparation
Cartilage explants were isolated from the lateral aspect of the femoral condyle of both OA
and age matched post-mortem donors with no history of joint disease, as indicated in Fig-
ure 3.1. Cartilage in this region was macroscopically undamaged compared to the medial
aspect of the joint, where cartilage had been degraded su ciently that the subchondral
bone was exposed (Figure 3.2). As the synovial fluid fills the joint space, however, the
chemical and inflammatory environment is the same across both joint aspects. Tissue
from post-mortem subjects is referred to as ‘healthy’ and tissue from joint replacement is
referred to as ‘OA’; patient data is presented in Table 3.1.
Figure 3.2: Femoral condyles as received in the laboratory from an OA patient following
TKR surgery. The dashed region indicates where cartilage explants were taken for this
study.
Table 3.1: Age and genders of the 20 patients whose cartilage was studied, n(explants)
corresponds to specimens used for DMA.
Tissue n (explants) Age Gender Thickness (mm)
Healthy 6 (22) 76 (53-87) M=3 1.465 ± 0.240
OA 14 (37) 71 (56-81) M=10 1.463 ± 0.206
DMA and thickness testing
Cylindrical cartilage explants were hydrated for 30 min in Ringer’s solution before DMA
was performed in unconfined cyclic compression. Prior to testing a 3 N preload was
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applied to prevent slipping. 1500 and 3000 cycles were then performed at 25 and 50
Hz respectively to achieve a dynamic ‘steady state’; this has been shown to occur after
between 1200-4500 preconditioning cycles in cartilage [55, 125, 220]. Cartilage samples
were then loaded cyclically between 16-36 N at 1, 8, 10, 12, 29, 49, 71 and 88 Hz for
17, 61, 73, 85, 190, 314, 450 and 550 cycles respectively (OA n=37; healthy n=22; total
testing time was 6 min 35 s). Cartilage explants of 5.2 mm diameter loaded between
16-36 N, induced a mean stress of 1.22 MPa, peak stress of 1.7 MPa, and 0.95 MPa stress
amplitude. Depending on specimen thickness the applied strain was between 1.8-4.8%.
Following viscoelastic testing, the samples were rehydrated in case of any water loss
during testing before thickness measurements were performed using a needle thickness
test [199]. Samples were then stored at -80°C prior to physicochemical analysis.
Physicochemical characterisation
Firstly TGA was used to determine the absolute water content in the matrix by heating
from 25-250°C at 1 K.min 1 (n=4). Some explants were then snap-frozen before cryosec-
tioning. µXRF was performed on 30 µm sections to map and quantify element distribution
in the sagittal plane of the cartilage, across tested and untested samples (n=3). To visu-
alise the proteoglycan distribution, alcian blue histological staining was performed on 10
µm sections before WLI was used to quantify the areal surface roughness of untested and
tested cartilage explants (n=4).
Data analysis and statistical methods
Statistical analyses were performed using Prism 7 (GraphPad, CA, USA). Two-way
ANOVA with Tukey’s post-hoc testing for multiple comparisons was used for mechan-
ical data. Student’s t-tests were used to compare di↵erences between healthy and OA
tissues, and also between samples tested and untested by DMA. Results where p<0.05
were considered significant. Logarithmic frequency dependent behaviour of the storage
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3.3 Results
Viscoelastic properties of OA and healthy cartilage
The frequency dependence of the storage (E’) and loss (E”) moduli are shown in Fig-
ures 3.3A and 3.3B for healthy and OA cartilage respectively. The storage modulus of
both healthy and OA cartilage showed logarithmic frequency dependent behaviour which
then plateaued from around 50 Hz (Figure 3.3A). Results of two-way ANOVA/Tukey
showed that in both the loss and storage modulus, there were significant e↵ects of fre-
quency (p<0.001). The e↵ects of disease in relation to frequency were significant in the
storage modulus (p<0.001) but not in the loss modulus (p=0.002). Student’s t-tests of
the mean moduli values showed that the storage modulus of healthy cartilage was signif-
icantly higher (p<0.05) than that of OA cartilage at all frequencies with the exception
of 88 Hz (p=0.058), as shown in Supplementary Table A.1. The loss moduli were also
logarithmically frequency dependent and plateaued from around 50 Hz.
Table 3.2 shows the values which satisfy equations 3.1 and 3.2 for both E’ and E”; the
viscoelastic behaviour was found to be linearly logarithmic. The area inside the hysteresis
loops (Figure 3.4) was greater for OA specimens than healthy at low frequencies (OA:
0.068 Nmm; healthy: 0.056 Nmm), and high frequencies (OA: 0.119 Nmm; healthy: 0.084
Nmm), indicating that the healthy specimens had a more elastic response. The mean
level of displacement was fairly stable throughout testing showing that there was not a
marked change to the height of samples during testing (Supplementary Figure A.1).
Table 3.2: Storage and loss modulus coe cients as equations 3.1 and 3.2 from regres-
sion analyses. All coe cients and constants values are MPa, p<0.05 indicates that the
logarithmic regression was significant.
Sample Property A B C D R2 P
Healthy E’ 2.155 31.79 - - 0.977 <0.05
OA E’ 1.968 28.07 - - 0.977 <0.05
Healthy E” - - 0.551 3.576 0.961 <0.05
OA E” - - 0.585 3.166 0.956 <0.05
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Figure 3.3: A) Storage modulus (E’) of healthy ( ) and OA (n) cartilage with 95%
confidence intervals, B) Loss modulus (E”) of healthy (õ) and OA (ó) cartilage with
95% confidence intervals; H n=22, OA n=37.





























Figure 3.4: Hysteresis loops of healthy (black) and OA (grey) cartilage at A)10 Hz and
B) 88 Hz, inset values of hysteresis area (Nmm)
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Thermogravimetric analysis of OA and healthy cartilage
The binding of water by the proteoglycan network provides a large contribution to the
compressive properties of articular cartilage, so to elucidate the changes seen in Figure
3.3, the amount of water in these samples was accurately measured. TGA was used to
quantify the amount of bound water in untested and post-DMA cartilage explants from
both healthy and OA subjects. Figure 3.5A shows the change in % mass of OA and
healthy cartilage between 25-250°C. Between these temperatures, the loss of water was
seen up to around 90°C and a further transition started at around 210°C. The linear region
of water loss as stated in Table 3.3 resulted in a larger change in mass in OA specimens
compared to healthy (Figure 3.5B). The OA samples showed a significantly larger change
in mass by 100°C (p<0.05) and a faster peak rate of mass change, as seen by the DTG
curve (dashed line). The further change in mass to 250°C was very similar between the
healthy and OA samples, -23.76 and -23.08% respectively.
Table 3.3: Thermogravimetric parameters of healthy and OA samples during linear water
loss transition, n=4
Sample Linear DTG peak DTG peak Lin. region
(N) region (￿) (￿) (%/min) mass change
Healthy (4) 52.30-78.50 69.71 -2.39 -54.22%
OA (4) 53.58-79.99 71.87 -2.74 -60.87%
Mapping and quantification of sulphur in cartilage sections
µXRF was used to quantify the changes in sulphur distribution in OA and healthy tissue
which likely corresponds to the aggrecan distribution across cartilage sections. Figure 3.6
shows that in untested samples, healthy cartilage had a consistent gradient across the
tissue where sulphur was most abundant in the deep zone and less so in the superficial
region. OA cartilage, however, had a less regular gradient towards the surface and visu-
ally the superficial region showed minor damage to the surface even in untested samples.














































Figure 3.5: Thermogravimetric analysis of OA (grey) and healthy (black) cartilage be-
tween (A) 20-250￿. Dashed line indicates kinetics of mass change (DTG). Inset (B) shows
the end of the water loss region, n=4.
direction of collagen fibril alignment in this region, but the surface was not macroscopi-
cally ruptured as seen in the OA samples. The OA cartilage had severe damage to the
articulating surface post-DMA, while the middle and deep regions retained their structure.
Figure 3.6B shows the relative quantification of sulphur distribution across the sections.
Healthy and OA sections had similar sulphur levels in the deep and middle zones, but
the OA samples had lower levels in the superficial zone. Quantification of the post-DMA
samples shows that in both OA and healthy samples, mechanical testing reduced the
sulphur content, which is likely due to changes in aggrecan proteoglycan organisation.
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However, this change was more marked in the superficial region of OA samples compared
to healthy. Quantification of the OA samples post-DMA was limited at the articulating
surface due to the mechanically-induced damage. In Figure 3.7, co-localisation of calcium
and phosphorus was evidence of mineral deposits in the cartilage. These were observed

































Figure 3.6: µXRF mapping of distribution of sulphur in cartilage sections (sagittal plane),
highest intensity is shown by brighter colour, closest to the bone interface at the bottom
of each image. B) Relative quantification of sulphur across healthy (black) and OA (grey)
cartilage sections that were untested (solid) and post-DMA (dashed) (n=3).
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Figure 3.7: µXRF mapping of sulphur, calcium and phosphorus showing evidence of Ca
and P localisation in mineral deposits in the middle and superficial regions of OA cartilage.
Figure 3.8: Representative alcian blue staining of 10 µm thick cartilage sections from
healthy (A-C) and OA (D-F) samples both untested (A, D) and post-DMA (B&C, E&F).
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Histological staining
Whilst µXRF was useful for quantifying the changes in element distribution, the resolution
was limited. Therefore, in order to better visualise both the proteoglycan distribution and
physical changes to the superficial region, alcian blue staining of 10 µm cartilage sections
was performed. In healthy cartilage (Figure 3.8A-C), there was a gradient of proteoglycan,
with the heaviest staining in the deep region which became progressively lighter towards
the superficial region. Following DMA of healthy cartilage, there was no visible di↵erence
in the surface structure (Figure 3.8C) from the untested sample (Figure 3.8A) In OA
cartilage, the distribution of proteoglycan was less ordered and there was evidence of cell
clusters. Further, although there was a gradient, there were also regions of darker staining
throughout the middle region (Figure 3.8D). Compared to the healthy tissue, the staining
was less even, alongside large cracks in the surface with fragments of tissue detaching
from the section (Figure 3.8E, F).
Articulating surface damage
To quantify the damage to the articulating surface following DMA, WLI was used to
measure surface roughness. Figure 3.9 shows that there was no di↵erence between healthy
specimens that have and have not undergone a dynamic testing protocol. In the OA
samples, the surface roughness prior to testing was significantly higher than that of the
healthy samples (p<0.05) indicating an initial degree of mechanical damage that was
not macroscopically visible. Following DMA, the surface roughness of OA specimens






























Figure 3.9: Surface roughness of healthy and OA cartilage samples with or without DMA
testing as measured by WLI; n=3, * p<0.05.
3.4 Discussion
This study aimed to understand the di↵erences in frequency-dependent viscoelastic prop-
erties of isolated healthy and OA human articular cartilage and to compare these to the
physicochemical changes seen. Tissue was excised from the lateral aspect of the OA joint,
which is known to be less exposed to mechanical stresses than the medial aspect, and
thus was used to represent cartilage which was not excessively mechanically loaded but
was exposed to the same chemical environment.
The first component of this study determined the viscoelastic properties of healthy
and OA human cartilage. The logarithmic frequency-dependent behaviour in both the
storage and loss modulus was similar to previous findings in human and bovine cartilage
[106, 161, 212]. The significant reduction in storage modulus across a range of frequencies
in OA specimens is likely to be indicative of disruption to the matrix structure as a
result of OA cytokines, MMPs and altered joint loading. The solid matrix components of
cartilage, Col II and the aggrecan-rich proteoglycan network, are primarily responsible for
the compressive sti↵ness of cartilage and was shown to be reduced in OA. This di↵erence
was statistically significant at all but the highest frequency, 88 Hz (P=0.0581), which has
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previously been implicated as a frequency brought about during a rapid heel strike rise
time that may predispose subjects to OA [55, 173]. The storage and loss moduli of healthy
femoral condyle cartilage were similar to that of ‘healthy’ human femoral head cartilage
(obtained from subjects who had experienced a traumatic fracture of the femoral neck)
and follow the same logarithmic trends [212]. The viscoelastic response in cartilage is
caused by a combination of fluid-dependent and fluid-independent behaviour [136, 137].
In healthy intact cartilage, the fluid dependent behaviour likely dominates the energy
dissipation characteristics. However, in the OA samples where the superficial region is
compromised, increasing the tissue permeability, the inherent viscoelasticity of the solid
matrix components will have a larger e↵ect on the energy dissipation of the tissue [196].
Cartilage is comprised of more than 70% water, and the binding of water to proteo-
glycans provides high osmotic pressure, which is a key factor in the compressive properties
of the tissue [74]. Therefore, the amount of water in each sample was measured by mea-
suring the change in mass as a function of temperature. The higher water content of OA
cartilage compared to healthy was shown thermogravimetrically by Sohar et al. [201].
However, their study showed the end of the water TG step at higher temperatures than
seen in this study (102.25°C and 104.60°C compared to 78.50°C and 79.99°C for healthy
and OA tissue respectively), which is likely due to the faster rate of heating used in their
study (5K.min 1). The increased water content in OA samples is a result of an increased
ability for the tissue to swell. This change in swelling capacity is due to breakdown of
the Col II network associated with matrix catabolism in OA as measured by Bank et al.
They found that an increased swelling percentage correlated with an increased percent-
age of degraded collagen in human samples from OA femoral head cartilage [8]. This
reduced the elastic restraint on the tissue, meaning more extra-fibrillar water can be held
[9, 201]. This reduction in restraint is likely to progressively increase during testing of the
OA samples as the superficial region becomes damaged and tissue permeability increases
[196]. The increase in area of hysteresis between 10 and 88 Hz in both healthy and OA
samples is likely caused by the e↵ect of superficial matrix disruption.
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Cartilage swelling as a result of changes to the matrix composition has been shown
previously using delayed gadolinium enhanced magnetic resonance imaging (dGEMRI),
where a correlation between increased cartilage thickness and decreased GAG content was
shown in the medial compartment of the knee [28]. The increased water content observed
in OA samples may contribute to the similarities in loss modulus seen between healthy
and OA tissue. The peak rate of mass change in the water TG step was higher in the OA
samples and the peak was shifted to a higher temperature. The faster peak mass change
was likely due to the increased water content, whilst the shifted peak suggests a higher
binding strength of water to the PG network.
The gradient distribution of matrix components Col II and aggrecan are known to be
critical to the proper mechanical functioning of cartilage. As water and its binding to PG is
so important in the load-bearing capacity of cartilage, the distribution of the PG network
was mapped. Benchtop µXRF was used to elementally map cartilage sections and was a
simple and e↵ective way to quantify the di↵erences in sulphur content, corresponding to
sGAG and aggrecan content in tissue samples. It is well known that the GAG content at
the superficial region is lower than that of the middle and deep zones [160]. Here, however,
seen by less bright pixels and quantified by line gradients from the deep to superficial
zones, we saw a further reduction in the superficial region in OA cartilage. The reason for
this may be proximity and contact with the synovial fluid, which, in the inflamed state
of OA has a higher concentration of catabolic MMPs and cytokines [166]. Further, the
identification of mineral-like deposits near the cartilage surface of OA cartilage suggests
that mineralisation in OA may occur prior to visible mechanical damage to the superficial
region. Tissue mineralisation of cartilage and meniscus are common in end-stage OA,
usually seen as deposits of HAp and calcium pyrophosphate dihydrate (CPPD) crystals
[54].
These mineral deposits were seen primarily in the upper middle and superficial re-
gions of the cartilage sections; they may have a role in the observed surface damage
following DMA. Relatively large (they can be seen radiographically), hard particles in a
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soft tissue could act as stress concentrations for cracks in cartilage to form, similar to the
cracks that form following a traumatic insult to the cartilage surface [184]. Changes in
surface roughness were measured using WLI, a technique commonly used in electronics
for profiling surfaces. It enabled the quantification of the surface damage by analysing the
peaks and valleys in the cartilage surface to quantify surface roughness. The significant
increase in surface roughness following DMA in the OA subjects indicated that the super-
ficial region was more susceptible to damage as has been shown previously in bovine tissue
[25, 116]. Further, the di↵erence in Sa between healthy and OA samples observed was
similar to the profile surface roughness (Ra) seen by Graindorge et al. between healthy
(Ra=1.06) and emery-roughened (Ra=23.2) samples [62]. Whilst there was evidence of
deformation of the superficial region of healthy tissue under µXRF, the superficial region
of OA cartilage showed severe rupturing of the cartilage surface. Disruption to the matrix
composition was likely responsible for this; as mentioned, there is a change in the collagen
network originating at the articulating surface [81, 143, 145]. This will reduce the tensile
strength of the cartilage surface which reduces its ability to resist deformation.
Age-related changes to the proteoglycan content of the superficial layer of cartilage
have been identified previously [74]. This e↵ect is enhanced when the biochemical balance
shifts in states such as trauma and OA causing increases in catabolic cytokines such as
interleukin-1 (IL-1) and tumour necrosis factor alpha (TNFa). Guilak et al. have discussed
how physiological joint loading has protective mechanisms for regulating cytokine levels
[67, 69, 189]. The balance between protective and damaging joint loading is likely key in
the progression of OA. Another factor shown to increase the severity of OA symptoms is
obesity; there is a combined e↵ect of increased loading on the joints due to higher body
mass alongside elevated production of adipose-derived cytokines (adipokines) [58, 67, 165].
These adipokines have been shown to increase production of many pro-inflammatory cy-
tokines and catabolic matrix proteases. Leptin, a well characterised adipokine, is increased
in OA synovial fluid and has been shown to increase MMP-1 and MMP-13 production
in human primary chondrocytes and to mediate greater IL-6 secretion from OA synovial
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fibroblasts [162, 166]. Importantly in this study, while the joint loading of the OA sub-
jects is focused in the medial compartment of the joint, the use of tissue from the lateral
compartment demonstrates the e↵ects of the inflammatory OA environment on cartilage
tissue.
Limitations: The use of human tissue samples is limiting in the number available,
particularly the numbers of post mortem samples. Firstly, this means that following a
power analysis, an e↵ect size of 0.31 should be expected for the presented number of
samples and an e↵ect size of 0.48 for the 22 patients that samples were retrieved from.
Secondly, due to the limited number of human samples, the testing protocols for DMA
were all performed in the same order, so the loading history may a↵ect the viscoelastic
measurements. Future studies could investigate whether the loading history a↵ects the
viscoelastic response by randomising the order of frequencies during testing. Further,
as the cartilage surface is semi-translucent, white light interferometry values are solely
relative to surfaces with similar optical properties to cartilage.
3.5 Conclusions
For the first time, we have linked the local changes in chemistry and structure to the dy-
namic mechanical properties of OA and healthy cartilage, isolated from the same anatom-
ical region in human donors. There is a significant reduction in the storage moduli of
cartilage from OA compared to age-matched healthy subjects, indicating that in OA the
elastic response of cartilage deteriorates. This reduction in storage modulus is likely due
to a disruption to the collagen network as OA tissues showed a higher capacity to swell
and bind water. Visible changes to the cartilage surface following DMA were investigated
and an increased surface roughness was observed in OA but not healthy tissue. Finally,
the mechanism for this disruption was investigated using histological staining and µXRF




THE EFFECT OF GEOMETRIC CONFINEMENT
ON CHONDROCYTE PHENOTYPE IN
3D CULTURE
Data in this chapter is also presented in the published article: Geometric Confinement
is required for recovery and maintenance of chondrocyte phenotype in alginate. APL
Bioengineering 1 (2017)1 2
Human articular chondrocytes lose their native phenotype when expanded in
traditional monolayer cultures. As a consequence, hydrogel encapsulation has
been investigated as a means to maintain natural phenotype. Alginate has
been widely used for cartilage engineering as it has been shown to enable the
recovery of a native collagen type II expressing chondrocyte phenotype. This
study has evaluated whether the capacity of the materials to maintain/revert
phenotype is due to the composition of the material or the physical entrapment
provided by the gel. To achieve this, an alginate fluid gel (a shear-thinning
structured gel system) was produced of identical chemistry to a traditionally
gelled alginate structure. Both were seeded with passaged primary human
articular chondrocytes. Chondrocytes in quiescent alginate showed recovery
of the native phenotype and a spherical morphology. Chondrocytes in algi-
nate fluid gel were unable to maintain a recovered phenotype despite having
spherical morphology and were shown to have a lower level of entrapment than
those in quiescent alginate. These findings indicate that geometric entrapment
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4.1 Introduction
An alternative to the pharmacological approaches being investigated to prevent OA pro-
gression is the surgical repair of focal defects in cartilage tissue in patients with early-stage
OA, via autologous chondrocyte implantation (ACI) [129]. This repair strategy is depen-
dent on the expansion of chondrocytes in vitro before re-implantation into the defect
site [109]. Critically, expansion in 2D monolayer culture causes chondrocytes to rapidly
de-di↵erentiate, with a marked loss in their expression of Col II and aggrecan, and an as-
sociated increase in the expression of Col I [6, 152, 192]. This loss of chondrogenicity leads
to the formation of an inferior hyaline cartilage, rich in Col I, which has been reported
to be functionally similar to the fibro-cartilage that is formed following micro-fracture
surgery [218]. Consequently, this means that the ACI process has been of limited clinical
success. There is therefore a need to develop an improved method for the expansion of
chondrocytes in vitro, which can maintain the chondrocyte phenotype and thus promote
regeneration of functional articular cartilage.
Hydrogels have been thoroughly investigated in regenerative medicine to act as
ECM mimics due to their high water content and high degree of tunability [38, 63]. One
such hydrogel is alginate, a linear, un-branched polysaccharide derived from brown algae
that has been used in drug delivery, wound healing, and tissue regeneration [38, 108, 158].
Containing b-D-mannuronic acid (M) and a-L-guluronic acid (G) residues arranged either
in blocks (GGG/MMM) or alternating sequences (GMGMGM) [108], alginate undergoes
ionotropic gelation upon introduction of divalent cations to form crosslinks between G
residues resulting in an egg-box structure [84, 110, 208].
Previously, alginate has been shown to maintain adult chondrocyte phenotype and
to drive bone marrow derived mesenchymal stem cells towards a chondrogenic phenotype
[1, 7, 16, 127]. Whether this is due to the physical entrapment of the chondrocytes in a
3D sca↵old or due to the chemical influence of alginate is relatively unknown. The forma-
tion of a cartilage matrix by the encapsulation of allogenic chondrocytes is a promising
approach to produce cartilage for surgical implantation.
85
In this chapter, the influence of the physical entrapment of alginate on the embedded
chondrocytes has been investigated by comparing markers of cartilage matrix formation
when chondrocytes are entrapped in an normal, quiescent alginate gel matrix and also
between the particles that are formed in an alginate fluid gel. Fluid hydrogels are pro-
duced through the introduction of shear during gelation, resulting in the production of
microparticles of gel with short-range interactions [47, 49, 72, 148]. Fluid gels exhibit
solid-like behaviour in the absence of external shear stresses, but flow like liquids under
shear, and hence could be utilized in an injectable therapeutic solution for the delivery of
chondrocytes to defects in the cartilage surface. The cells dispersed within this structure
are not physically entrapped as they would be in a normal, quiescently gelled structure;
instead, they are suspended between fragments of crosslinked alginate. They are, however,
exposed to the same chemical stimuli. The aim of this study was therefore to determine
the e↵ect of di↵erent levels of encapsulation on chondrocyte viability, morphology, and
phenotype by comparing quiescent and fluid alginate.
86
4.2 Methods
Alginate preparation and characterisation
Fluid (sheared) and quiescent (traditional statically crosslinked) alginate matrices were
produced of identical chemistry (1.5% w/v alginate with 10% 0.2 M CaCl2). Fluid alginate
was produced by shearing a sodium alginate solution at 500 s 1 using a vane geometry on
a rheometer while CaCl2 was added drop-wise. The mechanical properties of both matri-
ces were characterised using oscillatory rheology. Initial stress sweeps from 0.1-1000 Pa
were performed to determine the linear viscoelastic region (LVR) before frequency sweeps
from 0.1-100 Hz at 0.5% strain, to determine the e↵ect of frequency on the viscoelastic
properties. Further, the shear rate was ramped from 0.1-500 s 1 to determine the shear
thinning behaviour of these materials. To model fluid gel response to shearing through
a needle or pipette, the shear rate was ramped from 0.1-500-0.1-500-0.1 s 1 at constant
strain. The bulk architecture of the fluid gel was then investigated; PEG and fluid algi-
nate were mixed in a 4:1 ratio and imaged using phase contrast microscopy. The polymer
microarchitectures were then investigated by freeze drying and imaging with SEM.
Encapsulation of chondrocytes in alginate
Primary human chondrocytes, isolated from cartilage of the femoral condyles of OA pa-
tients, and immortalised chondrocytes were cultured in monolayer as described in Chapter
2. For quiescent gels, chondrocytes were mixed with 1.5% w/v alginate to a concentra-
tion of 1x106 cells/ml and seeded into the wells of a 96-well plate containing 0.2 M CaCl2.
The quiescent gel was then incubated for 20 min at 37￿ to allow cross-linking to occur.
Cell-seeded gels were then rinsed twice with PBS, 0.2 ml of chondrocyte growth medium
was added, and they were incubated at 37￿ for up to 30 days. Alginate fluid gel was




Firstly, the level of entrapment provided by the alginate matrices was visualised by mon-
itoring cell motion using Cell-iQ real-time imaging. An image was taken of a defined
z-plane in the gel matrix every 5 min for 24 h. The motion of the cells was then tracked
over this time and the relative motility quantified. Cell viability was investigated using
Calcein-AM/ethidium homodimer-1 assays and imaged using confocal microscopy. To de-
termine cell phenotype, total RNA was isolated from monolayer and hydrogel cultures with
TRIzol reagent before the concentration and purity was measured using spectrophotome-
try. qRT-PCR was performed using primers designed with Primer Express3 and data was
normalised to a  -actin reference gene. sGAG production was quantified using a DMMB
assay and aggrecan presence was confirmed using fluorescent immunohistochemistry.
Finally, full-thickness cartilage explants from femoral condyle tissue, or media con-
ditioned from these explants, were added to the alginate-chondrocyte cultures to examine
whether the secretome of the tissue and media conditioned from it aided recovery of the
chondrogenic phenotype. For the generation of conditioned media, cartilage discs (diam-
eter: 4.1 mm, height: 2 mm) were incubated with 250 µL culture media for 24 h before
being applied to cultures.
Statistical analysis
Statistical analyses were performed using Prism 7 (GraphPad, CA, USA). Student’s t-
tests were used in PCR and DMMB analysis. Mean values and standard error of the
mean are plotted. Results where p<0.05 were considered significant.
88
4.3 Results
Monolayer and quiescent alginate culture of chondrocytes
Firstly, the e↵ect of monolayer culture on the chondrogenic phenotype of primary hACs
was investigated. Freshly isolated (FI) primary hACs were found to express high levels
of Col II and lower levels of Col I (Figure 4.1A). After passaging these cells three times,
this had reversed and there was a significantly lower Col II expression (P<0.005). The
expression profile of Col I and Col II in passaged primary hACs was similar to that
observed in the chondrocyte TC28 cell line (Figure 4.1B). This change in gene expression
of hACs was accompanied by an elongated fibroblast-like morphology, as the natively
spherical cells adhered and spread onto the surface of the culture well (Figure 4.1C).
Primary hACs were then cultured in quiescent alginate matrices for 2 weeks before
cell viability and phenotype were investigated. Following 14 days of encapsulation, pri-
mary hACs showed high levels of cell viability and displayed a flattened morphology at
the edge of the constructs and a spherical morphology in the centre (Figure 4.2A and
4.2B). This is similar to chondrocytes in native cartilage, in contrast to the fibroblast-like
morphology of primary hACs cultured in monolayer. Analysis of COL2A1 and COL1A1
mRNA expression over 14 days showed that primary hACs encapsulated in quiescent al-
ginate recovered their native Col II phenotype. Further, the human chondrocyte cell line
(TC28) showed recovery of a native phenotype with encapsulation in a quiescent alginate
matrix (Figure 4.3).
In addition to measurements of collagen expression, proteoglycan production was
quantified over a timecourse of 30 days. This assay is sensitive to binding to uronic acids
groups which are also present in alginate, so alginate-only controls were used. Relative
to acellular alginate controls, sca↵olds containing encapsulated primary hACs and TC28s
showed a significant sGAG secretion over a period of 30 days, suggesting that alginate en-
capsulation supported and maintained aggrecan proteoglycan production (Figure 4.4A).
























































Figure 4.1: E↵ects of monolayer culture on primary chondrocyte phenotype. A) Relative
mRNA expression of Col I and Col II in primary human chondrocytes either directly
after isolation from cartilage or following 3 passages in monolayer. B) Relative mRNA
expression of Col I and Col II in the TC28 human chondrocyte cell line. C) Passage 3
human chondrocytes exhibiting a fibroblast-like morphology (SB: 200 µm, **P<0.005,
n=3.)
produces cartilage extracellular matrix components, was then further validated by histo-
chemical staining of alginate sca↵olds. Aggrecan staining was observed in the cytoplasmic
region of the chondrocytes (Figure 4.4B).
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A B
Figure 4.2: A) Primary human chondrocytes encapsulated in quiescent alginate showing
flattened morphology at the edge of the construct and spherical morphology in the centre























































Figure 4.3: Relative expression of Col I and Col II in TC28s and primary human chon-
drocytes (hAC) throughout 9 and 14 days of culture respectively *: P<0.05, n=3.
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Figure 4.4: A) Cumulative production of sGAGs as detected by DMMB assay at 9 time
points over 30 days (n=3) and B) evidence of aggrecan (green) in the cytoplasmic region
with nuclei counter stained with DAPI (blue), SB: 200 µm.
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Formulation of a deliverable fluid alginate
An alginate fluid gel was produced by drop-wise addition of CaCl2 to sodium alginate
solution under shear. The forming of the fluid gel is shown in Figure 4.5A, where the
addition of the divalent cation caused a sharp increase in the viscosity of the alginate solu-
tion. The viscosity continued to increase until around 6 minutes after which the viscosity
dropped slightly and then equilibrated. To ensure that the fluid alginate was deliverable
through a needle or cannula, the shear rate was ramped and recovered cyclically between
0.1-500 s 1. There was only evidence of a very small hysteresis loop in Figure 4.5B, in-
dicating that this fluid gel will be stable during manipulation and handling. Figure 4.5C
shows the di↵erent forms that alginate was produced in. As can be seen on the right
hand side of Figure 4.5C, the fluid gel was able to flow like a liquid under shear to then
rest as a solid-like material in the absence of shear. The presence of bubbles in the fluid
gel shows how the network of entangled polymer chains can reorder around structures.
Figure 4.5: Formulation of fluid alginate. A) Viscosity profile during the cross-linking of
alginate fluid gels (n=3). B) Change in shear stress with shear rate over ramps of shear
rate from 0.1-500-0.1-500 1, sol (left), quiescent (middle) and fluid (right) alginate.
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The interesting mechanical properties of fluid gels are partly due to their particu-
late architectures with short range interactions and entanglements. Figure 4.6A shows
the typical architecture of fluid gel fragments connected by ribbon-like structures. Chon-
drocytes were then seeded between fluid alginate particles and the morphology of all cells
was spherical, showing little interaction with the alginate particles. Further there were
high levels of cell viability in these cultures (Figure 4.6B and 4.6C).
Figure 4.6: Imaging of fluid alginate and seeded chondrocytes. A) Fluid gel architecture
(SB: 200 µm), B) fluid gel with chondrocytes showing interaction with alginate fragments
and ribbons SB: 100 µm), C) z-stack of chondrocytes in fluid alginate 4 days after seeding,
SB: 100 µm
Mechanical characterisation of fluid and quiescent alginate
Dynamic small deformation rheology was performed to determine the viscoelastic prop-
erties of both the quiescent and fluid gel systems. Firstly, by applying an increas-
ing oscillatory stress, the LVR of each alginate matrix was determined (Figure 4.7A).
The LVR of the fluid gel was shorter than that of the quiescent gel, highlighting the
ability of the fluid network to flow under stress. The frequency dependent behaviour
of the materials was then probed. The presence of weak interactions and entangle-
ments were confirmed through linear rheology (Figure 4.7B), with the sheared alginate
showing solid-like behaviours dependent on frequency, typical of weak gels. Interest-
ingly, the quiescent gel showed a similar mechanical spectrum (at higher G values) infer-
ring structures which mirror each other, complementing data obtained via microscopy
shown in Figure 4.8C. Fluid alginate (grey) showed strong shear thinning behaviour
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(Figure 4.7C), where increasing the shear to the systems caused reversible breakdown
of the entangled polymers. However, this was not seen in the quiescent gel; increasing
shear to strains above the LVR caused the gel to fracture (gel fracture points are high-
lighted in Figure 4.7C using #), resulting in artefacts that resembled thinning profiles.





















































Figure 4.7: Rheological characterisation of quiescent (black) and fluid (grey) alginate. A)
Oscillatory stress sweeps (0.1-100 Pa, 1 Hz, 37￿) showing variation in linear viscoelastic
region (LVR). B) Mechanical spectra (0.5% strain, 37￿) showing variation in storage
modulus (G) and loss modulus (G). C) viscosity sweeps (0.001-100 s 1, 37￿). (G: filled
symbols, G: open symbols)
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Table 4.1: Storage (G’), loss (G”) and complex (G*) moduli of alginates, n=3
Quiescent Fluid
Hz/Pa G’ G” G* G’ G” G*
0.1 615.87 34.45 616.83 146.30 27.84 148.93
1 654.00 42.45 655.38 181.30 33.60 184.39
10 727.13 76.72 731.17 247.30 68.21 256.82
Microstructural observations of fluid and quiescent alginate
To further understand the di↵erences in structure between the two materials, their mi-
crostructures were imaged using SEM following freeze drying. At all magnifications, fluid
alginate was seen to have a less interconnected pore structure than quiescent alginate.
Further, there were large voids observed throughout the fluid alginate structure that were
not seen in the quiescent microstructure (Figure 4.8).
Level of cell encapsulation in fluid and quiescent alginate
To understand how the di↵ering gel architectures influenced cell entrapment, chondrocytes
were continually imaged in culture over 24 hours. Video 1 (1) shows chondrocytes in fluid
gel moving laterally across the field of view over a number of hours, as well as downwards
through the gel (Screenshots in Figure 4.9A, Video 1). Chondrocytes in quiescent alginate
however, did not show as much movement over the same time-course (Figure 4.9B, Video
2). Cell movement was then quantified by frame-by-frame tracking and cells in fluid gel
were found to move further per frame than cells in the quiescent alginate, particularly
the 25% most motile cells (Figure 4.10A and 4.10B). Overall, this e↵ect was found to be
significant between the two gel matrices (Figure 4.10C, P<0.0001 by ANOVA).
1
Videos are available at https://tinyurl.com/yctb9eqm
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Figure 4.8: SEM images of thin sections of fluid (A, C, E) and quiescent (B, D, F) alginate
following freeze drying.
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The e↵ect of alginate fluid gel on the phenotype of primary articular chon-
drocytes
To compare the e cacy of alginate fluid gel with quiescent alginate in recovering and
supporting a chondrogenic phenotype, primary hACs were cultured in either alginate
fluid gel or in quiescent alginate for a period of 7 days. Following 7 days of culture Col
II and aggrecan expression were higher in the quiescent than fluid alginate and Sox9
expression was significantly higher in the quiescent alginate (Figure 4.11).
Figure 4.9: Tracking of chondrocytes in (A) fluid and (B) quiescent alginate over 14
hours. Movement of cells is demonstrated by coloured circles. Full videos are available at
https://tinyurl.com/yctb9eqm, Videos 1 and 2.
Driving chondrogenic phenotype of primary chondrocytes encapsulated in al-
ginate
Due to the proximity of native cartilage tissue during the ACI repair of cartilage defects,
ex vivo cartilage tissue and cartilage conditioned media were studied to determine their
e↵ect on the e cacy of using fluid and quiescent alginate as chondrocyte delivery matrices.
By adding a piece of explanted cartilage tissue, (Figure 4.12A) there was an increase in
the expression of COL2A1 in quiescent alginate following 14 days of culture (Figure 4.12).
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Figure 4.10: Quantitative analysis of cell tracking in A) fluid and B) quiescent alginate
matrices. C) shows the mean distance moved by the most motile 25%, 50% and 100%
cells in each video. 2-way ANOVA with Tukey post-hoc correction determined the e↵ect














































Figure 4.11: Relative mRNA expression of (A) Col II, (B) Sox9 and (C) aggrecan in
chondrocytes 7 days after seeding in fluid and quiescent alginate, n=3.
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The e↵ect of the physical presence of cartilage tissue was shown to be secondary to the
factors released from it (Figure 4.12B), since conditioned cartilage explant media resulted
in a greater increase (P=0.0376) in Col II expression than the cartilage tissue itself. This
suggests that in the in vivo environment, alginate encapsulation of hACs will be even more
e cacious in promoting and maintaining the chondrogenic phenotype due to the secretion
of endogenous anabolic factors from the surrounding cartilage matrix. This condition was
then investigated to determine if it could be used to drive the native alginate phenotype
in fluid alginate culture. However, when comparing conditioned and basal media, there
was no significant di↵erence between the conditions (P=0.3126, Figure 4.12C); this further






















































Figure 4.12: A) Experimental set-up for explant (left) and blank/conditioned media (CM)
(right). Relative Col II expression in B) quiescent and C) fluid alginate when cultured
with basal media (blank), a cartilage explant or conditioned media, n=3.
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4.4 Discussion
Alginate has been investigated for cartilage repair and regeneration strategies over the last
three decades since it was shown to support the re-di↵erentiation of chondrocytes that
had lost their native Col II and proteoglycan-producing phenotype [22, 70, 155]. The
mechanism of this e↵ect is relatively unknown but has been attributed to chondrocyte
morphology as well as matrix mechanical properties [57, 192]. Here the aim was to resolve
the di↵erence between the geometric and chemical influence of alginate matrices.
The findings of this study support previous observations that chondrocytes are
not phenotypically stable in 2D culture on untreated tissue culture plastic, with freshly
isolated, primary human chondrocytes rapidly losing Col II expression and adopting a
fibroblast-like morphology within 3 passages. This is a well-known phenomenon in chon-
drocyte culture, and has been attributed to the change in morphology when cultured on
a sti↵ substrate [6, 22, 70]. In contrast, when primary chondrocytes were geometrically
confined by encapsulation in quiescent alginate they maintained native morphologies de-
pending on the construct region, akin to native chondrocytes in articular cartilage tissue
[202]. Additionally, it was found that primary human chondrocytes remained viable for up
to 14 days culture in quiescent alginate constructs. Importantly, this data demonstrates
that the geometric confinement of human chondrocytes in quiescent alginate promotes a
chondrogenic phenotype with maintenance of Col II expression and aggrecan proteogly-
can production. These results support the findings of Murphy & Sambanis who showed
that the maintenance of spherical chondrocyte morphology is necessary for recovery of
the chondrogenic phenotype following monolayer culture [139].
Since use of a quiescent alginate hydrogel construct for the regeneration of articular
cartilage would require highly invasive surgery, the use of an alginate fluid gel, which would
be suitable for intra-articular injection, was examined to determine if it would exhibit the
same chondrogenic phenotype promoting properties. Using the same alginate solution that
was used to produce the quiescent constructs, shear was introduced during its gelation
with the same concentration of cross-linking cations. This produced a self-supporting
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network of gel microparticles referred to as alginate fluid gel [49, 56]. This gelation
process was highly reproducible, with little variation between batches. Furthermore,
rheological characterization demonstrated that with repeated frequency ramps there was
a consistent shear stress. These non-time-dependent shear-thinning properties suggest
that alginate fluid-gel could be delivered by intra-articular injection without modification
of its structural properties. Mechanically, alginate in its quiescent state was more elastic
than fluid alginate and showed a higher complex modulus. The reduction in elastic-like
behaviour of the fluid alginate is attributed to the presence of shear during gelation, where
mixing prevents a complete network from forming [48]. There were also di↵erences in the
liquid-like and frequency dependent properties of the two materials. Both materials were
stable at lower frequencies, with the fluid alginate showing a shorter LVR as it can flow
when stressed. Such a phenomenon arises through the prevention of a completely gelled
network, allowing polymer strands to move freely once the required energy has been met
to yield any weak inter-particle interactions or entanglements [47, 48].
Following the investigation into the mechanical properties and the increased loss
modulus of fluid alginate compared to quiescent alginate, the level of entrapment provided
by the two alginate matrices was investigated. Using cell tracking, it was found that cells
in fluid alginate were able to move laterally as well as vertically through the matrix,
whereas in quiescent alginate cells were confined to distinct regions. This e↵ect may be
due to fluid flow through larger pores and voids in the fluid alginate structure that allowed
cells to move laterally through the gel network. This would be also be likely observed
in an in vivo situation due to joint motion. Further, the di↵erence in microstructure of
the alginate may introduce local di↵erences in the sti↵ness of the gel matrix resulting in
changes to cell behaviour.
Despite the success of resuspending chondrocytes in alginate fluid gel and for cell
viability to be maintained, this study found that fluid alginate was not as e↵ective at
maintaining chondrocyte phenotype as quiescent alginate upon culturing of constructs.
This lack of e↵ectiveness of fluid alginate to maintain and promote the chondrogenic phe-
101
notype of primary chondrocytes was observed despite culturing hydrogels in the presence
of explant conditioned growth media. As such, physical entrapment provided by the qui-
escent alginate gel has been shown to be critical in maintenance of a native chondrocyte
phenotype.
4.5 Conclusions
By producing a chemically identical fluid alginate, it has been shown that with a lack of
physical entrapment, passaged chondrocytes lose their ability to recover/maintain their
phenotype. Even the introduction of growth factors released from ex vivo cartilage, which
show a significant increase in Col II expression in quiescent alginate, has no e↵ect. There-
fore it has been demonstrated that maintenance of a spherical morphology alone is insuf-
ficient to recover a native Col II phenotype in passaged adult human chondrocytes. A
certain level of geometric confinement for the chondrocytes is also essential.
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CHAPTER 5
USING SUSPENDED MANUFACTURE TO
MODEL THE OSTEOCHONDRAL UNIT
Data in this chapter is also presented in the published article: Suspended Manufacture of
Biological Structures. Advanced Materials (2017)1,2
In this study we describe a novel method of suspended manufacture for the
production of complex soft structures of closely defined morphology, mechan-
ical properties, and chemistry. The process conditions are su ciently mild
that embedded populations of cells maintain high levels of viability and retain
phenotype and function. Given the simplicity of the process, it can be used
for many existing gel materials without special modification. The method of
manufacturing replaces the 2D print bed with a 3D “bed” of gel particles (of-
ten referred to as fluid or sheared gels), which behave in bulk as a viscoelastic
fluid with rapid elastic recovery, thereby providing support to the complete
part. The final structure is formed through the dispersion of a gelling material
into the interstices between the supporting fluid gel particles. This enables
relatively complex structuring while providing su cient support to prevent
the structure collapsing under its own weight. Once the sca↵old structure
has been formed the supporting phase may be removed the gentle application
of shear. This manufacturing process allows for the use of a wide range of
polymeric materials, including many already approved by regulatory bodies.
Here we demonstrate the power of this method by manufacturing anisotropic
structures with spatially controlled mechanical and chemical properties, which




The aforementioned paper was published as joint first authorship; data produced by Dr Sam Moxon
has been removed and additional research has been undertaken. Further co-authors on the published
article provided assistance with equipment, proof-reading or supervision of the work.
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5.1 Introduction
Tissues are formed of populations of cells distributed within an extracellular matrix
(ECM), which is structured down to the molecular level. Local variations in organi-
zation and biochemistry mean that the encapsulated populations of cells are exposed to
environments that di↵er both mechanically and chemically. These environments have
been shown to play a strong role in shaping the phenotype of both stem cells and cells
of a committed lineage [121, 175, 185, 206]. For some time now researchers have sought
to recapitulate tissue structure using a combination of isolated cells and polymeric hy-
drogels that have a structural resemblance to the ECM [38]. However, often the spatial
distribution of biological material within hydrogel sca↵olds is uncontrolled and for many
applications, the shape and size of the sca↵old is important for translation in preclinical
and clinical testing.
Biofabrication is a developing field and many printing techniques and bioinks have
developed in recent years to enable additive layer manufacturing (ALM) of biological
material supported by sca↵olds [11, 65, 135]. Tissue constructs with control over the
spatial deposition of cells and other biological factors can now be achieved through a
number of methods for bioprinting [15]. The majority of soft-solid structures produced by
ALM exhibit relatively low complexity and are typically broader at their base than at their
peak to reduce the risk of the structure collapsing [15, 94, 99]. A number of research groups
are working on the development of novel polymers for ALM, but often the structures
they form with these polymers are simplistic, with a self-supporting lattice arrangement
frequently being used to build large structures [91, 226]. A limitation of many of these
techniques is the printing of low viscosity or slow crosslinking hydrocolloid solutions prior
to gelation. Upon extrusion onto a 2D print bed, the capability of traditional methods
to build tall or geometrically complex constructs from hydrocolloid solutions is limited
without the use of a rigid support structure such as PCL or HAp [27, 94, 238].
Embedded printing describes a sub-set of bioprinting techniques that have been
developed as a solution to this limitation and to enable freeform fabrication [12, 40, 78,
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79]. They have been used for bioprinting as well as in sensors, soft-robotics and other
applications [142, 228, 236]. The principle behind these techniques is that the 2D print
bed is replaced by a 3D matrix that acts as a support during the printing of a secondary
phase or can have a secondary structure embedded within it. Using this principle, slow
crosslinking, low viscosity hydrocolloid solutions and more complex geometries can be
printed without the need for rigid support structures [78]. They can then be crosslinked
before being recovered from the 3D print matrix for subsequent tissue maturation.
Key properties of the 3D print matrix for embedded bioprinting include:
• Ability to suspend the printed material
• Allow freeform fabrication, unlimited by broad-based bottom-up printing
• Exhibit rapid recovery to prevent voids forming due to shear induced by needle or
bioink movement through the matrix
• Ability to remove printed part
• Non-cytotoxicity
Fluid gels fulfil these requirements as support materials for bioprinting. They are
formed by introducing shear during the sol-gel transition of hydrogels and result in an
entangled microparticulate network [49]. They have unique mechanical properties in that
at low shear stresses they behave like weak gels whilst at higher shear stresses they act
like liquids [26]. Agarose is a thermally crosslinking polysaccharide that is stable at both
room temperature and cell culture conditions. Further, in its use as a 3D matrix for
osteochondral tissue engineering, it has been shown to have low cytotoxicity [198].
The development of in vitro tissue and organ models are of growing interest as they
can be useful tools in modelling biological systems in vitro as well as for initial screening
of therapeutics prior to use in preclinical animal models [186, 188]. Such models have the
potential to refine, reduce and replace the use of animals in early preclinical testing as they
could provide more robust in vitro testing platforms than commonly used 2D monolayer
cultures. In modelling the osteochondral region, recapitulating the continuous interface
between the two tissues of distinct chemical and mechanical properties is important [76, 90,
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223]. Physical integration of materials with di↵ering mechanical and chemical properties
can be challenging, particularly when solid precursor layers are used as they may be
prone to delamination. However it has been shown that by using liquid precursors and
then allowing for controlled di↵usion prior to solidification, a gradient interface can be
produced [76].
In this chapter, a novel method of embedded printing is used to replace the tra-
ditional 2D print bed with a 3D fluid gel matrix. This allows the extrusion of a sec-
ondary hydrogel phase without mixing and supports the printed phase prior to crosslink-
ing. Termed suspended manufacture, this process supports the fragile construct as it is
formed, in a similar manner to the way amniotic fluid suspends the developing foetus.
Liquid precursors are used to produce bi-layered cell seeded constructs that recapitulate
the osteochondral unit, with distinct chemical and mechanical environments.
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5.2 Methods
Preparation and characterisation of the agarose fluid gel
In this study, an agarose fluid gel was used as the print bed. A solution of 0.5% w/v agarose
was produced on a magnetic stirrer at 90￿ which was then cooled to 20￿ whilst stirring at
700 rpm. The introduction of shear prevented the formation of a traditional quiescent gel
structure and instead produced a fluid or ‘sheared’ gel. The structure of the gel was imaged
by mixing the gel with PEG in a 1:4 ratio and imaging using phase contrast microscopy.
The mechanical properties under shear were then investigated using oscillatory rheology.
An oscillatory stress sweep was performed from 0.1-100 Pa to determine the LVR before a
frequency sweep from 0.1-100 Hz at 0.1% strain. To investigate the recovery of viscosity,
the shear rate was alternated between 0.1 and 100 s 1, holding for 120 s at each point.
The recovery of elasticity was investigated by an initial 60 s at 1 Hz and 0.5% strain
before a 60 s hold at 100 s 1. Elasticity was then measured again at 1 Hz and 0.5% strain
for 30 s, sampling every 2.5 s.
The printing process
A low-cost FDM printer (Wanhao duplicator i3) was modified by re-wiring the extruder
to power a screw-driven syringe extrusion unit. This unit was printed in PLA by an un-
modified Wanhao duplicator i3. The design and slicing of 3D models was performed using
open source software. 3D models were designed using Fusion 360 software (Autodesk).
They were then converted to stereolithography (stl) files and sliced using Cura software
(Ultimaker, Netherlands) to produce RepRap flavour g-code.
Figure 5.1 shows the printing process. Firstly, (1) the agarose fluid gel was placed in
a petri dish which was secured to the print bed to prevent any movement during printing.
At this stage, human cells were seeded into the bioink at 1 x106 cells/mL. Secondly (2)
the bioink was extruded into the fluid gel as programmed by the g-code produced during
slicing. Following printing (3) the crosslinker (CaCl2) was introduced and left for 20 min.
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Figure 5.1: The suspended manufacturing print process: 1. Agarose fluid gel and cell-
seeded bioink (alginate or gellan gum) produced. 2. Bioink extruded into the fluid gel
support matrix 3. Bioink crosslinked 4. Gelled part removed from fluid gel.
In cell seeded constructs, after the first 5 min, culture media was added to the print bath.
Finally (4), the crosslinked construct was removed from the agarose print bed and any
residual fluid gel was removed by gentle shear and washing with PBS before culture or
further analysis. For all experiments, printing was performed at a print speed of 15 mm/s
with 0.4 mm layers and 100 % infill density to prevent inclusion of agarose particles.
Determining print resolution and di↵usion limitations
To determine printing resolution, 3-layer prints were produced with di↵erent needles and
immediately imaged optically. The were then recoloured to greyscale in ImageJ and the
profile tool was used to measure the width of the printed section. To measure di↵usion,
a series of walls of 1 mm height and width were printed with 2 mm gaps. They were
printed from dyes of di↵ering molecular weight (Mw) and charge: Alcian Blue (1299
g.mol 1, cationic) and Fast Green FCF (808 g.mol 1, anionic), and then imaged over 2
hrs to measure di↵usion of the dye across the gap. They were analysed as above, using
ImageJ.
Recapitulation of the osteochondral region
Human femoral condyle tissue from the ‘una↵ected’ region of the joint was washed in
PBS to remove residual fat or blood before a cylindrical core was drilled and removed
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from the centre using a diamond coated drill bit (10 mm outer diameter) and surgical
saw. Primary chondrocytes and osteoblasts were isolated from the tissue of the core and
expanded in monolayer. The remaining tissue was scanned using µCT, whilst immersed
in culture media to maintain hydration, before being incubated during the expansion of
the cell populations. The following µCT parameters were used: 0.5 mm Al filter, 80 kV,
100 µA, 27.05 µm pixels, 670 ms exposure time, 0.6° rotation step, 3 frame averaging.
The expanded cells were mixed with hydrogel solutions in preparation for printing. The
cartilage-like region used 1.5% w/v gellan gum and the bone-like region used 1.5% w/v
gellan gum with 0.6% w/v nanoHAp from solution.
Bilayered structures were printed by extruding the first (non-mineralised) layer and
then swapping the syringe to print the second (mineralised) layer; the print geometry
was defined by the results of µCT scanning following coring to produce an exact fit for
the plug. The whole structure was then ionically crosslinked to gel the two layers into a
single structure. For imaging, acellular constructs were sectioned and freeze-dried prior to
attaching to 25 mm aluminium conductive SEM stubs using adhesive carbon discs. µCT
was used to visualise the mineral inclusion in the sca↵olds; the following parameters were
used: 30 kV, 70 µA, 6.76 µm pixels, 1000 ms exposure time, 0.3° rotation step, 4 frame
averaging. For mechanical characterisation of the influence of the mineral component,
constructs were printed solely of either gellan or gellan-mineral before crosslinking and
removal of the part.
Biological characterisation of the osteochondral model
Following printing, cell viability was measured using a LIVE/DEAD assay within 2 h. Bi-
layered constructs were re-implanted into the defect sites in the ex vivo tissue that they
were isolated from and cultured for 28 days. Following 28 days culture, n=3 constructs
were partitioned into cartilage, interface and bone regions before being homogenised for
qRT-PCR while some were used for immunohistochemical imaging.
To verify that cells were still functional following following suspended printing, they
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were exposed to increasing doses of IL-1  and the resultant production of IL-6 was mea-
sured using solid phase sandwich ELISA. The same protocol was applied to chondrocytes
in monolayer as a control.
Statistical analysis
Statistical analyses were performed using Prism 7 (GraphPad, CA, USA). Student’s t-
tests were used in PCR analysis. Data are presented as mean ± standard deviation (SD)
with the exception of qRT-PCR data which is presented as mean ± standard error of the
mean (SEM). Results where p<0.05 were considered significant.
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5.3 Results
Characterisation of the agarose fluid bed
Agarose fluid gel was produced by introducing shear as the hydrocolloid solution was
cooled. This resulted in the formation of an entangled microparticulate gel network as
can be seen in Figure 5.2 using phase contrast microscopy. Individual tadpole-shaped
particles were formed (as indicated by arrow in Figure 5.2A) which then appeared to
interact from the head-regions to form larger aggregate particles of between 150-200 µm
in diameter. The shape of the particles prior to agglomeration was likely due to the way
that shear was applied during gelation. The hypothesised production of these particles is
shown in Figure 5.2D. The high shear in the column above the stirrer (region marked (1)
within dashed lines) may cause the formation of elongated gel particles and the toroidal
motion of the bulk gel in 3D forces these individual particles into regions of lower shear.
This would allow for the agglomeration and entanglement of these particles. In a bulk,
Figure 5.2: Phase contrast imaging of fluid agarose particles showing A) individual units
indicated by arrow B) characteristic ‘hairy’ aggregates and C) interaction of aggregates.
D) Schematic hypothesis of formation of individual particles and aggregates at high (1)
and low (2) shear regions respectively. SB=150 µm
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as seen in Figure 5.2C, the aggregates interact and entangle by the tails which project
from the core. These weak entanglements are likely responsible for the unique mechanical
properties of fluid gels.
Rheological investigations were performed to investigate the properties of agarose
fluid gel under shear. Firstly a stress sweep was performed; the LVR was found to be
fairly short with a cross-over between G’ and G” at 32 Pa. A frequency sweep was then
performed at 1% strain which showed a higher G’ than G” (tan  = 0.17±0.013), and slight
frequency dependence indicating weak gel, or structured liquid, behaviour (Figure 5.3 A,
B). The shear rate was alternated between 0.1 and 100 s 1 to investigate the recovery
of viscosity. As expected, the fluid gel was highly shear thinning and the recovery of
viscosity was very fast (Figure 5.3C). Finally, a high shear rate (100 s 1) was applied and
then removed to determine the recovery of elasticity in the agarose matrix. Figure 5.3D
shows that there was a rapid increase in shear storage modulus immediately following
shearing, although the recovery to the original elasticity takes longer than 30 s.



























































0.1 s-1 0.1 s-1 0.1 s-1
100 s-1100 s-1
Figure 5.3: Rheological characterisation of 0.5 w/v% agarose fluid gel A) Stress sweep
from 0.1-100 Pa B) Frequency sweep from 0.1-100 Hz at 0.1% strain C) Recovery of
viscosity between shear rates of 0.1 and 100 s 1 D) Recovery of elasticity at 1 Hz and 0.5
% strain following a 60 s peak hold at 100 s 1. Data plotted are mean ±SD, (n=3).
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Suspended printing resolution and di↵usion limits
Printing into a particulate fluid system restricted the resolution of print geometries to
features that were larger than the interstices between gel particles. By printing a dye
with a similar viscosity to water, the movement of material through the continuous phase
into the interstices between fluid gel particles was visualised (Figure 5.4A-F). The achieved
resolution decreased as the inner diameter of the needle increased (and Birmingham gauge
number decreased) (Figure 5.4, R2 = 0.9846). There was also larger variability of the
printed wall width when a larger needle was used.
Figure 5.4: Resolution capabilities of 0.5 w/v% fluid agarose print bed with increasing
needle diameter (decreasing gauge) A-F. SB: 5 mm; data are presented as mean ± SD,
n=18.
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Figure 5.5: Di↵usion of low viscosity dyes of varying molecular weight across a 2mm gap
following printing. A) Di↵usion data over time, B and C) Optical images of di↵usion over
120 min in B) Alcian Blue solution of 1299 g.mol 1 and C) Fast Green FCF solution of
808 g.mol 1. SB: 5 mm, bottom right = time (min); data are presented as mean ± SD,
n=9.
Further, whilst low viscosity solutions could be printed and supported, there was
a limitation of di↵usion through the particulate gel matrix. This resulted in a finite
crosslinking time before printed features were lost. Figure 5.5 shows the time-dependent
di↵usion of dye solutions of di↵erent molecular weight (Mw) across 2 mm gaps. The
di↵usion of the dye as it filled the gap was imaged over 2 h as shown in Figures 5.5 B and
C. The dye with a lower Mw (Fast Green FCF, Figure 5.5C) showed significantly faster
di↵usion than the higher Mw dye (Alcian Blue, Figure 5.5B)) (P=0.0063).
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Bioprinting of low viscosity solutions into complex geometries
To demonstrate that this technique allows for freeform fabrication, a number of structures
were printed. Printing of helical structures with overhangs showed the capability of the
agarose fluid bed to support a suspended low viscosity gel prior to crosslinking (Figure
5.6D and video 3 (1)). In more practical applications, the printing of tubular structures
and perfusable bifurcations were also possible using this technique (Figure 5.6).
Figure 5.6: Examples of geometries that can be printed from 1% w/v alginate (with food
dye for visualisation) using suspended manufacture including hollow (A,B) and hollow
bifurcating (C) structures. D) is a snapshot of Video 3, showing the printing of a helical
structure with overhangs without the need for additional support structures.
Bioprinting of bi-layered constructs and subsequent characterisation
To produce constructs that model the OCU, mineralised and non-mineralised regions were
required. As such, HAp was combined with gellan gum and printed into gellan/gellan-
1
Video available at https://tinyurl.com/yctb9eqm
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mineral constructs with continuous interfaces. This was observed visually in Figure 5.7A,
as the addition of mineral increased the opacity of the gel construct. Mineral is highly
attenuating so its distribution in the whole construct was investigated using µCT as
in Figure 5.7B. The interaction of HAp with the gellan polymer network can be seen
in Figure 5.7 C, as it coated the polymer throughout in individual particles but also
formed aggregates, as indicated by the arrow. Finally, inclusion of HAp resulted in faster
relaxation behaviour following loading to 20% strain (Figure 5.7D).
Figure 5.7: Introduction of mineral for production of bi-layered constructs. A)
Gellan/Gellan-HAp construct. B) µCT reconstruction of a bi-layered construct. C) SEM
of HAp integrated into gellan structure, arrow indicates aggregated HAp. D) Stress re-
laxation behaviour of gellan (GG) and GG-HAp constructs.
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Characterisation of embedded printed cell populations
Human osteoblasts and chondrocytes were isolated and cultured prior to printing into a
bi-layered construct. The printing process showed very good cell viability (Figure 5.8)
with very few dead cells. qRT-PCR was used to determine the stability of cell phenotype
following printing and 28 day culture of osteochondral plugs. The retrieved constructs
were sectioned as shown in Figure 5.9A prior to homogenisation for analysis. Figure 5.9
shows that Col II and aggrecan expression remained highest in the cartilage-like region
of the constructs and lowest in the bone-like region. Col I characterisation showed the
opposite, with the highest expression in the bone-like region.
Figure 5.8: Viability of TC28 cells directly after printing SB: 200 µm
For the development of tissue models, it is important that the embedded cell popula-
tions maintain their ability to produce cartilage matrix and maintain functional responses
to stimulation. Production of aggrecan (ACAN) by chondrocytes following SusMan was
investigated using IHC; Figure 5.10A shows strong evidence of aggrecan in the peripheral
regions of cells and some evidence of aggrecan in the extracellular regions. The response
of chondrocytes to inflammatory stimuli in printed constructs was evaluated by measuring
the production of IL-6 as a function of IL-1  dosage. Figure 5.10B shows this response
at 4 and 24 h. In the 3D printed (SusMan) group, the peak response was delayed and
seen to occur at a higher IL-1  concentration than in the monolayer group. The increase
between 4 and 24 h in both groups was similar however.
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Figure 5.9: qRT-PCR of partitioned constructs following 28 days culture. A) Retrieved
construct after culture in an ex vivo defect B) COL1A1, C) COL2A1 and D)ACAN
expression relative to 18S. Data are shown as mean + SEM, n=3.
Figure 5.10: Functional characterisation of SusMan constructs A) Aggrecan staining in
cartilage-like region. B)IL-6 production as a result of IL-1  stimulation at varying doses




Bioprinting is a growing field and has already enabled the production of cell-seeded tissue
constructs with high degrees of control over both the spatial deposition of both biological
material and support materials [94]. The development of embedded printing has allowed
for more complex geometries to be produced and from a wider pool of bioinks [13, 79].
In this study, the aim was to use a novel technique for embedded printing to produce
functional cell-seeded models of the OCU.
Using this technique, the traditional 2D print bed was replaced by a 3D fluid gel
support matrix. The agarose fluid gel showed hairy particle morphology similar to that
seen by Ellis et al. in the production of an agar fluid gel in a pin stirrer [42]. The hypoth-
esised method of formation of these fluid gel particles is based on the toroidal fluid motion
seen in vortex flow generated by a magnetic stirrer [73]. As the hydrocolloid solution un-
dergoes sol-gel transition, the central, vertical shear forces cause elongation of a spherical
particle into a tadpole-like morphology. These then entangle to form aggregates, which
are presumed to take a largely spherical morphology based on their circular appearance
in 2D by phase contrast microscopy.
The entanglements between neighbouring particles are responsible for their rheologi-
cal properties; in the absence of shear, particles are highly entangled and exhibit weak-gel
behaviour. However, these are weak entanglements, such that upon the application of
low shear (30-40 Pa) they are easily disrupted, allowing the particles to move past each
other in a fluid-like motion [132]. During printing, the movement of the needle through
the gel, as well as extrusion of the bioink into the gel, displaces the fluid gel. When the
local forces involved in printing are removed, the matrix quickly restructures as shown by
the fast viscous recovery of the fluid gel after shearing. Increasing the needle diameter
resulted in thicker walls being printed and also more variability which is likely due to both
the increased volume of material that was extruded and also because the needle itself was
larger, so induced greater shear forces on the surrounding fluid gel.
The use of fluid gel as the support matrix draws similarities with some other tech-
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niques that have been employed for embedded printing. The FRESH method, developed
by Hinton et al., uses a gelatin slurry, produced by blending crosslinked gelatin into
microparticles, that polysaccharide and protein-based bioinks can be printed into [79].
Following printing, the gelatin slurry matrix is heated to liquefy it and it is then removed.
This was also possible in agarose fluid gels as they are thermogelling, however, fluid gels
could also be removed by the gentle application of shear using sterile instruments or shear
from washing. Another technique with similarities has also been investigated by Hinton
but was first developed by Bhattacharjee et al.; ‘Writing in the granular gel medium’,
employs carbopol, a highly hydrophilic granular polymer of 7 µm particles, into which
hydrophobic inks can be printed with high (100 µm) resolution [12, 80].
In SusMan, the combination of the fluid gel particles and residual phase of partially
gelled material (the continuous phase), limited the print resolution and allows di↵usion of
liquid material through the matrix. Increasing the Mw of the bioink reduced the rate of
di↵usion, enabling longer times for crosslinking before feature resolution was lost. In this
study, dyes of Mw from 808-1299 with viscosities close to that of water were used to study
resolution and di↵usion. Using low viscosity solutions represents the worst-case scenario
for di↵usion as the movement of liquid into the interstices between fluid gel particles
will be at its highest. A number of polysaccharide and protein-based bioinks have been
printed using SusMan, including collagen which has a crosslinking time of between 0.5-2
h depending on the protein concentration (Senior, Cooke et al. In preparation).
In this study, a 1% w/v alginate solution was shown to be suitable for producing
complex geometries by SusMan; tubular constructs of up to 30 mm in height as well as
perfusable bifurcating structures were printed, crosslinked and removed from the fluid
gel matrix. For cell-seeded constructs, gellan gum was used; gellan has previously been
shown to be suitable for cell culture and can be easily modified by the introduction of HAp
to alter its chemical and mechanical properties [88, 118]. Here, bi-layered gellan/gellan-
mineral constructs were produced. The use of sol-HAp ensured that the mineral was fairly
evenly distributed in the polymer, with a few larger aggregates. The interface between the
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mineralised and non-mineralised regions appears to be continuous optically and by µCT;
upon removal of the construct following the culture period, the structure was still intact.
The addition of nanoHAp was also shown to increase the rate of stress relaxation, which
has previously been shown to favour mineralisation in culture [24]. The process conditions
applied to the cells during printing were su ciently mild that very good viability was seen
in chondrocytes after printing.
Primary human chondrocytes and osteoblasts were isolated and cultured in printed
sca↵olds for 28 days. The expression of Col II and Col I changed gradually throughout
the structure inline with what would be expected with the native tissue region. This
indicated that while the two sections of the osteochondral sca↵old were well integrated,
the embedded cell population retained their native phenotype. As in chapter 4, quiescently
gelled polysaccharide matrices restricted cell migration. The production of aggrean shown
by IHC, indicated that the embedded chondrocytes were still metabolically active and
capable of laying down matrix, as has been seen previously in chondrocyte culture in gellan
[150]. Further, their functional response to stimuli was confirmed by the production of IL-
6 in response to IL-1  stimulation. The response was delayed, compared to chondrocytes
in monolayer, in relation to both timing and dosage. The level of cytokine production at
4 h in monolayer was not seen in the printed constructs until 24 h. This delayed response
may be due to the di↵usion of both the IL-1  into the construct and IL-6 out of the gellan
matrix. Further, the peak response in printed constructs was at 1 ng/mL compared to 0.3
ng/mL in monolayer culture. This may be due to reduced proliferation in the 3D matrix
compared to in monolayer, although this was not quantified.
The use of ALM to produce functional tissue constructs has two potential appli-
cations: 1) to replace damaged or defective tissue and 2) to produce in vitro models.
These models may be used for the testing of novel therapeutics prior to preclinical animal
models as well as developing a better understanding of in vivo processes [187, 188]. It is
widely accepted that osteochondral cell behaviour in 3D culture is much closer to that of
the in vivo environment than 2D culture [38]. Therefore, development of 3D models as
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platforms for drug profiling may enable better in vitro testing of potential therapeutics to
reduce the number of animals used in preclinical studies. Further, by integrating multiple
cell types, the mode of action of therapeutics on both the bone and cartilage aspects of
the joint may be assessed simultaneously.
5.5 Conclusions
In this study, a new method of embedded printing was used to manufacture comparatively
complex soft-solid structures by extruding a hydrocolloid solution into a supporting fluid
gel matrix. The fluid gel matrix was characterised and a hypothesis for the morphology of
the gel particles was presented. The resolution and di↵usion of low viscosity solutions were
measured to determine the limits of the technique. The method allowed the structuring of
soft-solid materials into geometries not possible by traditional bioplotting techniques. It
was shown that suspended manufacture could recapitulate the structure of the osteochon-
dral region as defined by CT scanning. The printed structure maintained its morphology
and mechanical robustness over a period of four weeks of culture during which the en-
capsulated cells retained their phenotype. Further, the embedded cell population was
responsive to inflammatory stimuli showing that cells maintain their functional response
such that this model could be developed into a testing platform for novel therapeutics.
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CHAPTER 6
CONCLUSIONS AND FUTURE WORK
6.1 General overview
The osteochondral unit is a highly specialised structure that serves many functions. In
OA and traumatic cartilage injuries, there are both clinically detectable and clinically
silent changes in remodelling of cartilage, bone and other joint tissues. As the prevalence
of OA and other degenerative diseases continues to increase with the world’s ageing and
increasingly obese population, developing a better understanding of the changes is highly
important in order to develop better and more e↵ective treatment strategies.
In this thesis, new findings about the clinically silent changes that occur in the
OA joint have been presented by utilising techniques that are established in the fields of
engineering and material science but are infrequently used to study biological systems.
Further, unanswered questions about the phenotypic changes commonly reported in chon-
drocyte culture in 3D have been investigated alongside development of new methods for
delivery of cell populations by structuring hydrogels. Finally, by utilising these hydrogel
structuring methods, a novel bioprinting method was developed to overcome some of the
limitations in traditional bioprinting. This enabled the production of bioprinted models of
the osteochondral unit that could maintain cell phenotype and function whilst providing
distinct chemical and mechanical environments.
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6.2 Limitations and future investigations
6.2.1 Mechanical and physicochemical analysis of cartilage
The early, clinically silent changes that occur in OA prior to mechanical cartilage damage
are clinically important, as interventions at this stage may help to slow or prevent degen-
erative OA. In chapter 3, methods more commonly seen in materials science were used to
investigate the changing matrix properties of OA cartilage.
Cartilage has long been known to be a viscoelastic tissue, and here the frequency-
dependent viscoelastic behaviour of human OA and healthy cartilage was compared for
the first time. Due to the use of human tissue, the sample number was limited; particularly
the number of ‘healthy’ post mortem samples available. As such, all mechanical testing
was performed in the same order of increasing frequency. It is likely that during testing,
some fluid was pushed out of the cartilage explant as they were tested in unconfined
compression. Therefore, there will be small and gradual decreases in the level of hydration
during testing. To investigate this, future studies should consider randomising the order
in which the frequencies are applied or test in a hydrated system. Further, in this study
a wide range of frequencies were measured to investigate both typical and atypical heel
strike rise times. It would be interesting to look more closely at the viscoelastic behaviour
at the lower frequencies, as they are more commonly experienced in normal loading.
Regarding the physicochemical characterisation of cartilage samples, it would be
interesting to further investigate the mineral identified in cartilage sections from OA
subjects. Determining whether this was HAp (the most common mineral found in bone) or
calcium pyrophosphate dihydrate (CPPD) may help identify the mechanism of formation
or deposition. This could be achieved by investigating the Ca:P ratio in inclusions from
quantitative µXRF data. The use of TGA allowed for a very accurate quantification of
the amount of water present in OA and healthy tissues but could also be used to gather
more information about the changing cartilage matrix. TGA has been used previously to
identify the amount of organic material in bone, both between species and also between
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disease states in humans so could provide interesting information about the state of the
cartilage matrix in healthy and OA samples [131].
Another interesting observation that could be achieved in future studies is the depth
dependence of the dynamic mechanical properties reported. As the structure and chem-
istry of cartilage varies through the di↵erent zones of cartilage, the di↵erence in properties
in OA could be further elucidated; as was seen in this study, the superficial region was
susceptible to damage whilst the middle and deep zones were undamaged in this loading
regime. This further study could be achieved by performing DMA at su ciently low fre-
quencies that none of the tissues were damaged, then removing a defined depth of tissue
using a microtome and re-testing (following full recovery). For this investigation, it would
be important to maintain the cartilage on the subchondral bone to ensure that the full
depth of cartilage was being tested.
6.2.2 Geometric confinement of chondrocytes
Cartilage was one of the first tissues that researchers sought to regenerate and to model
in vitro, with its seemingly simple composition and structural organisation. However,
this was not to be the case and after over 30 years of research, tissue engineered hya-
line cartilage has still not reached clinical use. This can be attributed to many reasons.
Cartilage is formed during early development and matures into a tissue with very low
matrix turnover in adult life. Therefore, adult chondrocytes exhibit low anabolic capac-
ity for matrix production. Many strategies have investigated the use of stem cells, and
embryonic stem cells have shown great potential for cartilage (and other) tissue engineer-
ing strategies. However, the ethics surrounding their use are di cult to navigate. Over
decades of cartilage engineering research, alginate has consistently been shown to promote
chondrocyte phenotype and matrix production.
In chapter 4, alginate matrices of identical chemistry but di↵erent structures were
produced and seeded with human chondrocytes. In fluid alginate, chondrocytes were
able to migrate laterally and vertically through the gel matrix compared to the quiescent
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matrix where they were static. Reducing the level of confinement reduced the capacity of
the chondrocytes to redi↵erentiate following monolayer expansion. Work by Lee, Mooney
and Chaudhuri, that was published a week prior to the work presented in this thesis,
showed very similar results [107]. Using alginate matrices of di↵ering stress relaxation
times they showed that more elastic hydrogels, with faster relaxation times, caused a
larger upregulation of expression of Coll II and aggrecan. They also showed that in the
slower relaxing gels, there was upregulation of IL-1 , MMP-13 and ADAMTS-4, which
are all markers of cartilage matrix breakdown [107].
In this study, fluid gel matrices were shown to be unsuitable for chondrocyte cul-
ture regarding the maintenance of phenotype. However, they support cell viability and
also allow migration of cells so may show potential in culture and delivery of other cell
types. As the alginate particles produced during shear are on the range of 10-20x the
size of chondrocytes, it is hypothetically possible to produce an alginate fluid gel with
chondrocytes entrapped within the gel, which would provide the level of confinement re-
quired. The limitation here however would be cell viability as the introduction of high
shear during gelation would likely cause cell death. Another avenue for chondrocyte cul-
ture in fluid gels is to modify the alginate chains to introduce cell-binding ligands; this
may act to constrict their movement or stimulate the mechanosensory pathways that are
active in entrapped cells. Generally, future investigations into the use of fluid gels for
unconfined 3D cell culture should focus on cell types which require a soft substrate (or
are non-adherent) and those for the investigation of cell migration in 3D.
6.2.3 Biofabrication of osteochondral tissue models
Embedded printing shows great potential to produce bioprinted constructs of greater com-
plexity without gravitational limitations typically seen in ALM of hydrogels. In chapter
5, a novel method for embedded printing was presented and utilised for the production
of bilayered sca↵olds to recapitulate the osteochondral unit. The same concept of intro-
ducing shear during gelation as demonstrated in chapter 4 was used to produce a support
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matrix for low viscosity materials in bioprinting. The agarose fluid gel was shown to be
a suitable support matrix for the printing of materials with low viscosity - even water
could be printed into the fluid gel matrices. There are, however, limitations surrounding
the use of particulate print matrices. These were investigated via the di↵usion of dyes of
di↵erent Mw. Further investigations into the di↵usion of hydrocolloid solutions through
the matrix would be valuable in developing a fuller understanding of the di↵usion limita-
tions in polysaccharide, protein and synthetic bioinks. Regarding the resolution limitation
investigated, the use of smaller needles and hardware with increased print resolution may
reduce the size of features that can be printed. Developing a more complete understand-
ing of the continuous phase of partially gelled material within the fluid gel would also
help these investigations.
To advance the presented osteochondral model as an in vitro model of OA, a po-
tential study could explore the co-culture of osteoblasts and chondrocytes from di↵erent
cohorts of patients and investigating cellular crosstalk. By using chondrocytes from OA
patients and osteoblasts from ‘healthy’ patients (and vice versa), cross-talk between the
healthy and OA groups could help to better understand the sequence of events that oc-
cur. Further, co-cultures of cells isolated from OA patients of di↵ering BMI classifications
could be used to probe the e↵ects of adipokines on inflammation-based drivers of OA
progression. In this context, adipose tissue-conditioned media could be an e cient way
to deliver adipokines. As the hydrogel constructs can be easily divided into regions for
analysis, these bioprinted co-culture systems are simple to section for analysis compared
to having mixed cell populations in a single-layered 3D sca↵old. When a co-culture is well
established, the validation of potential therapeutic targets should be performed. These
could be therapeutics that aim to dampen the inflammatory response and also those that
aim to recover normal production of cartilage matrix.
To develop this model further in the future, increasing the number of cell types used
in co-culture would enable the production of a construct that more closely modelled the
whole joint environment. This, however, would present greater challenges in designing
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bioinks to promote native phenotype and production of extracellular matrix in more cell
types, in a single culture media. This would likely involve employing di↵erent base bioinks,
prior to additives, in di↵erent regions. This has been achieved from a materials aspect
(Senior, Cooke et al. In preparation), but the integration of cells and further biological
material would be critical for the development of a more sophisticated model. An elegant
demonstration of the ability to modify cell phenotype could be achieved by the seeding of a
single stem cell population into materials of di↵erent mechanical properties and chemistry
within the same construct, and measuring the potential for di↵erentiation directed by the
sca↵old rather than growth factors in culture media.
Finally, this printing technique is not limited to producing models of the osteochon-
dral unit. One example is the modelling of a blood vessel lumen. As shown, tubular
structures can be printed of complex and bifurcating geometries that can then be per-
fused. By integrating smooth muscle cells into the bioink, they could be printed into
tubular structures, before seeding endothelial cells onto the inner surface. Following es-
tablishment of the cell populations, the e↵ects of di↵erent flow regimes on the endothelial
and muscle cell populations could be investigated. Suspended manufacture is a flexible
and inexpensive way to bioprint complex and physiologically-sized constructs from mate-
rials that support cell culture but are not ‘printable’ by other methods. There is potential
for this technique to be used in the production of both in vitro models and potentially
implantable in vivo constructs for tissue regeneration.
6.3 Overall summary
The three studies presented in this thesis answer novel questions and provide potential
solutions surrounding the changes to the cartilage extracellular matrix in osteoarthritis
and cartilage injuries. By structuring hydrogels in a unique way, materials which have
been well characterised for use in TE have new usability. Further investigations into
components of each of these studies should be sought to continue their development.
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APPENDIX A
CHAPTER 3 SUPPLEMENTARY MATERIAL
Frequency Healthy OA p
(Hz) n=22 n=37
1 32.50 ±1.60 28.74 ±0.98 0.039
8 35.63 ±1.74 31.63 ±1.08 0.043
10 36.26 ±1.77 32.13 ±1.09 0.040
12 36.93 ±1.82 32.74 ±1.11 0.041
29 38.84 ±1.91 34.42 ±1.16 0.040
49 40.29 ±1.99 35.76 ±1.21 0.043
71 41.13 ±2.01 36.63 ±1.25 0.050
88 42.03 ±2.10 37.52 ±1.30 0.058
Table A.1: Storage modulus mean ±SD and p-values
157



















































































































































































































Figure A.1: Temporal displacement of OA (grey) and healthy (black) cartilage during A)
preconditioning cycles and B) testing frequencies. For a representative healthy specimen,
the displacement amplitude for 1 Hz at the beginning of cycling was 0.025 mm and for
1 Hz at the end of the testing was 0.022 mm. In this OA specimen, the displacement
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1. Introduction
Hydrogels are extensively used in regenerative medicine 
research as a consequence of their high-water content, meaning 
that they can be placed into a biological system without com-
promising viability.[1–3] Furthermore, given that they are formed 
from large, organic molecules, there is considerable scope for 
customizing the materials through modifications in the chem-
istry of the polymer backbone (the introduction of cell adhe-
sion moieties, etc.), or by manipulating the gel cross-linking 
The development of new materials for clinical use is limited by an onerous 
regulatory framework, which means that taking a completely new material 
into the clinic can make translation economically unfeasible. One way to get 
around this issue is to structure materials that are already approved by the reg-
ulator, such that they exhibit very distinct physical properties and can be used 
in a broader range of clinical applications. Here, the focus is on the structuring 
of soft materials at multiple length scales by modifying processing condi-
tions. By applying shear to newly forming materials, it is possible to trigger 
molecular reorganization of polymer chains, such that they aggregate to form 
particles and ribbon-like structures. These structures then weakly interact at 
zero shear forming a solid-like material. The resulting self-healing network is 
of particular use for a range of different biomedical applications. How these 
materials are used to allow the delivery of therapeutic entities (cells and pro-
teins) and as a support for additive layer manufacturing of larger-scale tissue 
constructs is discussed. This technology enables the development of a range 
of novel materials and structures for tissue augmentation and regeneration.
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process.[4,5] The first application of encap-
sulation to protect mammalian cells was 
in the 1980s, to enable the delivery of 
pancreatic islets as a treatment for dia-
betes.[3] This has ultimately spawned a 
very active research field, where gels are 
often used for the delivery of cells or other 
therapeutics.[6–8] In the last ten years, gels 
have been used widely to study how cells 
are able to respond to their local environ-
ments, enabling ground-breaking work 
that not only starts to reveal how cell 
fate can be determined by tailoring stiff-
ness,[9,10] the geometry of moieties dis-
tributed around the cells,[11,12] and the 
viscoelasticity of cell attachments/envi-
ronments,[13] but can be exploited to syn-
thesize unique delivery systems.[14,15] All 
of this points to the fact that there should 
be a panapoly of novel gel-based materials 
that are making their way to clinical appli-
cation. Despite all of this progress, how-
ever, this is not the case and one of the major reasons for this 
is that new medical materials must pass a very large number of 
biological safety tests before they are used. In addition, mate-
rials to be used in clinical trials or for sale on the market must 
be supplied via a manufacturing process that is developed, vali-
dated, and operated in accordance with Good Manufacturing 
Practice (GMP). This requires engagement with appropriate 
GMP-licensed pharmaceutical/medical device manufacturing 
facilities. The use of bespoke chemistries and formulation con-
ditions can preclude the use of processing methods and equip-
ment that are standard to the pharmaceutical/medical device 
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manufacturing industry. Thus, this furthers the increasing level 
of innovation required to develop a finished product. In many 
cases, this means that it is not economically viable to move these 
materials to the point of clinical trial and so clinical researchers 
tend to stick with a very small number of materials, which they 
use to deliver a multitude of therapeutic entities. In an attempt 
to take a much more rational approach to the use of hydrogels 
in clinical applications, we have pushed forward research on 
the structuring of materials that have already secured MHRA/
EMA/FDA approval so that they can exhibit distinct physical 
properties. We have done this by modifying gelation condi-
tions through the application of shear and by the absorption of 
reactive molecules into the gel structure in order to enable the 
formation of third phases within and between the gel particles. 
Although not completely void of the substantial costs required 
to deliver new therapeutic molecules, which require significant 
investment in toxicological and safety testing, the significant 
reduction gained from previously obtained data sets allows a 
more direct route to translation, which may result in higher 
degrees of adoption. Therefore, this paper summarizes the 
work that we have done in this area in the past few years and 
suggests areas for further research and development opportuni-
ties in the coming years.
2. Structuring Hydrogels by Shear—Formation  
of Fluid Gels
The diverse and controllable characteristics of gels, in par-
ticular hydrogels (water-based gels), have initiated great interest 
across a multitude of industries and applications. Within the 
field of biomedical research, many FDA/MHRA/EMA-approved 
synthetic polymers have been studied for their ability to form 
gelled networks.[16] However, more recently, there has been a 
push toward more natural biopolymers such as polysaccha-
rides and sugar-based hydrogelators[17] for both their ready 
availability and frequent similarity to the extracellular matrix 
(ECM). It is of no surprise therefore, that polysaccharide hydro-
gels have become widely used in the field of tissue engineering: 
predominately used as scaffolds, presenting a mimetic of ECM 
with the intrinsic ability to stimulate growth and the formation 
of new tissue.[18]
Their key ability to structure large volumes while creating 
an elastic system arises through the material microstructure; 
where coupling of long, structurally regular chains forms inter-
molecular junction zones that pack in a fashion comparable 
to those of solid-state materials.[19] However, to better under-
stand the origins of the macroscopic properties, it is necessary 
to consider structure–property relationships from the mole-
cular level. It is common to distinguish protein structures at 
multiple levels of organization.[20] These descriptions are also 
apt for polysaccharides: the primary structure detailing the 
sugar chain sequence, secondary structure defining geometric 
arrangement (helices and ribbons), and tertiary structure high-
lighting the 3D association of secondary structures.[21] This 
structuring across the polymer chains leads to varying levels of 
chain associations during the disorder–order transition upon 
gelation. For example, in the case of carrageenan (a galactopyra-
nose polymer), domains of linked helices (tertiary structures) 
are formed through intermolecular association, but further 
require ionic-mediation to develop a continuous gel structure 
(Figure 1ai).[22] Therefore, inevitably, the number and density 
of junctions formed in this way between polymer chains is a 
direct function of the final gel strength and elasticity.[23]
This results in an array of material behaviors varying from 
strong gels, with relatively large moduli independent across 
a large range of frequencies, indicative of self-supporting 
structures, to weak maleable gels, where weakly associated 
chains lead to high-frequency sensitive systems with com-
paratively low moduli (Figure 1b).[24] However, the reliance 
on molecular configuration to achieve certain properties is a 
major problem, since when implanted or formed in situ the 
large number of other molecules that are present in the in 
vivo milieu interfere with these processes and can make them 
unpredictable. Such unpredictability is a significant barrier to 
clinical translation.
In an effort to produce more predictable systems, microgel 
suspensions known as “fluid” or “sheared” gels are being 
employed for their unique flow behaviors,[25] engineering the 
ability to self-structure post-shearing.[26–28] This presents a much 
more dynamic scaffold, which can be prepared exogenously 
for potential injection into the body.[29,30] Patented in 1990 as a 
system of microgels for use in food and cosmetics, derived upon 
shearing throughout gelation, fluid gels are substantially less 
rigid than their quiescently formed counterparts.[30] Shearing 
during the sol–gel transition results in networks of weakly 
flocculated, discrete gel entities (Figure 1aii), whereby particle 
sizes become dependent on the applied shear, and suspension 
rheology based on particle volume fractions.[31,32] However, 
in reality, such systems are more complicated, as interactions 
between particles on a mesoscopic level (structuring between 
particles) effectively dictate the bulk rheology of the systems. 
The particulate nature of these networks engenders a level of 
self-healing following manipulation, which is a key property 
that can be exploited in a number of biomedical applications.
The differences between quiescent gels and the properties 
of the microgels formed on shearing again lie in the micro-
structural changes upon gelation. One such example is the sig-
nificantly reduced enthalpies of melting in carrageenan fluid 
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gels when compared to their quiescent form (Figure 1d). Such 
data infers a heterogeneous polymer density across the gelled 
entities, with fewer ordered helices toward the particle periph-
eries.[33] This is not true for all polysaccharides however, as agar 
systems do not show such disparities.[32] Here, rapid gelation 
kinetics result in more uniform helical domains across the par-
ticles.[34,35] This suggests a mechanistic change in the microgel 
formation, driven by competition between two major factors: gela-
tion kinetics and shear separation time/length scale (Figure 1c). 
Particle morphology also demonstrates a dependency on the 
competition between the two phenomena. In systems where 
gelation kinetics “k” greatly outweighs the time scale of separa-
tion “γ” (k > γ), rapid aggregation followed by subsequent shear 
breakdown develops large anisotropic morphologies. Whereas, 
in the counter case, k < γ, large shear forces confine growth, 
leading to more regular particles.[27] The consequential effects 
of such changes in particle morphology upon the aforemen-
tioned mesoscopic structuring have been clearly identified for 
both linear and nonlinear rheological properties. In the case 
of spherical particles, suspensions agree with Hertzian models 
resulting in elastic moduli arising through particle deforma-
tion, as systems become closely packed (Figure 1e).[25,36] Elastic 
response for anisotropic particles however, occurs at much 
lower volume fractions.[25] This is also reflected in the nonlinear 
measurements, with particles enhancing viscosities at volume 
fractions as low as Φ =  0.2.[37] In these cases, large effective 
hydrodynamic volumes associated with anisotropic morpholo-
gies allow a vast degree of continuous phase to become struc-
tured by very few particles.[37–41]
Although some of the literature highlights the differences 
between quiescent and fluid gels, projecting the design rules 
in which to engineer systems with specific intrinsic properties, 
the actual nature of the interstitial space between particles is 
yet to be adequately defined. One theory proposes that disor-
dered “hairy-like” polymers at the particle interfaces interlink 
to form a weak network between particles.[32] This may be the 
case for closely packed particles, where the interstitial layer 
is of the order of several hundred nanometers. However, an 
alternative explanation proposed here would be a combina-
tion of entropically driven structuring,[40,41] resulting in steric 
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Figure 1. a) i) Schematic showing a typical gelled network where polymers interconnect to form junction zones (highlighted using red dots). ii) Diagram 
of a fluid/sheared gel system, where anisotropic gelled particles interact to form a weak continuous network. b) Idealized mechanical spectra showing G′ 
and G′′ dependency on frequency for both a strong “quiescent” and weak “fluid” gel system. c) 3D plot depicting the effects of processing on resulting 
suspension elastic response for protein fluid-gel particles. d) Differential scanning calorimetry (DSC) curves for carrageenan fluid gels. Note the change 
in peak height for the first and second melts, showing a change in degree of ordering between the fluid gel in the first heat and quiescent gel in the second 
heat. Adapted with permission.[34] Copyright 2012, Elsevier Ltd. e) Comparison of elastic moduli for sheared and spherical microgel systems: (⬤) 0.75% 
agar sheared gel, (○) 1.75% agar sheared gel, (▾) 2% agar microgel spheres, and (△ ) 5% agar microgel spheres. Trend lines show both power and 
Hertz fits to sheared and spherical systems respectively. Adapted with permission.[25] Copyright 2000, the Royal Society of Chemistry. f) Structuring as a 
function of time for carrageenan fluid gels (FG) prepared at various shear rates: (⬤) 5 s−1, (▽ ) 100 s−1, and (⬛) 300 s−1. Reproduced with permission.[27] 
Copyright 2009, Elsevier Ltd.
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confinement of particles, and/or weak electrostatic bridging 
between microgel interfaces at smaller length scales. Such 
a theory would encompass hysteretic effects, where self- 
structuring postshearing through entropic interweaving and 
electrostatic bridging, results in the observed recovery of an 
elastic network (Figure 1f).[26–28]
3. The Delivery of Biological Therapeutics  
Using Hydrogels
Many hydrogel materials have been used for the encapsula-
tion and culture of cells in vitro, both for continued immunoi-
solation[42,43] and for the controlled delivery of biotherapeutics 
(both cells and proteins).[44–48] With the use of traditional “qui-
escently” gelled materials this can be very challenging, since 
gelation in a complex biological environment rich in ions and 
proteins can modify the kinetics of the gelation process and 
result in a material that gels unpredictably or behaves unpre-
dictably following the gelation process – something that is 
completely unacceptable in a clinical environment. Up until 
relatively recently, there was also little consideration to how 
the local environment has a strong influence on the dynamic 
mechanical properties of these materials. Alginate, for example, 
is now known to lose mechanical integrity when placed into 
a physiological environment,[49,50] due to ion exchange of the 
divalent cations that enable the formation of “egg-box” junc-
tions for monovalent ions such as sodium.[51] This causes the 
dispersion of the polymeric material and a loss of its ability to 
structure the surrounding liquid. This unpredictable behavior 
may explain why immunoisolation using polymers like algi-
nate has proven ineffective when applied clinically, unless 
other poly mers are incorporated as mechanically protective and 
permselective coatings.[42] What is also becoming very clear is 
that the materials are not “biologically inert”, but rather provide 
subtle environmental cues that strongly drive cellular behavior. 
Initially, this was thought to be principally a consequence of the 
modulus of the materials,[9,10] but more recently reports have 
suggested that this can be modified by changing the distribu-
tion of grafted adhesion moieties and the nature of the interac-
tions that may be formed with the polymer chain.[4,11,12] It has 
become clear that the level of entrapment that can be provided 
by the relatively stiff quiescently gelled matrix can have a signif-
icant influence on biological properties, including the capacity 
of cells to proliferate, maintain specific phenotypes or even 
secrete functional protein molecules as shown in Figure 2.[52–54]
3.1. Sheared/Fluid Gels as Delivery Agents
The shear processing of gels offers an additional degree of 
freedom for the production of cell and protein-delivery devices. 
From the perspective of handling, the reversible structural prop-
erties of fluid gels allow it to liquefy upon the application of 
shear, but may also be combined with biological fluids such as 
platelet-rich plasma or bone marrow aspirate and still thicken/
solidify in situ. This is often very difficult to achieve with inject-
able hydrogels that solidify through a process of cross-linking, 
in situ. As such, fluid gels have the capacity to act as delivery 
agents for a great number of different cell and protein products 
(Figure 3).
Mesenchymal stem cells alone have been proposed to have 
beneficial effects in patients suffering a multitude of patholo-
gies across body systems, including: the lungs,[55] brain,[56] mus-
culoskeletal system,[57,58] peripheral nervous system,[59] skin,[60] 
and the heart.[61] Although some have reported that direct 
injection of these cells into the affected tissues can have ben-
eficial therapeutic effects, the level of engraftment of the cells 
to the site of application typically ranges between only 1% and 
10%,[62–65] and has been proposed to be as low as 0.001%.[66] 
As a result, the number of cells that are typically used in these 
therapies tend to be very large, ultimately creating the poten-
tial for carcinogenesis and other negative outcomes. The cost 
of such a treatment is, of course, considerable and as has been 
shown with autologous chondrocyte implantation (ACI), the 
clinical outcome and patient benefit over standard of care is 
unclear.[67,68] There are a number of ways to overcome these 
issues, which include the retention of the cells at the site of the 
implant within a material or through the use of cheaper autolo-
gous therapies. These are classified as minimal interventions 
by the regulator.
We have been able to develop materials for the repair and 
regeneration of cartilage, the cornea, and the skin that can be 
delivered in a way that is amenable to eventual clinical applica-
tion. Through careful formulation, we have been able to pro-
duce materials that may be delivered using a range of different 
applicator technologies already used by clinicians, including 
cannulas/needles, sprays, and eyedroppers. Below, is a brief 
description of how we have used fluid gels to produce these 
therapeutics along with our progress in taking these to the 
point of clinical application. Furthermore, we have outlined 
major challenges that still need to be overcome in order to 
enable transition to the clinic. For each example, we have also 
outlined the clinical problems that we are attempting to address 
in order to place the technologies in context.
3.1.1. Cell Delivery for Cartilage Regeneration
Articular cartilage is a specialized avascular connective tissue 
layer covering the ends of bones that come together to form 
joints. It provides a smooth lubricated surface to minimize 
friction between the contact areas of the bones, and facilitates 
efficient load distribution through to the subchondral hard 
tissue. Chondrocytes, the sole cell type within cartilage, are 
sparsely distributed within a dense extracellular matrix that is 
mainly composed of collagen, water, proteoglycans, and glyco-
proteins. The high concentrations of hyaluronan and proteo-
glycan aggrecans allow for large volumes of aqueous medium 
to be entrapped within the matrix, and for covalent binding to 
other structural proteins, respectively, providing articular carti-
lage with its shock-absorbing properties.[69] Collagen organiza-
tion, as well as relative matrix composition, cell density, and cell 
morphology, vary as a function of depth from the articular sur-
face and act collectively to resist the range of forces experienced 
by the joint.
The avascular nature of cartilage and the low number of cells 
that are found within articular cartilage matrix result in a tissue 
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with poor regenerative capacity following damage. Articular 
cartilage is one of the most challenging tissues to engineer or 
mimic synthetically due to the complex transitions in composi-
tion and ultrastructure, which are vital to its overall mechan-
ical function. Consequently, most therapies for the repair of 
damaged cartilage involve tissue grafts or exploiting the local 
biology to facilitate new tissue formation. The current gold 
standard treatments in the repair of focal cartilage defects are 
microfracture or mosaicplasty. Microfracture involves removing 
the damaged cartilage and making a series of small holes in the 
subchondral plate causing bleeding from the marrow, and the 
formation of a clot that fills the focal defect. The aim here is to 
introduce and retain progenitor cells (present in marrow) into 
the defect site, a fraction of which have the potential to develop 
into chondrocytes and facilitate new cartilage formation. In 
mosaicplasty, small portions of cartilage are transplanted from 
nonarticulating regions of the affected joint into the carti-
lage defect site. This approach enables the engraftment of an 
already fully developed native cartilage structure. A common 
drawback with both methods is the formation of a fibrocarti-
laginous matrix as opposed to hyaline cartilage.[70,71] Fibrocarti-
lage does not exhibit the same specialized surface structure as 
hyaline cartilage. As a consequence, the new tissue is mechani-
cally inferior to the surrounding intact cartilage (particularly in 
resisting shear forces), which increases the risk of failure. A 
range of cell-based therapies, such as ACI, have been developed 
for the production of a native articular cartilage. To date, none 
of these methods have been able to surpass microfracture as the 
method of choice for orthopedic surgeons. Although there has 
been some success with the use of bone-derived mesenchymal 
stem cells for cartilage regeneration, there is a recognized need 
for culture and delivery systems that successfully maintain the 
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Figure 2. Effect of entrapment on cellular activity. a) Live/dead staining of encapsulated fibroblasts 4 d postencapsulation in 5% w/v alginate quiescent 
gel. Live cells stain green and dead cells stain red. b) Growth curves of the encapsulated 3T3 fibroblasts shown in (a), compared with nonencapsulated 
3T3s (control). The encapsulated fibroblasts remain at a constant viable cell number up to 33 d postencapsulation, rather than exhibiting the normal 
bell-shaped growth curve seen with monolayer cultured fibroblasts. c) Fibroblasts released from encapsulation in 5% w/v alginate quiescent gel display 
normal growth in monolayer culture after both 1 and 3 weeks encapsulation. Adapted with permission.[52] Copyright 2009, Elsevier Ltd. d) Relative 
transcription of Coll1a by 3T3 fibroblasts encapsulated in 2% w/v Ca–alginate quiescent hydrogel for 7 and 21 d. Expression is shown for encapsulated 
cells and those that are released and grown as monolayers for 48 h and control fibroblasts, grown as monolayers having never been encapsulated. Col1a 
transcription was found to be only approximately 25−30% lower than before encapsulation. e) Despite the relatively high Col1a transcription levels while 
encapsulated, Haematoxylin Van Gieson (HVG) staining of the samples revealed very little collagen matrix had been produced by the encapsulated cells 
even after 3 weeks. f) However, soluble collagen was detected within the alginate structures and could be released into physiological media. Overall, 
this suggested that while the alginate gel system allowed for the passage of essential collagen precursor molecules and their assembly into soluble 
collagen, it sterically hindered collagen fibrillization. Adapted with permission.[53] Copyright 2012, the American Chemical Society.
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required chondrogenic phenotype during culture expansion in 
the lab, and upon implantation – especially for maintaining 
chondrogenic phenotype during the healing process. Alginate-
based gels have been used as a biomaterial in chondrocyte cul-
ture since the 1980s as demonstrated by Guo et al. in 1989.[72] 
The general popularity of alginates in bioengineering stems 
from their good biocompatibility/tolerance with a range of tis-
sues, low cost, and ease of gelation using divalent ions (many 
of which are endogenous to the human body). However, it is 
the similarility between the ultrastructure of gelled alginates 
and that of native extracellular matrix that has made alginates 
favorable for use in research and development into chondro-
cyte culture.[51,73] The 3D structure of the gels is thought to 
help the chondrocytes exhibit more in vivo-like behavior.[74] Fur-
thermore, the ability to form 3D structures with tunable bulk 
mechanical properties, incorporate cell binding moieties, and 
allow the diffusion of soluble factors have proven to be impor-
tant features in supporting chondrogenesis and maintaining 
chondrogenic phenoptype. Thus, their regenerative potential is 
maximized.[51,75] Hwang et al. demonstrated that the porosity 
in a gel system can be tuned by the addition of gelatin micro-
beads as a means of enhancing the mass transport of oxygen, 
nutrients, secreted biomolecules, and waste products.[76] Prom-
ising human cell-based models have also been developed with 
good medium to long-term cell viability. Choi et al. successfully 
cultured human articular chondrocytes in alginate beads over 
15 d, and Loeser et al. successfully cultured human articular 
chondrocytes in alginate exposed to the chondrogenic growth 
factor insulin-like growth factor-1 and reported 95% survival 
at 21 d.[77,78]
Beyond the successful culture of chondrocytes in a lab, 
a major issue is the delivery and retention of chondrocytes 
into a focal defect using a non-invasive approach. Many have 
attempted to form in situ gelling materials that are capable of 
solidifying in the focal defect, and there are clinical products on 
the market that form a polymerized biological scaffold within 
the defect (BST-CarGel, Smith & Nephew; GelrinC, Regents 
Biomaterials; Chondron, RMS Regrow). We have demon-
strated that it is possible to use “sheared” or “fluid” gels as 
vehicles to deliver and retain populations of chondrocyte cells. 
These materials can be injected into an aqueous medium and 
will retain their mechanical integrity over a period of 21 d of 
ageing (Figure 4). Importantly, the material can be injected 
through a narrow gauge needle while maintaining the viability 
of the incorporated cell population (Figure 3). Once injected 
into a defect, unlike gel systems that are gelled in situ or before 
implantation, the cells are able to move within the structure of 
the fluid gel and can migrate down into the bottom of the tissue 
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Figure 3. a) Optical microscopic image of diluted alginate fluid gel negatively stained with blood. Red blood cells (black) become sterically localized 
by the sheared alginate gel (white). Scale bar represents 200 µm. b) Schematic diagram depicting the stabilization of PRP (platelet rich plasma) via 
fluid-gel particles for in situ cartilage repair. c) Section of a tibial plateau with defect plugged using alginate/BMAC (bone marrow aspirate concentrate) 
fluid gel using a syringe. d) Flow profile obtained for 10% blood serum in 1% alginate fluid gel. The plot shows data for both increasing and decreasing 
shear, highlighting its reversible shear thinning behavior, crucial for application via syringe. e) Frequency sweep obtained for the same sample showing 
the typical weak solid-like structure exhibited by fluid gels under static conditions.
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defect (Figure 4). However, recent work within our group has 
also suggested that the lack of physical entrapment of the cells 
can result in the dedifferentiation of the encapsulated cells into 
a fibroblastic phenotype. While this lack of physical entrapment 
may ultimately hinder the use of fluid gels for the delivery of dif-
ferentiated chondrocyte cells, we have demonstrated that fluid 
gels are effective in the delivery of other biological agents, such 
as platelet rich plasma and bone marrow aspirate concentrate, 
and their stabilization within a model joint defect. Our current 
work aims to translate this technology into a usable minimal 
intervention for cartilage augmentation (Figure 3). The ability 
of fluid gels to facilitate cell migration can actually be an advan-
tage when designing therapies for other tissue applications. In 
the case of the skin, the ability for cells to migrate through the 
surface of the material would enable a topically applied cell pop-
ulation to fully colonize the wound bed.
3.1.2. Skin—Keratinocyte Delivery to Aid Wound Closure
Skin exhibits a multilayered structure with the uppermost 
layer of the epidermis consisting of layered keratinocytes that 
differentiate from the basal lamina over a period of several 
weeks.[79] The layer below the epidermis, known as the dermis, 
consists of a population of fibroblast cells that play a role in 
secreting extracellular matrix molecules such as collagen types I 
and IV and glycosaminoglycans.[80]
Serious damage to the epidermal and dermal layers break 
this fragile interplay until healing occurs and the wound is 
closed. In the case of large and deep burns, wound healing 
without intervention can take several weeks, wherein a patient 
is likely to develop acute systemic dysfunction with high risk of 
death through systemic infection and dehydration.[81] In order 
to speed the process of conventional skin grafting, it is possible 
to grow a multilayer sheet of keratinocytes in the laboratory in 
a period of up to 3 weeks.[82–85] These cells may then be applied 
to the surface of the wound. The keratinocytes then accelerate 
the closure of the wound by secreting factors that are able to 
stimulate collagen deposition (TGF-β1) and differentiation of 
the cells in the wound bed into myofibroblasts, which are able 
to fully close the wound. Although this process was pioneered 
in the 1970s and has found use in the clinic, the cost of the 
treatment, in addition to the amount of time it takes to gen-
erate sufficient cells, limits utility.[86] Poor outcomes in terms 
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Figure 4. a) Sedminentation of cells through a fluid-gel network over 7 d. b) Mechanical stability of fluid alginate over 3 weeks (day 7: circles; day 14: 
squares; day 21: triangles; G′: closed symbols; G′′: open symbols). c) Cell tracking showing lateral movement of cells through fluid alginate. d) Quan-
tification of the cell movement in the x–y plane. e) Fluid alginate architecture showing voidage regions in the polymer network.
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of graft take, formation of bullae (blisters), poor handling 
due to fragility of sheets, and wound contraction have been 
reported. More recently, spray technologies have been used to 
deliver autologous and allogenic keratinocytes to the surface 
of wounded skin. Preconfluent cells have demonstrated utility 
in regenerating the skin and require a similar culture period 
of approximately 2–3 weeks.[87–89] Consequently, there is now 
a drive to develop allogeneic therapies from immunogenically 
privileged neonatal foreskin fibroblasts and keratinocytes.[90] 
However, a phase 3 clinical trial in nonhealing wounds was 
stopped prematurely due to low efficacy.[91] There are also prod-
ucts available that eliminate the in vitro culturing step by sepa-
rating epithelial cells from patient biopsies in the clinical set-
ting, and these cells may then be dispersed and sprayed onto 
the wound surface in a single procedure.[92,93] Although these 
technologies have been available for some time, there are as yet 
few clinical trials that show a conclusive benefit for using this 
approach.[94,95] One potential reason for this is that the cells 
themselves are delivered using a low-viscosity spraying system 
and anecdotally the level of “run-off” from the wound surface 
following spraying is high.[86] Although some products now try 
to remedy this using fibrin glue as an adjunct, the technology 
has yet to find strong traction in the clinic.[96,97] One of the 
major advantages of using a fluid gel system for the delivery of 
keratinocytes is that the material itself shear-thins considerably 
under the rapid shear forces experienced in a spraying system. 
We have utilized fluid-gel systems that are formed from a 
polysaccharide called gellan gum. Populations of cells may be 
incorporated into this system and can then be sprayed through 
a nozzle and deposited onto a surface as shown in Figure 5a–c. 
The soft solid then rapidly structures as it impacts on the 
skin, where the cells are retained on the surface, rather than 
running off, maintaining high-levels of viability. Importantly, 
the structure of the fluid gel allows cell movement within it, 
and we have shown that the viscosity of the material can be 
tailored to allow sedimentation of cells onto the upper surface 
of the tissue. In addition to being sprayed onto the surface of 
the skin, the gellan fluid gel may also be used to spread cells 
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Figure 5. Cell encapsulation and spray deposition of gellan gum fluid gel. Video of a) spray delivery with handheld spray pump of material to tilted 
gelatin substrate demonstrated poor adherence of water b) compared to gellan gum fluid gel. c) Airbrush spray delivery system was used to stand-
ardize air pressure at delivery (15 PSI) and nozzle size (0.75 mm). d) Comparison of dyed gellan fluid gel (left), quiescent gellan gel (middle) and 
sodium chloride (right) droplets to porcine skin indicates a low rate of spreading of the gellan explained by the higher viscosity and structural stability 
of the material. e) Airbrush spray delivery of dyed sodium chloride to porcine skin showed rapid run-off with pooling of material at the bottom of the 
substrate, f) whereas uniform distribution without run-off was achieved by gellan fluid-gel spray delivery. g) Fluorescence cell viability assay of human 
dermal fibroblasts (HDF) 7 d after encapsulation in gellan fluid gel (live cells green, dead cell red), cells are viable and attach to the bottom of the well 
and seem to migrate out of the gel. h) High viability of cells at day 1 following spraying of encapsulated HDFs in gellan fluid gel.
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across a surface, yet be retained in place once the spreading 
process has been completed. Figure 5d–f demonstrates how 
the material is retained on the surface of the skin. The mate-
rial is compared against sodium chloride and a gellan quies-
cent gel. When the surface of the skin was inclined, the fluid 
gel was retained on the surface of the skin in exactly the same 
way as the gellan quiescent gel. It is worth noting that in order 
to get the quiescently gelled gellan to spread and then reset on 
the surface of the skin, the material was heated to around 50 
°C before being allowed to cool, which would not have been 
conducive to cell survival. Shear structuring of the material 
was a successful way to enhance functionality without com-
promising cell viability (Figure 5g–h). The next challenge with 
this material will be to develop a manufacturing and packaging 
process that will not compromise the properties of the finished 
product. At present, the delicate structure tends to breakdown 
when exposed to doses of gamma irradiation considered low 
by industry standards. The development of non traditional 
sterilization methods may prove essential in the transit of 
these materials to the clinic. Although autoclaving is a possi-
bility without causing a significant change in the properties of 
the final product, this method is unsuitable for the delivery of 
delicate therapeutic proteins that may be required to enhance 
the regenerative capacity of the tissue.
3.1.3. Cornea—Scar Prevention
The cornea is a layered structure exhibiting very high levels 
of organization in order to both protect the inside of the eye 
and provide the majority of the eye’s refractive power.[98] The 
cornea is composed of five layers, with the anterior surface 
of the cornea consisting of epithelial cell layers that overlay a 
tough collagenous layer (Bowman’s layer), mostly consisting of 
tightly woven collagen type I meshworks. The corneal stroma is 
an optically transparent layer composed of heterotypic collagen 
type I and V fibrils of around 30 nm in diameter, embedded 
within a proteoglycan matrix.[98,99] The stroma makes up 90% 
of the overall corneal thickness and is maintained by resident 
keratinocytes.[98] The collagen fibrils are arranged in flattened 
tightly spaced bands called lamellae that traverse the diameter 
of the cornea and are superimposed over one another making 
up most of the stromal thickness.[100] Further structuring 
occurs from the interlacing of the lamellae, which is most 
prominent within the anterior and mid-stromal layers and less 
so in the posterior stroma, where they are stacked in a similar 
fashion to layers in plywood.[98] The posterior stromal region, 
particularly in the central corneal region, is more hydrated 
than the rest of the stroma and thus the corneal stroma overall 
is akin to a highly structurual and mechanical anistotropic 
hydrogel system. The predominant collagen orientation within 
the stroma also varies as a function of depth. In the anterior 
region, the collagen does not exhibit any preferred orientation, 
whereas the mid- and posterior regions demonstrate preferred 
orthogonal arrangement of collagen along the nasal-temporal 
and superinferior directions.[101] The key structural factors of 
the cornea, leading to high optical transparency, are the uni-
formity of the collagen fibril diameters and tight regulation of 
the distances between adjacent collagen fibrils.[98,99,102,103] The 
fourth layer of the cornea, Descemet’s membrane, is composed 
of a thin layer of collagen type IV and is designed to support 
the corneal endothelium layer that makes up the posterior 
surface of the cornea. When the corneal surface is damaged, 
it is typically capable of healing itself. However, in the case of 
infection (e.g., microbial keratitis), a significant inflammatory 
process is triggered, resulting in the upregulation of growth 
factors such as TGF-β1, which is a potent fibrogenic factor 
leading to disorganized deposition of collagen and extracellular 
matrix within the stroma.[104] Dysregulated collagen and ECM 
deposition prevents light transmission through the cornea 
and ultimately leads to blindness.[105] Treatment of diseases 
such as microbial keratitis may result in a corneal transplant if 
standard treatments with antibiotics and steroid fail.[106] Thera-
peutic proteins such as decorin have been shown to regulate 
the deposition of collagen by binding the inflammatory cytokine 
TGFβ-1.[107] This prevents collagen upregulation as well as 
the differentiation of keratocytes to the myofibroblastic pheno-
type that causes wound contraction and ECM deposition.[108] 
Topical delivery of therapeutic proteins/molecules to the surface 
of the eye has previously been attempted, however with limited 
success.[109–112] Gellan fluid-gel based eyedrops allow for the ini-
tial retention and then tailored release of the therapeutic agents 
onto the surface of the eye over a period of hours, as opposed 
to seconds/minutes as experienced with the majority of eye-
drops (Figure 6a–c).[113] Since gellan is optically transparent, a 
patient’s vision would not be compromised by the gellan when 
placed on the eye. During blinking, the eyelid sweeps over 
and applies shear to the surface of the gellan eyedrop, causing 
layers of the material to be removed. The eyedrop is cleared 
from the surface of the eye over a period of around 2 h. This 
technology has been exploited to deliver a sustained dose of 
decorin to the surface of the eye, which we have demonstrated 
facilitates reepithelialization of the eye surface (Figure 6d,e), 
both ex vivo in an organ culture model of corneal abrasion and 
when challenged in an in vivo corneal abrasion model. In addi-
tion to delivering the molecule to the surface of the eye over an 
extended period of time, we believe that the eyedrop will pro-
vide some relief to patients with this very painful condition, by 
lubricating the surface. Indeed, it has previously been reported 
that fluid gels, if formulated correctly, can be used as an ade-
quate lubricant for surfaces.[114]
4. Bioprinting
In addition to enabling the encapsulation of cells and pro-
teins for in situ delivery, the “self-healing” structure of fluid 
gels means they have found application as supports for addi-
tive layer manufacturing (ALM) of soft material structures, 
with complexity that is far beyond what has previously been 
reported. For many years, researchers have sought to replicate 
tissue structure and composition by using a combination of 
isolated cells and polymeric hydrogels that have a structural 
resemblance to ECM, to create an implantable living con-
struct.[115] Most constructs have been fabricated using a gel 
casting process that provides little control over the microscale 
geometry of the deposited material, or the local mechanical 
properties so important to controlling cell fate. Innovation in 
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this area has been driven largely by the desire to develop ther-
apies that come close to offering the same key advantages as 
auto- and allografts, in that they are structurally and biologically 
the same as the surrounding tissue, while moving away from 
harvesting graft material itself. This is because the grafts are 
only suitable for relatively small defects and the graft approach 
in general is unlikely to be able to meet future clinical demand.
3D bioprinting using ALM has become a useful approach 
for creating structures with a greater level of complexity than 
traditional processing methods, such as casting, with some 
degree of control over the distribution of biological material 
throughout the structure.[116] While ALM of hard materials is 
relatively mature and adopted by a number of industries, ALM 
of soft mateials remains challenging. One of the major chal-
lenges for 3D bioprinting is the lack of suitable materials that 
are both able to replicate tissue material behavior and com-
patible with current 3D printing technologies. The advantage 
of biopolymer materials for tissue engineering applications is 
their similarity to native ECM. However, controlling their phys-
ical properties to be optimal for both the tissue engineering 
application and the mechanics of the printing process is more 
difficult than of synthetic materials. Biopolymers used for 
tissue engineering tend to have relatively low viscosities in the 
pregelled state that facilitates mixing with cells. Furthermore, 
many of these materials exhibit pseudoplastic (shear thinning) 
flow behavior that also can be advantageous for extrusion, when 
fabricating scaffolds. Unfortunately, low-viscosity materials can 
be problematic when 3D bioprinting, as the printed structure 
can collapse and lose its shape before solidification can be 
initiated.[117] Another problem when 3D printing biopolymer 
hydrogels is the inability to integrate multiple layers of material 
once gelled, preventing the production of integrated gels with 
regional variations in mechanical behavior. To overcome these 
problems, researchers often incorporate highly viscous mate-
rials to maintain a 3D shape after deposition,[117–119] which is 
not ideal as highly viscous materials can impede homogeneous 
cell mixing and often require increased extrusion pressure in 
order to print. This can lead to reduced cell viability as a result 
of the shear stresses inflicted on cells and has therefore limited 
their use in 3D bioprinting.[120]
We recently developed a technique that overcomes some of 
the issues associated with additive layer manufacturing when 
using low-viscosity materials, allowing them to be used as a 
bioink to create relatively complex soft-solid structures.[116] 
This was achieved by extruding a gelling biopolymer solution 
into a self-healing fluid-gel matrix, which suspends the fragile 
printed construct in the liquid state to prevent flow and thus 
retaining the deposited morphology. Additionally, as the printed 
construct remained in the liquid state, it was possible to build 
the construct layer by layer and interface two different materials 
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Figure 6. Optical coherance tomography (OCT) images illustrating the flow and clearance rate of fluid-gel eyedrops: a) when compared to PBS drops. 
b) On the surface of intact rat eyes over a 2-h period, fluid gel remained on the surface of the eye for nearly 60 min and some residue was noticed at 
120 min. The PBS drop however cleared within 60 min. Fluid-gel thickens on the surface of freshly enucleated pig eyes, indicated by the black arrow. 
c) Eyes treated over 4 d with fluid gels containing decorin demonstrated significant reepithelialization in ex vivo organ culture models e) when com-
pared to d) fluid gels without decorin.
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with dissimilar mechanical properties, creating a structure with 
distinct regions of anisotropic physical behavior. To demon-
strate the potential for clinical application of the technique, we 
created a structure that recapitulated the osteochondral region 
as directed by microcomputed tomography (CT) imaging.[116]
Native osteochondral tissue has a gradually changing micro-
structure that extends from disordered mineralized collagen in 
subchondral bone[121] to cartilage, across which there are dis-
tinct variations in the relative concentrations of noncollagenous 
proteins, and orientation of collagen fibers as a function of 
depth.[122] This graded structure allows applied stress to be dis-
tributed across the interface without specific stress localization, 
helping to prevent delamination from occurring.[123] In our 
work, femoral condyle tissue was donated from patients fol-
lowing total knee replacement surgery and a full-thickness 
osteochondral defect was introduced using a surgical drill. The 
tissue containing the defect was scanned using micro-CT to 
generate a 3D model. Chondrocytes and osteoblasts were iso-
lated from the tissue samples and, following primary cell cul-
ture, were added to 1.5% gellan and 1.5% gellan mixed with 
5% nanohydroxyapatite (HA), respectively. Using the 3D model 
as a guide for accurate dimensions, an osteochondral implant 
was manufactured with the lower layer loaded with gellan, HA, 
and osteoblast cells, while the upper layer of the construct was 
manufactured using gellan gum loaded with chondrocytes. The 
manufactured cell-laden construct was then implanted into the 
defect of the ex vivo femoral condyle. After 4 weeks in culture, 
the construct maintained morphology and the encapsulated 
cells retained their phenotype within the distinct layers of the 
manufactured structure.
Our suspended additive layer manufacturing process has 
since been integrated into a commercially available extrusion-
based 3D bioprinter (Cellink, Sweden), adding the ability to 
manufacture more geometrically intricate structures. To dem-
onstrate the ability to retain the structural integrity of printed 
low-viscosity materials, an S-hook shaped construct was printed 
from a G-code file using 1% w/w gellan gum (Figure 7a). When 
printed onto a planar surface, the structure collapsed as the 
material began to flow under gravitational force (Figure 7b). 
However, when printed into a fluid-gel bed (prepared from 
0.5% agarose), the structure retained the S-hook shape, clearly 
demonstrating protective support afforded by the surrounding 
fluid gel on the printed construct (Figure 7c). We then dem-
onstrated the ability of the process to manufacture graded 
interfaces between soft-solid structures over relatively large 
length scales. Our model for this was printing conjoined dou-
blet and triplet cuboids from single cuboid units measuring 
10 mm × 10 mm × 5 mm, using gellan gum and gellan gum 
containing an orange dye (Figure 7d–f). Once the first cuboid 
was printed and remained in the liquid state, a second cuboid 
was printed with a 1 mm overlap with the first cuboid in the 
lateral plane to create an interfacial region. Once printed, the 
structures were crosslinked in situ using 100 × 10−3 M CaCl2 
for 30 min, and recovered as a single structure from the sus-
pending particulate gel by gently washing with distilled water. 
This technique could potentially be used to model diffusion 
of molecules from one gel system to another, or fabricate dis-
crete molecular reservoirs within a larger structure. Finally, we 
explored the potential to integrate different materials each with 
different gelation mechanisms using suspended bioprinting. 
Figure 7g–i shows the manufacture of cylindrical constructs 
consisting of a layer of gellan gum and a layer of type 1 collagen 
(PureCol EZ Gel, Advanced BioMatrix, USA), each layer with 
dimensions of 5 mm × 5 mm × 2.5 mm. In this example, the 
fluid gel base was maintained at 37 °C while the gellan cylinder 
was deposited first and left in the liquid state. The collagen was 
then deposited at 20 °C and left for 60 min to allow thermal 
gelation to occur, as the collagen equilibrated to 37 °C tempera-
ture of the supporting particulate bed. To initiate gelation of the 
gellan cylinder, 100 × 10−3 M CaCl2 was added to the construct 
and left to gel for a further 30 min. Once fully crosslinked, 
the construct could be removed as one piece (Figure 7h). The 
finished construct exhibited a clear interfacial region between 
the two layers, which could not be physically separated, thus 
suggesting the formation of an interpenetrating polymerized 
network across the interface (Figure 7i). The order in which the 
different materials are gelled during fabrication of a construct 
can strongly influence the stability of the interface between them. 
Successful integration of collagen and gellan layers required the 
gelation of the collagen layer before gelation of the gellan layer. 
This is attributed to a mechanism reported by Gillette et al. 
when attempting to integrate collagen into crosslinked alginate, 
whereby the small pore size of the gelled alginate inhibited 
the formation of a network of collagen fibers within the algi-
nate structure.[124]
In summary, the easily removable physical support offered 
by the fluid gel bed enables the deposition of biological mate-
rials in the liquid phase in 3D, with complex geometries and 
interfaces, before solidifying into a single construct with graded 
mechanical, chemical, and structural properties. This approach 
effectively decouples the viscosity of the starting material from 
the desired mechanical properties of the final printed construct. 
Biopolymers can be prepared at the relatively low viscosities 
required for low-pressure extrusion-based bioprinting, with the 
final mechanical properties engineered into the materials by 
gelation postextrustion.
Suspended bioprinting is, therefore, an enabler for a range 
of soft-solid materials, for which their full potential in tissue 
engineering is well established but not fully realized to date, to 
be used in the ALM of implantable biological constructs.
5. Conclusions and Outlook
Soft-solid materials have long been used as basic building 
blocks in the fields of tissue engineering and regenerative 
medicine, with certain materials having found use as wound 
dressings, eyedrops, and for the immunoisolation of cells. 
Despite extraordinary amounts of innovation around the 
manipulation of chemistry and local mechanics, which has 
significantly improved our understanding of how local envi-
ronments can influence cell behavior, relatively few new 
so-called “smart materials” have made the transition to full 
clinical use. One of the reasons for this relative lack of pro-
gress is that the costs of taking new compositions to the clinic, 
through toxicity testing and characterization, is so high as to 
make it uneconomical. We have focused a large amount of 
research on modifying material structures by making changes 
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to processing conditions, without modifying composition. In 
the case of hydrogels, this has allowed us to take existing reg-
ulator-approved materials, and process them in a manner that 
allows us to produce structures that exhibit very distinct proper-
ties from the conventionally processed materials. Of particular 
use is the capacity of these materials to self-heal following the 
application of mechanical shear. This means that the materials 
are able to be delivered through a narrow aperture, which gen-
erates local shear and liquefies the material sufficiently that it 
may be deposited over a surface, where it solidifies. This has 
allowed us to produce eyedrops, cell spraying devices, and 
injectable delivery devices. Importantly, these materials are 
ready for translation to the clinic having undergone less cum-
bersome toxicity testing than for a completely new material. We 
have also used the self healing capacity of these materials to 
provide support in a new method for the additive layer manu-
facturing of cell containing soft-solids. This method differs to 
other soft-solid additive layer manufacturing methods, in that 
both the support phase and the cell-bearing phase can exhibit 
exactly the same composition. When the part has been removed 
from the print-bed, the support material can be dispersed by 
the application of gentle shear. This enables us to produce com-
plex structures with a supporting medium without the worry of 
contaminating the implant surface.
These systems are still far from being exploited to their 
full potential and also still need considerable refinement 
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Figure 7. Suspended bioprinting of various biopolymer structures. a,b) G-code image for an S-shape hook with dimensions of 25 mm × 40 mm × 2.5 mm 
was printed using 1% w/w gellan gum onto a planar surface and imaged at the end of the printing process. c) The same structure printed into a 0.5% 
w/w agarose particulate gel bed. The construct printed onto the planar surface lost all structural integrity, collapsing under its own weight and flowed 
across the surface, resulting in a distorted structure. The construct printed within the particulate bed retained accurate dimensional conformation. 
d–f) Design and manufacture of multilayered constructs using suspended bioprinting. d) G-code file of a 10 mm × 10 mm × 5 mm cuboid. Two cuboids 
integrated using suspended bioprinting process; one contained a dye highlighting the ability to interface two separate biopolymer structures e) and 
another incorporating a double interface of gellan/dyed gellan/gellan to illustrate the potential for creating compositional gradients. g–i) Suspended 
bioprinting of a composite hydrogel cylindrical structure. g) G-code image of the single cylindrical structure with dimensions of 10 mm × 10 mm × 5 mm. 
h) Composite structure prepared from 1.5% gellan with 0.5% type 1 collagen using the suspended bioprinting process. i) A microscopic image of the 
interfacial region between the two dissimilar materials. These example constructs illustrate the potential of this approach to 3D bioprinting to manu-
facture biopolymer constructs with distinct anisotropic chemical and mechanical properties.
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before eventually finding widespread use across medical 
fields. The polymeric gels are very difficult to sterilize using 
standard methods, and at present require non-cost effective 
low-throughput processes that allow for sterile-filling. Future 
innovations and collaborative work with the regulators should 
seek to develop new, more gentle sterilization methods, that are 
not likely to cause destruction of the polymeric material from 
which the structure is formed. Gamma irridation, ethylene 
oxide, and high temperatures are all very useful for sterilizing 
metallic materials, but impart enough energy into hydrated 
polymer systems to cause significant breakdown, and there-
fore significantly modify the properties exhibited by the mate-
rials. The use of alternative light sources (UV and blue light) 
and supercritical processing technologies may well provide the 
answer to this significant problem, but need to be validated and 
widely accepted by regulators worldwide.
We have also only just begun to explore the potential of 
these materials for delivering complex, composite struc-
tures. The incorporation of secondary materials into the fluid 
gel, which are capable of inducing osteogenesis in codistrib-
uted bone marrow aspirate and other sources of cell popu-
lations, has significant potential for shaping the local cel-
lular environment in vivo, thereby enabling superior tissue 
regeneration (Figure 8a). Indeed, providing the reactants to 
generate a third phase between the polymeric components 
of the gel, enabling hardening into a comparatively stiff 
structure has already been achieved with some success 
(Figure 8b,c).[125]
Figure 8. Fluid-gel materials may be loaded with osteogenic ceramics materials and extruded through a syringe, before they thicken upon a surface. a) The 
ceramic particles remain evenly distributed throughout the process. b,c) It is also possible to deliver the precursors of bone mineral formation within 
gel materials such that they harden in situ to form a relatively stiff composite matrix, but remain liquid prior to administration. This flexibility enables 
the tailoring of local environments to create more regenerative localized conditions. b,c) Reproduced with permission.[125] Copyright 2018, Wiley-VCH. 
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a b s t r a c t
Osteoarthritis (OA) is a degenerative disease that affects 25% of the world’s population over fifty years of
age. It is a chronic disease of the synovial joints, primarily the hip and knee. The main pathologies are
degradation of the articular cartilage and changes to the subchondral bone, as a result of both mechanical
wear and a locally elevated inflammatory state. This study compares the viscoelastic properties of carti-
lage that represents the biochemical changes in OA and age-matched healthy tissue. Further, the mechan-
ical damage induced by this compressive loading cycle was characterised and the mechanism for it was
investigated. The storage modulus of OA cartilage was shown to be significantly lower than that of
healthy cartilage whilst having a higher capacity to hold water. Following mechanical testing, there
was a significant increase in the surface roughness of OA cartilage. This change in surface structure
occurred following a reduction in sulphated glycosaminoglycan content of the superficial region in OA,
as seen by alcian blue staining and quantified by micro X-ray fluorescence. These findings are important
in understanding how the chemical changes to cartilage matrix in OA influence its dynamic mechanical
properties and structural integrity.
Statement of significance
Cartilage has a very specialised tissue structure which acts to resist compressive loading. In osteoarthritis
(OA), there is both mechanically- and chemically-induced damage to cartilage, resulting in severe degra-
dation of the tissue. In this study we have undertaken a detailed mechanical and chemical analysis of
macroscopically undamaged OA and healthy cartilage tissue. We have demonstrated, for the first time
in human tissue, that the mechanical degradation of the tissue is attributed to a chemical change across
the structure. In macroscopically undamaged OA tissue, there is a reduction in the elastic response of
cartilage tissue and an associated destabilisation of the matrix that leaves it susceptible to damage.
Understanding this allows us to better understand the progression of OA to design better therapeutic
interventions.
! 2018 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
In osteoarthritis (OA), a degenerative disease of synovial joints,
there are both mechanical and inflammation-induced processes
that result in changes to joint tissues [1–3]. Of these, the most com-
monly reported is degeneration of hyaline cartilage, whilst there
are also pathological changes to the subchondral bone and
synovium [4,5]. Cartilage is avascular and therefore has a limited
capacity for self-repair, so structural damage to its surface is
largely irreversible. It has three main non-water components:
chondrocytes, a network of collagen type II (Col II), and proteogly-
cans. These proteoglycans bind water, which, in turn, makes up
between 70–80% of cartilage by weight [6,7]. The distribution and
alignment of these three constituents results in a graduated tissue
structure which brings about distinct mechanical properties [8].
Mechanically, cartilage provides both a low-friction surface for
articulation of the joint and acts to transmit compressive loading
forces to the underlying subchondral bone. Similar to many other
tissues in the body, it exhibits time-dependent viscous and elastic
https://doi.org/10.1016/j.actbio.2018.07.037
1742-7061/! 2018 Acta Materialia Inc. Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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behaviour in both compression and tension [9]. The superficial
region consists of Col II fibres oriented parallel to the articulating
surface giving local tensile strength. This collagen network
becomes more disordered in the middle region and in the deep
zone and through the tidemark, fibres are aligned perpendicular
to the articulating surface. In OA, the Col II network deteriorates,
starting from the articulating surface in early OA and progressing
through the tissue with increasing OA severity, as measured by
Hollander et al., using Mankin grading [10]. Aggrecan, the most
common proteoglycan, is found primarily in the middle and deep
zones. It is the second most abundant protein in cartilage following
Col II and it sits along a hyaluronic acid backbone. Individual aggre-
can molecules have sulphated glycosaminoglycan (sGAG) chains
(keratan and chondroitin sulphate) coming from the aggrecan core
protein that form a bottle-brush structure. These sGAG chains have
a negative charge resulting in a high binding affinity to water.
The binding of water to proteoglycans is partly responsible for
the compressive mechanical properties of cartilage. The carboxyl
and sulphate groups of chondroitin sulphate and sulphate group
of keratan sulphate provide fixed charge density (FCD) to the
tissue, which, in combination with repulsion between neighbour-
ing negatively charged chains results in a high osmotic pressure
[11]. In healthy cartilage this pressure is compensated by the Col
II network which restricts over-swelling and allows the tissue to
resist compressive forces [11]. In OA an increase in matrix metallo-
proteins (MMPs) and aggrecanases, particularly members of the
ADAMTS (A Disintegrin and Metalloproteinase with Throm-
bospondin motifs) family, have been identified as primary factors
in the catabolism of articular cartilage matrix proteins including
aggrecan and Col II [2,10]. Changes in these matrix components
have been shown to affect the mechanical properties of human
cartilage [12] and the dynamic mechanical properties of canine
tissue with destabilisation-induced OA [13].
The viscoelastic properties of a material can be quantified by
numerous methods including creep, stress relaxation and dynamic
mechanical analysis (DMA). Unlike creep and stress relaxation
which usually have long time constants, DMA is a dynamic testing
method. By applying an oscillating force to a specimen and analysis
of the out-of-phase displacement response, the frequency-
dependent storage and loss moduli can be calculated. The storage
modulus (E
0
) describes a material’s ability to store energy for elas-
tic recoil while the loss modulus (E
00
) characterises the material’s
ability to dissipate energy [14]. Studies have examined articular
cartilage at low strain rates [15,16] and others have used DMA to
assess frequency-dependency of the viscoelastic properties of
cartilage in bovine and human specimens [17]. However, the
effects of OA on the viscoelastic properties of human cartilage have
so far only been examined using indentation methods and these
looked at femoral head cartilage, where the direction and magni-
tude of loading is harder to define [18].
Changes to both the mechanical and physicochemical proper-
ties of cartilage are of interest in osteoarthritis, and physical tech-
niques for tissue analysis are becoming more commonly utilised.
As such, quantitative mapping of chemical elements present in tis-
sues is now possible using micro X-ray fluorescence. This gives
good spatial resolution of elements and has been used in a number
of tissues including cartilage [19–21]. Other quantitative tech-
niques that are traditionally used in materials science but not bio-
logical analysis such as thermogravimetric analysis are also being
transferred to understand the chemical structure of tissues and
biomaterials. Cartilage is interesting thermogravimetrically due
to its high water content, and such, the changes in hydration in dif-
ferent disease states and from different anatomical locations are
interesting when considering the importance of water on the
inherent mechanical properties of cartilage [22]. In OA, there is
an observed change in the joint surface as cartilage becomes fibril-
lated. Interferometry is a commonly used technique in the analysis
of surfaces but as yet its use in characterising biological surfaces is
infrequent. These techniques can all be used to enhance knowledge
and understanding of biological tissues.
Varus knee alignment as measured by the femorotibial angle
has been shown to be a key factor for development and progression
of OA [23]. In this position, the medial aspect of the knee joint
experiences more damaging mechanical loading, as seen by a
larger reduction in cartilage thickness [24]. However, the local
inflammatory environment affects both aspects of the joint equally
as the synovial fluid fills the joint space. In this study we have used
human cartilage from the lateral aspect of the femoral condyles
(Fig. 1) of OA subjects. This tissue is exposed to the same chemical
environment but is macroscopically undamaged. As yet, no one has
studied the links between the early mechanical and chemical
changes to human OA cartilage. Therefore, the aim of this study
was to determine the dynamic mechanical properties at a range
of physiological frequencies and undertake a detailed chemical
analysis to understand the differences observed in early, less struc-
turally degraded, OA and healthy cartilage from the same anatom-
ical region.
Fig. 1. Representation of healthy (A) and OA (B,C) joint structures. Varus loading in
OA causes a reduced joint space in the medial aspect such that cartilage of the
medial aspect including the medial femoral condyle (MFC) undergoes severe
mechanical degradation, revealing the underlying subchondral bone. The lateral
aspect of the joint maintains a wider joint spacing such that tissue of the lateral
femoral condyle (LFC) experiences less mechanical damage. The dashed region in C
indicates where cartilage explants were taken for this study.
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2. Methods
2.1. Materials
All materials listed below were supplied by Sigma Aldrich,
Gillingham, UK unless otherwise stated.
2.2. Tissue source and preparation
OA tissue was donated by consenting patients following
elective total knee replacement and was approved by the United
Kingdom National Research Ethics Service (Nottingham Research
Ethics Committee 1 (05/Q2403/24)). Ethical approval was also
obtained (Derby Research Ethics Committee 1 (11/H0405/2)) to
collect non-OA knee cartilage from post mortem donors (mean !
SEM age: 74 ! 5 years) (Kings Mill Hospital, Sutton in Ashfield,
UK) with no history of joint pain or evidence of cartilage fibrillation
based on chondropathy assessment. Consent was obtained from all
patients or their families.
Medial patellofemoral OA was diagnosed radiographically, by a
narrowing of the joint space; healthy tissue was donated post mor-
tem by patients with no history of joint disease and with no gross
evidence of OA. 22 healthy cartilage explants were taken from 6
subjects and 37 OA explants were taken from 14 subjects; further
details are shown in Table 1.
Full thickness cartilage was excised from the underlying sub-
chondral bone of the lateral femoral condyle using a scalpel, as
indicated by the dashed region in Fig. 1. This region has been
shown to be less mechanically loaded in OA than the medial side
[25]. Cylindrical cartilage explants of 5.2 mm diameter were then
produced using a cork borer. Each specimen underwent one
freeze–thaw cycle; freezing and thawing has been shown to not
alter the dynamic properties of cartilage [26].
2.3. Dynamic mechanical analysis (DMA)
The viscoelastic properties of healthy and OA specimens were
quantified using a Bose ElectroForce 3200 testing machine and
the accompanying Bose WinTest 4.1 DMA software (TA Instru-
ments, New Castle, DE, USA). Prior to testing, cartilage specimens
were fully hydrated in Ringer’s solution for 30 min before being
removed from the solution for testing. Cartilage specimens were
placed on an aluminium base plate and were loaded using a
20 mm cylindrical compression platen that made contact with
the articulating surface. Similar to previous cartilage studies, a
sinusoidal compressive force of 16 to 36 N was applied to each
specimen [27–30]. As the cartilage specimens were 5.2 mm in
diameter, the peak load of 36 N induced a peak stress of 1.7 MPa
which is similar to the estimated physiological peak stress during
walking [31]. The mean applied stress was 1.22 MPa and the
amplitude of applied stress was 0.95 MPa; the applied strain was
1.8–4.8% depending on specimen thickness. Before applying a
frequency sweep, each specimen was preloaded to 3 N (to avoid
initial slipping) and subjected to two preconditioning cycles.
1500 and 3000 cycles at 25 and 50 Hz respectively were applied,
with 60 s between them, to achieve a dynamic ‘steady-state’ which
has been stated to occur after around 1200 to 4500 precondition-
ing cycles for ex vivo cartilage [27,32,33]. The shift in mean level
of displacement following these cycles is shown in Appendix
Fig. A.8A as some excess fluid was removed. Following precondi-
tioning, eight different physiologically-relevant sinusoidal
frequencies (1, 8, 10, 12, 29, 49, 71 and 88 Hz for 17, 61, 73, 85,
190, 314, 450 and 555 cycles respectively) were applied to each
cartilage specimen in order of increasing frequency [27]. The total
testing time for each specimen was limited to 6 min and 35 s to
reduce dehydration of the samples. For each frequency, the WinT-
est DMA software performed Fourier analyses of the sinusoidal
force and displacement waves. From this analysis, the magnitudes
of the load (F*) and displacement (d*), the phase lag (d) and the
frequency were quantified [32,34]. The viscoelastic properties,
complex stiffness (k*), storage stiffness (k
0
) and loss stiffness (k
00
)
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For Eq. (4), d) is the specimen diameter (5.2 mm) and (t) is the
specimen thickness which was measured as below.
2.4. Cartilage thickness
The thickness of each cartilage specimen was measured using a
needle thickness test following DMA. Briefly, a sharp needle was
attached to the machine’s displacement transducer (1 lm resolu-
tion) and the needle was pushed through the full thickness of the
cartilage specimen. Further details of this technique are described
elsewhere [35].
2.5. Thermogravimetric analysis
The mass change relating to water loss in healthy and OA carti-
lage samples was measured using thermogravimetric analysis
(TGA) in air. Cartilage explants were heated from 25–250 "C at a
rate of 1 K.min& 1 and gas flow rate of 30 ml.min& 1 using a TG209
F1 (Netzsch, Germany) in aluminium oxide crucibles with lids
(Netzsch, Germany). A background correction of the crucible envi-
ronment was performed prior to testing cartilage samples. The
mass was measured continually during heating and the change
in mass plotted; the rate of mass change was calculated by the
accompanying Netzsh TA4 software (Netzsch, Germany).
2.6. Micro-X-ray fluorescence (lXRF)
Elemental maps of cartilage sections were generated using a M4
Tornado lXRF system and accompanying M4 software (Bruker
Nano Gmbh, Berlin, Germany). 30 lm cartilage sections were
mapped with a pixel size of 20 lm and scanning at 100 ms/px
under vacuum of 200 mbar. The distribution of sulphur was
imaged and quantified in different regions of OA and healthy
Table 1
Age and genders of the 20 patients whose cartilage was studied, n (explants)
corresponds to specimens used for DMA.
Tissue n (explants) Age Gender Thickness (mm)
Healthy 6 (22) 76 (53–87) M = 3 1.465 ! 0.240
OA 14 (37) 71 (56–81) M = 10 1.463 ! 0.206
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cartilage without and with mechanical testing protocols applied to
it. Absolute quantification was used to compare sulphur content
between samples; relative quantification was used to visualise
calcium, phosphorus and sulphur content (M4 software).
2.7. Tissue sectioning and histology
Sections were snap-frozen in liquid nitrogen and embedded in
TissueTek OCT (optimal cutting temperature) compound (Sakura,
Finetek, Torrance, CA, USA) for sectioning using an OFT5000 cryo-
stat (Bright Instruments Ltd, Luton, UK). 10 lm sections were fixed
to slides and kept at & 20 "C until staining. OCT was washed twice
with dH2O before an alcian blue working solution of (in 3% acetic
acid) was added for 10 min. Following staining, sections were
dehydrated using 50, 70, 90, 95 and 100% ethanol before clearing
with xylene and mounting with DPX (distyrene, plasticiser and
xylene) resin (Honeywell-Fluka, NJ, US).
2.8. Interferometry
A MicroXAM Interferometer (KLA Tencor, UK) was used to map
and quantify surface roughness of healthy and OA cartilage
explants both untested and after DMA testing. For each 5.2 mm
diameter cartilage explant, 9 216 x 198 nm regions were imaged,
stitched and areal surface roughness (Sa) was calculated using
Scanning Probe Image Processor software (Image Metrology,
Denmark).
2.9. Data analysis and statistical methods
Statistical analysis was performed using Prism 7 (GraphPad, CA,
USA). Two-way ANOVA with Tukey’s post hoc testing for multiple
comparisons was used for mechanical data. Student’s t-tests were
used to compare differences between healthy and OA tissues, and
also between samples tested and untested by DMA. Results where
p < 0.05 were considered significant. Logarithmic frequency depen-
dent behaviour was described by Eqs. (7) and (8), where (f) refers
to frequency.
E0 ¼ Alnðf Þ þ B ð7Þ
E00 ¼ Clnðf Þ þ D ð8Þ
3. Results
3.1. Viscoelastic properties of healthy and OA specimens
The frequency dependence of the storage (E
0
) and loss (E
00
) mod-
uli are shown in Figs. 2A and 2B for healthy and OA cartilage
respectively. The storage modulus of both healthy and OA cartilage
was logarithmically frequency dependent and the behaviour pla-
teaued from around 50 Hz (Fig. 2A). Results of two-way ANOVA/
Tukey showed that in both the loss and storage modulus, there
were significant effects of frequency (p < 0.001), the effects of dis-
ease in relation to frequency were significant in the storage modu-
lus (p < 0.001) but not in the loss modulus (p = 0.002). Students
t-tests of the mean moduli values showed that the storage modu-
lus of healthy cartilage was significantly higher (p < 0.05) than that
of OA cartilage at all frequencies with the exception of 88 Hz
(p = 0.058), as shown in Appendix Table A.4. The loss moduli were
also logarithmically frequency dependent and plateaued around





; the viscoelastic behaviour was found to be linearly
logarithmic. The area inside the hysteresis loops (Fig. 3) was
greater for OA specimens than healthy, at both low and high
frequencies, indicating that the healthy specimens had a more
elastic response. The mean level of displacement was fairly stable
throughout testing (Appendix Fig. A.8B).
3.2. Thermogravimetric analysis of OA and healthy cartilage
The binding of water by the proteoglycan network provides a
large contribution to the compressive properties of articular carti-
lage, so to elucidate the changes seen in Fig. 2, the amount of water
in these samples was accurately measured. TGA was used to quan-
tify the amount of bound water in untested and post-DMA
cartilage explants from both healthy and OA subjects. Fig. 4A
shows the change in % mass of OA and healthy cartilage between
25–250 "C. Between these temperatures, the loss of water was seen
up to around 90 "C and a further transition started at around 210
"C. The linear region of water loss as shown in Table 3 resulted in a
larger change in mass between the healthy and OA specimens
(Fig. 4B). The OA samples showed a significantly larger change in
mass by 100"C (p < 0.05) and a faster peak rate of mass change,
as seen by the DTG curve (dashed line). The further change in mass
to 250 "C was very similar between the healthy and OA samples,
& 23.76 and & 23.08% respectively.
3.3. Mapping and quantification of sulphur in cartilage sections
lXRF was used to quantify the changes in aggrecan distribution
in OA and healthy tissue by measuring the levels of sulphur across
cartilage sections. Fig. 5 shows that in untested samples, healthy
cartilage had a consistent gradient across the tissue where sulphur
was most abundant in the deep zone and less so in the superficial
region. OA cartilage, however, had a less regular gradient towards
the surface and visually the superficial region showed minor dam-
age to the surface even in untested samples. Following DMA, the
surface of healthy cartilage was slightly deformed along the
Fig. 2. A) Storage modulus (E
0
) of healthy (() and OA (j) cartilage with 95%
confidence intervals, B) Loss modulus (E
00
) of healthy ( ) and OA ( ) cartilage with
95% confidence intervals; H n = 22, OA n = 37.
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normal direction of collagen fibril alignment in this region. How-
ever, the surface was not macroscopically ruptured as seen in the
OA samples. The OA cartilage had severe damage to the articulating
surface post-DMA,while themiddle and deep regions retained their
structure. Fig. 5B shows the relative quantification of sulphur distri-
bution across the sections. Healthy and OA sections had similar sul-
phur levels in the deep and middle zones, but the OA samples had
lower levels in the superficial zone. Quantification of the post-
DMA samples shows that in both OA and healthy samples, mechan-
ical testing reduced the sulphur content, which is likely due to
changes in aggrecan proteoglycan organisation. However, this
change was more marked in the superficial region of OA samples
compared to healthy. Quantification of the OA samples post-DMA
was limited at the articulating surface due to the mechanically-
induced damage. In Fig. 5C, co-localisation of calcium and phospho-
rus was evidence of mineral deposits in the cartilage. These were
observed in the OA but not healthy cartilage samples.
3.4. Histological staining
Whilst lXRF was useful for quantifying the changes in element
distribution, the resolution was limited. Therefore, in order to bet-
ter visualise both the proteoglycan distribution and physical
changes to the superficial region, alcian blue staining of 10 lm car-
tilage sections was performed. In healthy cartilage (Fig. 6A-C),
there was a gradient of proteoglycan, with the heaviest staining
in the deep region and getting progressively lighter towards the
superficial region. Following DMA of healthy cartilage, there was
no visible difference in the surface structure (Fig. 6C) from the
untested sample (Fig. 6A) In OA cartilage, the distribution of pro-
teoglycan was less ordered and there was evidence of cell clusters.
Further, although there was a gradient, there were also regions of
darker staining throughout the middle region (Fig. 6D). Compared
to the healthy tissue, the staining was less even. There were large
cracks visible in the surface with fragments of tissue detaching
from the section (Fig. 6E, F).
3.5. Articulating surface damage
Following DMA, the surface region of OA cartilage samples was
visibly damaged, and it was also seen in histological sections
(Fig. 6). To quantify the damage, interferometry was used to mea-
sure surface roughness. Fig. 7A shows that there was no difference
between healthy specimens that have and have not undergone a
dynamic testing protocol. In the OA samples (Fig. 7B), the surface
roughness prior to testing was significantly higher than that of
the healthy samples (p < 0.05) indicating an initial degree of
mechanical damage that was not macroscopically visible. Follow-
ing DMA, the surface roughness of OA specimens was significantly
higher than subject-matched samples that have not undergone
DMA (p < 0.05).
Table 2
Storage and loss modulus coefficients as Eqs. (7) and (8) from regression analyses. All coefficients and constants values are MPa, p < 0.05 indicates that the logarithmic regression
was significant.
Sample Property A B C D R2 P
Healthy E
0
2.155 31.79 – – 0.977 <0.05
OA E
0
1.968 28.07 – – 0.977 <0.05
Healthy E
00
– – 0.551 3.576 0.961 <0.05
OA E
00
– – 0.585 3.166 0.956 <0.05
Fig. 3. Hysteresis loops of healthy (black) and OA(grey) cartilage at A)10 Hz and B)
88 Hz, inset values of hysteresis area (Nmm).
Fig. 4. Thermogravimetric analysis of OA (grey) and healthy (black) cartilage
between (A) 20–250 "C. Dashed line indicates kinetics of mass change (DTG). Inset
(B) shows the end of the water loss region.
Table 3
TG parameters of healthy and OA samples during linear water loss transition.
Sample (N) Linear region ("C) DTG peak ("C) DTG peak (%/min) Linear region mass change
Healthy (4) 52.30–78.50 69.71 & 2.39 & 54.22%
OA (4) 53.58–79.99 71.87 & 2.74 & 60.87%
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4. Discussion
This study aimed to understand the differences in frequency-
dependent viscoelastic properties of isolated healthy and OA
human articular cartilage and compare these to the physicochem-
ical changes seen. Tissue was excised from the lateral aspect of the
OA joint, which is known to be less exposed to mechanical stresses
than the medial aspect, and thus was used to represent cartilage
which was not excessively mechanically loaded but was exposed
to the same chemical environment.
The first component of this study determined the viscoelastic
properties of healthy and OA human cartilage. The logarithmic
frequency-dependent behaviour in both the storage and loss mod-
ulus was similar to findings in human and bovine cartilage
[17,29,30]. The significant reduction in storage modulus across a
range of frequencies in OA specimens is likely to be indicative of
disruption to the matrix structure as a result of OA cytokines,
MMPs and altered joint loading. The solid matrix components of
cartilage, Coll II and the aggrecan-rich proteoglycan network, are
primarily responsible for the compressive stiffness of cartilage
and was shown to be reduced in OA. This difference was statisti-
cally significant at all but the highest frequency, 88 Hz
(P = 0.0581), which has previously been implicated as a frequency
brought about during a rapid heel strike rise time that may predis-
pose subjects to OA [27,36]. The storage and loss moduli of healthy
femoral condyle cartilage were similar to that of ‘healthy’ human
femoral head cartilage (obtained from subjects who had
experienced a traumatic fracture of the femoral neck) and follow
the same logarithmic trends [29]. The viscoelastic response in car-
tilage is caused by a combination of fluid flux and polymer chain
Fig. 5. A) lXRF mapping of distribution of sulphur in cartilage sections, highest intensity depicted by brighter colour closest to the bone interface at the bottom of each image.
B) Quantification of sulphur across healthy (black) and OA (grey) cartilage sections that are untested (solid) and post-DMA (dashed) (n = 3). C) Sulphur, calcium and
phosphorus map showing evidence of Ca and P localisation in mineral deposits.
Fig. 6. Representative alcian blue staining of 10 lm thick cartilage sections from healthy (A-C) and OA (D-F) samples both untested (A, D) and post-DMA (B&C, E&F). The
radial gradient observed in the lower magnification images is an artefact of the light microscope used to image these sections.
M.E. Cooke et al. / Acta Biomaterialia 78 (2018) 320–328 325
sliding. The linear log trends seen in both moduli suggest that the
compressive viscoelastic response may be dominated by the solid
matrix components involved in polymer chain sliding.
Cartilage is comprised ofmore than70%water, and the bindingof
water to proteoglycans provides high osmotic pressure, which is a
key factor in the compressive properties of the tissue [11]. There-
fore, the amount of water in each sample wasmeasured bymeasur-
ing the change in mass as a function of temperature. The higher
water content of OA cartilage compared to healthywas shown ther-
mogravimetrically by Sohar et al. [22]. However, their study showed
the end of thewater TG step at higher temperatures than seen in this
study (102.25 "C and 104.60 "C compared to 78.50 "C and 79.99 "C
for healthy andOA tissue respectively),which is likely due to the fas-
ter rate of heating used in their study (5 K.min& 1). The increased
water content in OA samples is a result of an increased ability for
the tissue to swell. This change in swelling capacity is due to break-
down of the Col II network associated with matrix catabolism in OA
as measured by Bank et al. They found that an increased swelling
percentage correlated with an increased percentage of degraded
collagen in human samples from OA femoral head cartilage [37].
This reduces the elastic restraint on the tissue, meaning more
extrafibrillarwater can be held [22,38]. Cartilage swelling as a result
of changes to the matrix composition has been shown previously
using delayed gadolinium enhanced magnetic resonance imaging
(dGEMRI), where a correlation between increased cartilage thick-
ness and decreased GAG content was shown in themedial compart-
ment of the knee [39]. The increased water content observed in OA
samples may contribute to the similarities in loss modulus seen
between healthy and OA tissue. The peak rate of mass change in
the water TG step was higher in the OA samples and the peak was
shifted to a higher temperature. The faster peak mass change was
likely due to the increased water content, whilst the shifted peak
suggests a higher binding strength of water to the PG network.
The gradient distribution of matrix components Col II and aggre-
can are known to be critical to the propermechanical functioning of
cartilage. As water and its binding to PG is so important in the load-
bearing capacity of cartilage, the distribution of the PG networkwas
mapped. BenchtoplXRFwas used to elementallymap cartilage sec-
tions andwas a simple and effective way to quantify the differences
in sulphur content, corresponding to sGAG and aggrecan content in
tissue samples. It is well known that the GAG content at the super-
ficial region is lower than that of the middle and deep zones [40].
Here, however, seen by less bright pixels and quantified by line gra-
dients from thedeep to superficial zones,we sawa further reduction
in the superficial region in OA cartilage. The reason for this may be
proximity and contactwith the synovial fluid,which, in the inflamed
state of OAhas a higher concentration of catabolicMMPs and cytoki-
nes [1]. Further, the identification of mineral-like deposits near the
cartilage surface of OA cartilage suggested thatmineralisation in OA
may occur prior to visible mechanical damage to the superficial
region. Tissuemineralisation of cartilage andmeniscus are common
in end-stage OA, usually seen as deposits of hydroxyapatite (HAp)
and calcium pyrophosphate dihydrate (CPPD) crystals [41].
These mineral deposits were seen primarily in the upper middle
and superficial regions of the cartilage sections; they may have a
role in the observed surface damage following DMA. Relatively
large (they can be seen radiographically), hard particles in a soft
tissue could act as stress concentrations for cracks in cartilage to
form, similar to the cracks that form following a traumatic insult
to the cartilage surface [42]. Measuring the changes in surface
roughness was achieved using interferometry, a technique com-
monly used in electronics for profiling surfaces. It enabled the
quantification of the surface damage by analysing the peaks and
valleys using light reflectance to quantify surface roughness. The
significant increase in surface roughness following DMA in the
OA subjects indicated that the superficial region was more suscep-
tible to damage as has been shown previously in bovine tissue
[43,44]. Further, the difference in Sa between healthy and OA
samples observed was similar to the profile surface roughness
(Ra) seen by Graindorge et al. between healthy (Ra = 1.06) and
emery-roughened (Ra = 23.2) samples [45]. Whilst there was evi-
dence of deformation of the superficial region of healthy tissue
under lXRF, the superficial region of OA cartilage showed severe
rupturing of the cartilage surface. Disruption to the matrix compo-
sition was likely responsible for this; as mentioned, there is a
change in the collagen network originating at the articulating sur-
face [10,46,47]. This reduces the tensile strength of the cartilage
surface which reduces its ability to resist deformation.
Age-related changes to the proteoglycan content of the superfi-
cial layer of cartilage have been identified previously [11]. This
effect is enhanced when the biochemical balance shifts in states
such as trauma and OA causing increases in cytokines such as
interleukin-1 (IL-1) and tumour necrosis factor alpha (TNFa) which
drive matrix catabolism. Guilak et al. discuss the interplay between
how physiological joint loading has protective mechanisms for reg-
ulating cytokine levels [48–50]. This balance between protective
and damaging joint loading is likely key in the progression of OA.
Another factor shown to increase the severity of OA symptoms is
obesity; the increased loading on the joints due to higher body
mass in combination with elevated production of adipose-
derived cytokines (adipokines) [51]. These adipokines have been
shown to increase production of many pro-inflammatory cyto-
kines. Leptin, a well characterised adipokine, is increased in OA
synovial fluid and has been shown to increase MMP-1 and MMP-
13 production in human primary chondrocytes and to mediate
greater IL-6 secretion from OA synovial fibroblasts [1,52]. Impor-
tantly in this study, while the joint loading of the OA subjects is
focused in the medial compartment of the joint, the use of tissue
from the lateral compartment demonstrates the important effects
of the inflammatory OA environment on cartilage tissue.
Limitations: The use of human tissue samples is limiting in the
number available, particularly the numbers of post mortem sam-
ples. Firstly, this means that following a power analysis, an effect
size of 0.31 should be expected for the presented number of sam-
ples and an effect size of 0.48 for the 22 patients that samples were
retrieved from. Secondly, due to the limited number of human
samples, the testing protocols for DMA were all performed in the
same order, so the loading history may affect the viscoelastic
measurements. Future studies could investigate whether the load-
ing history affects the viscoelastic response by randomising the
order of frequencies during testing. Further, as the cartilage surface
is semi-translucent, white light interferometry values are solely
relative to surfaces with similar optical properties to cartilage.
Fig. 7. Surface roughness of A) healthy and B) OA cartilage samples with or without
DMA testing; *p < 0.05.
326 M.E. Cooke et al. / Acta Biomaterialia 78 (2018) 320–328
5. Conclusions
For the first time, we have linked the local changes in chemistry
and structure to the dynamic mechanical properties of OA and
healthy cartilage, isolated from the same anatomical region in
human donors. There is a significant reduction in the storage mod-
uli of cartilage from OA compared to age-matched healthy sub-
jects, indicating that in OA the elastic response of cartilage
deteriorates. This reduction in storage modulus was found to be
likely due to a disruption to the collagen network as OA tissues
showed a higher capacity to swell and bind water. Visible changes
to the cartilage surface following DMA were investigated and an
increased surface roughness was observed in osteoarthritic but
not healthy tissue. Finally, the mechanism for this disruption was
investigated using histological staining and lXRF mapping to
determine and quantify the proteoglycan distribution in both
healthy and OA tissue.
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Appendix A
Fig. A.8. Temporal displacement of OA (grey) and healthy (black) cartilage during A) preconditioning cycles and B) testing frequencies. For a representative healthy specimen,
the displacement amplitude for 1 Hz at the beginning of cycling was 0.025 mm and for 1 Hz at the end of the testing was 0.022 mm. In this OA specimen, the displacement
amplitude for 1 Hz was 0.024 mm at both the start and end of the testing protocol.
Table A.4
Storage Modulus mean ! SD and p-values.
Frequency (Hz) Healthy n = 22 OA n = 37 p
1 32.50 ! 1.60 28.74 ! 0.98 0.039
8 35.63 ! 1.74 31.63 ! 1.08 0.043
10 36.26 ! 1.77 32.13 ! 1.09 0.040
12 36.93 ! 1.82 32.74 ! 1.11 0.041
29 38.84 ! 1.91 34.42 ! 1.16 0.040
49 40.29 ! 1.99 35.76 ! 1.21 0.043
71 41.13 ! 2.01 36.63 ! 1.25 0.050
88 42.03 ! 2.10 37.52 ! 1.30 0.058
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Human articular chondrocytes lose their native phenotype when expanded in
traditional monolayer cultures. As a consequence, hydrogel encapsulation has been
investigated as a means to maintain the natural phenotype. Alginate has been widely
used for cartilage engineering as it has been shown to enable the recovery of a native
collagen type II expressing chondrocyte phenotype. This study has evaluated
whether the capacity of the materials to maintain/revert the phenotype is due to the
composition of the material or the physical entrapment provided by the gel. To
achieve this, an alginate “fluid gel” (a shear-thinning structured gel system) was pro-
duced of identical chemistry to a traditionally gelled alginate structure. Both were
seeded with passaged primary human articular chondrocytes. Chondrocytes in quies-
cent alginate showed the recovery of the native phenotype and a spherical morphol-
ogy. Chondrocytes in alginate fluid gel were unable to maintain the recovered
phenotype despite having a spherical morphology and were shown to have a lower
level of entrapment than those in quiescent alginate. These findings indicate that geo-
metric entrapment is essential for the maintenance of a recovered chondrocyte phe-
notype in alginate. VC 2017 Author(s). All article content, except where otherwise
noted, is licensed under a Creative Commons Attribution (CC BY) license (http://
creativecommons.org/licenses/by/4.0/). https://doi.org/10.1063/1.5006752
INTRODUCTION
Osteoarthritis (OA) affects 25% of the over-50 population, which is expected to rise with
the increasingly obese world population.1,2 OA is characterized by the degeneration of articular
cartilage, narrowing of the joint space, and pathological changes to subchondral bone; it is a
painful and disabling condition.3 At present, there is no cure for OA, and many patients will
eventually require joint replacement surgery. The native cartilage matrix is rich in collagen
type II, proteoglycans, and chondrocytes, the cartilage-matrix producing cells.4 Critically, artic-
ular cartilage is avascular and hence has a limited capacity for self-regeneration. Indeed, it is
widely believed that in end-stage OA, the cartilage loss is irreversible. Furthermore, as an avas-
cular tissue, the delivery of pharmacological entities to the cells of the cartilage, the chondro-
cytes, is highly challenging.
An alternative to the pharmacological approaches being investigated to prevent OA pro-
gression is the surgical repair of focal defects in cartilage tissue in patients with early-stage
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OA, via autologous chondrocyte implantation (ACI).5 This repair strategy is dependent on the
expansion of chondrocytes in vitro before re-implantation into the defect site.6 Critically,
expansion in 2D monolayer culture causes chondrocytes to rapidly de-differentiate, with a
marked loss of their expression of type II Collagen, aggrecan, and proteoglycan, and an asso-
ciated increase in the expression of type I Collagen.7–9 This loss of chondrogenicity leads to
the formation of an inferior hyaline cartilage, rich in collagen type I, which has been reported
to be functionally similar to the fibro-cartilage that is formed following micro-fracture sur-
gery.10 Consequently, this means that the ACI process has been of limited success. Therefore,
there is a need to develop an improved method for the expansion of chondrocytes in vitro,
which can maintain the chondrocyte phenotype and thus promote regeneration of functional
articular cartilage.
Hydrogels have traditionally been used in regenerative medicine to act as extracellular
matrix mimics due to their high water content and high degree of tunability.11,12 One such hydro-
gel is alginate, a linear, un-branched polysaccharide derived from brown algae that has been used
in drug delivery, wound healing, and tissue regeneration.13 Containing b-D-mannuronic acid (M)
and a-L-guluronic acid (G) residues arranged either in blocks (GGG/MMM) or alternating
sequences (GMGMGM),13 alginate undergoes ionotropic gelation upon introduction of divalent
cations to form crosslinks between G residues resulting in an “egg-box” structure.14–16
Previously, alginate has been shown to maintain the chondrocyte phenotype and to drive
bone marrow derived mesenchymal stem cells towards a chondrogenic phenotype.17–20 Whether
this is due to the physical entrapment of the chondrocytes in a 3D scaffold or due to the chemi-
cal influence of alginate is relatively unknown. The formation of a cartilage matrix by the
encapsulation of allogenic chondrocytes is a promising approach to produce cartilage for surgi-
cal implantation.
In this study, the influence of the physical entrapment of alginate on the embedded chon-
drocytes has been investigated by comparing markers of cartilage matrix formation when chon-
drocytes are embedded in an alginate gel and between the particles that are formed in an algi-
nate fluid gel. Fluid hydrogels are produced through the introduction of shear during gelation,
resulting in the production of microparticles of gel.21–24 The microparticles interact with one
another, and by doing so, they thicken in the absence of external shear stress and hence could
be utilized in an injectable therapeutic solution for the delivery of chondrocytes to defects in
articular cartilage. The cells dispersed within this structure are not physically entrapped as they
would be in a normal, quiescently gelled structure; instead, they are suspended between frag-
ments of crosslinked alginate (Fig. 1). They are, however, exposed to the same chemical stim-
uli. The aim of this study was therefore to determine the effect of different levels of encapsula-
tion on the chondrocyte viability, morphology, and phenotype by comparing quiescent and fluid
alginate.
FIG. 1. Schematic of cells (a) encapsulated in quiescent alginate and (b) suspended between fragmented alginate
fluid gel.
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RESULTS
Primary articular chondrocytes cultured in quiescently gelled alginate retain their
viability and chondrogenic phenotype
We first examined the effect of traditional monolayer culture on the chondrogenic pheno-
type of primary human articular chondrocytes (hACs). Freshly isolated (FI) primary hACs were
found to express high amounts of type II collagen and low amounts of type I collagen, as deter-
mined by quantitative real-time polymerase chain reaction (qRT-PCR) analysis of COL2A1 and
COL1A1 mRNA expression [Fig. 2(a)]. As expected, upon culturing in monolayer, primary
hACs rapidly de-differentiated, adopting a more fibroblast-like morphology [Fig. 2(b)], and by
passage 3, they exhibited significantly reduced (P < 0.01) expression of type II collagen [Fig.
2(a)]. Indeed, the expression profile of type I and type II Collagen in passaged primary hACs
was similar to that observed in the chondrocyte TC28 cell line [Fig. 2(c)].
Next, we examined the effect of encapsulating primary hACs in quiescent alginate on both
the cell viability and the chondrogenic phenotype over a period of 2 weeks. Following 14 days
of encapsulation in alginate, cells in the scaffolds were stained using a live/dead stain (Calcein
AM/ethidium homodimer-1 stain). Encapsulated primary hACs showed high levels of cell via-
bility and displayed a flattened morphology at the edge of the constructs and a spherical mor-
phology in the centre [Figs. 3(a) and 3(b)]. This is similar to chondrocytes in native cartilage,
in contrast to the fibroblast-like morphology of primary hACs cultured in the monolayer.
Analysis of COL2A1 and COL1A1 mRNA (messenger ribonucleic acid) expression over a time
course of 14 days showed that primary hACs encapsulated in quiescent alginate did not de-
differentiate since type II collagen expression was maintained throughout. Furthermore, encap-
sulation of the TC28 chondrocyte cell line in quiescent alginate suggests that they can be re-
differentiated to a more native chondrocyte collagen phenotype [Figs. 3(c) and 3(d)]. In addi-
tion to measurements of collagen expression, the release of sulphated glycosaminoglycan
(sGAG) side-chains was quantified over a time course of 30 days, as a marker of aggrecan pro-
teoglycan turnover in the alginate scaffolds. Relative to alginate without cells, scaffolds con-
taining encapsulated primary hACs or TC28s showed a significant accumulation of sGAG
secretion over a period of 30 days, suggesting that alginate encapsulation supported and main-
tained aggrecan proteoglycan production [Fig. 3(e)].
The ability of quiescent alginate to support an anabolic chondrocyte phenotype, which pro-
duces cartilage extracellular matrix components, was then further validated by histochemical
staining of alginate scaffolds. Aggrecan staining was observed in the cytoplasmic region of the
chondrocytes [Fig. 3(f)].
FIG. 2. (a) Relative mRNA expression of collagen types I and II in primary human chondrocytes either directly after isola-
tion from cartilage or following 3 passages in the monolayer. (b) Passage 3 human chondrocytes exhibiting a fibroblast-like
morphology (scale bar (SB): 200 lm). (c) Relative mRNA expression of collagen types I and II in the TC28 human chon-
drocyte cell line. **P < 0.005.
016104-3 Cooke et al. APL Bioeng. 1, 016104 (2017)
Formulation of a deliverable fluid alginate
An alginate fluid gel was produced by the drop-wise addition of CaCl2 to sol alginate under
shear. The fluid alginate architecture is characterized by fragments connected by ribbon-like
structures as shown in Fig. 4(c). Following shear ramps, the alginate fluid gel alginate showed
a very small hysteresis loop, indicating that this fluid material will be stable during manipula-
tion and handling [Fig. 4(b)]. After seeding of chondrocytes, they maintained a spherical mor-
phology and showed high levels of viability [Figs. 4(d) and 4(e)].
Dynamic small deformation rheology was performed to determine the viscoelastic proper-
ties of both the alginate quiescent and fluid gel systems. The introduction of shear during the
FIG. 3. (a) Primary human chondrocytes encapsulated in quiescent alginate showing a flattened morphology at the edge of
the construct and a spherical morphology in the centre of the construct, SB: 200 lm. (b) z-stack demonstrating the cell mor-
phology in 3-D, SB: 100 lm. (c) Relative expression of collagen types I and II in TC28s and primary human chondrocytes
(hACs) throughout 9 and 14 days of culture, respectively, with collagen type II to type I ratios (d). (e) Cumulative produc-
tion of sGAGs as detected by the DMMB assay at 9 time points over 30 days; (f) evidence of aggrecan (green) in the cyto-
plasmic region with nuclei counterstained with DAPI (40,6-Diamidino-2-Phenylindole) (blue), SB: 200 lm. *: P < 0.05.
FIG. 4. (a) Sol (left), quiescent (middle), and fluid (right) alginate; (b) change in shear stress with the shear rate over con-
tinuous ramps of the shear rate from 0.1-500-0.1-500 s!1; (c) fluid gel architecture (SB: 200 lm); (d) fluid gel with chon-
drocytes showing the interaction with alginate fragments and ribbons (SB: 100 lm); (e) z-stack of chondrocytes in fluid
alginate 4 days after seeding, SB: 100 lm.
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gelation process resulted in a reduction in the storage modulus of fluid alginate, when compared
to the quiescent gels prepared under static conditions [in the absence of shear (Table I)]. The
presence of weak interactions and entanglements is confirmed through linear rheology [Fig.
5(b)], with the sheared alginate showing solid-like behaviours dependent on frequency, typical
of weak gels. Interestingly, the quiescent gel shows a similar mechanical spectrum (at higher
G0 values) inferring structures which mirror each other, complementing data obtained via
microscopy images shown in Fig. 6. Changes throughout the gel microstructure were probed
through stress sweeps [Fig. 5(a)], where shortening of the linear viscoelastic region (LVR) high-
lights the fluid gels’ ability to flow upon being stressed. Fluid alginate (closed circles) shows
strong shear thinning behaviour [Fig. 5(c)], where increasing the shear to the systems causes
the reversible breakdown of the entangled polymers. However, this is not observed for the qui-
escent gel, as increasing shear to strains above the LVR causes fracturing of the gel resulting in
artefacts that resemble thinning profiles [gel fracture points highlighted in Fig. 5(c) using “#”].
Microstructural observations of fluid and quiescent alginate
To further understand the differences in the structure between the two materials, their
microstructures were observed using scanning electron microscopy (SEM) following freeze dry-
ing. Fluid alginate was seen to have a less interconnected pore structure than quiescent alginate.
Further, there were larger voidage regions observed throughout the fluid alginate structure,
which were not seen in the quiescent microstructure (Fig. 6).
Level of cell encapsulation in fluid and quiescent alginate
To understand the level of encapsulation and confinement provided by alginate matrices of
different structures, chondrocytes were imaged over time in culture. Individual chondrocytes in
fluid gel were seen to move laterally across the field of view over a number of hours in the
fluid alginate as well as downwards through the gel [Fig. 7(a), Multimedia view]. Chondrocytes
in quiescent alginate, however, did not show as much movement over the same time-course
[Fig. 7(b), Multimedia view]. Cell movement was quantified by frame-by-frame tracking, and
then, the gel drift caused by contraction of the gel was normalized. Cells in fluid gel were
TABLE I. Storage (G0), loss (G00), and complex (G*) moduli of alginates.
Quiescent Fluid
Hz/Pa G0 G00 G* G0 G00 G*
0.1 615.87 34.45 616.83 146.3 27.84 148.93
1 654.00 42.45 655.38 181.3 33.60 184.39
10 727.13 76.72 731.17 247.3 68.21 256.82
FIG. 5. (a) Oscillatory stress sweeps (0.1–100 Pa, 1 Hz, 37 "C) showing the variation in the linear viscoelastic region
(LVR). (b) Mechanical spectra (0.5% strain, 37 "C) showing the variation in the storage modulus (G0) and the loss modulus
(G00). C: viscosity sweeps (0.001–100 s!1, 37 "C). (Quiescent alginate, squares; fluid alginate, circles; G0, filled symbols;
G00, open symbols.)
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FIG. 6. SEM images of thin sections of quiescent [(a) and (b)] and fluid [(c) and (d)] following freeze drying.
FIG. 7. Tracking of chondrocytes in (a) fluid and (b) quiescent alginate over 14 h. Movement of cells is demonstrated by
coloured circles. Quantification of chondrocyte movement in 2D in (c) fluid and (d) quiescent alginate. Multimedia views:
https://doi.org/10.1063/1.5006752.1; https://doi.org/10.1063/1.5006752.2
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found to move further per frame than cells in the quiescent alginate, particularly 25% most
motile cells [Figs. 7(c) and 7(d)].
The effect of alginate fluid gel on the phenotype of primary articular chondrocytes
To compare the efficacy of alginate fluid gel with that of quiescent alginate in supporting a
chondrogenic phenotype, primary hACs were cultured in either alginate fluid gel or quiescent
alginate for a period of 7 days. Following 7 days of culture, collagen type II and aggrecan
expression were higher in the quiescent than fluid alginate, and sox9 expression was signifi-
cantly higher in the quiescent alginate (Fig. 8).
Ex vivo cartilage explant tissue promotes the chondrogenic phenotype of primary
chondrocytes encapsulated in quiescent alginate
Due to the proximity of native cartilage tissue during the ACI repair of cartilage defects,
ex vivo cartilage tissue and cartilage conditioned media (CM) were studied to determine their
effect on the efficacy of using fluid and quiescent alginate as chondrocyte-carrying matrices.
Following the encapsulation of a hAC population in quiescent alginate, the presence of a carti-
lage explant tissue [Fig. 9(a)] resulted in an increase in the expression of COL2A1 [Fig. 9(b)]
following 14 days of culture. The effect of the physical presence of cartilage tissue was shown
to be secondary to the factors released from it [Fig. 9(b)] since conditioned cartilage explant
FIG. 8. Relative mRNA expression of (a) collagen type II, (b) aggrecan (day 7), and (c) sox9 (day 7) in chondrocytes
seeded in fluid and quiescent alginate.
016104-7 Cooke et al. APL Bioeng. 1, 016104 (2017)
media resulted in a greater increase (P ¼ 0.0376) in collagen type II expression than the carti-
lage tissue. This suggests that in the in vivo environment, alginate encapsulation of hACs will
be even more efficacious in promoting and maintaining the chondrogenic phenotype due to the
secretion of endogenous anabolic factors from the surrounding cartilage matrix. This condition
was then investigated to determine if it could be used to drive the native alginate phenotype in
fluid alginate culture. However, when comparing conditioned and basal media, there was no
significant difference between the conditions [P ¼ 0.3126, Fig. 9(c)]; this further supports that
physical entrapment of chondrocytes is critical to maintenance of the native collagen type II
phenotype.
DISCUSSION
Alginate has been investigated for cartilage repair and regeneration strategies over the last
three decades since it has been shown to support the redifferentiation of chondrocytes that have
lost their native collagen type II and proteoglycan-producing phenotype.27–29 The mechanism of
this effect is relatively unknown but has been attributed to the chondrocyte morphology, ligand
adhesion, and matrix mechanical properties.9,30 Here, we aim to resolve the difference between
the geometric and chemical influences of alginate.
FIG. 9. (a) Experimental set-up for explant (left) and blank/conditioned media (CM) (right). Relative collagen type II
expression in (b) quiescent and (c) fluid alginate when cultured with basal media (blank), a cartilage explant, or conditioned
media.
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The findings of this study support previous observations that chondrocytes are not phenotypi-
cally stable in 2D culture on untreated tissue culture plastic, with freshly isolated primary human
knee OA chondrocytes rapidly losing collagen type II expression and adopting a fibroblast-like
morphology within 3 passages. This is a well-known phenomenon in chondrocyte culture and has
been attributed to the change in the morphology when cultured on a stiff substrate.8,27,29 In con-
trast, when primary chondrocytes were geometrically confined by encapsulation in quiescent algi-
nate, they maintained native morphologies depending on the construct region, akin to native
chondrocytes in articular cartilage tissue.31 Additionally, we found that primary human chondro-
cytes remained viable for up to 14 days of culturing in quiescent alginate constructs. Importantly,
our data demonstrate that this geometric confinement of human chondrocytes in quiescent algi-
nate promotes a chondrogenic phenotype with maintenance of collagen type II expression and
aggrecan proteoglycan production. These data support the findings of Murphy and Sambanis who
showed that the maintenance of the spherical chondrocyte morphology is necessary for the recov-
ery of the chondrogenic phenotype following monolayer culture.32
Since the use of a quiescent alginate hydrogel construct for the regeneration of articular
cartilage would require highly invasive surgery, we then examined whether alginate fluid gel,
which would be more suitable for intra-articular injection, would exhibit the same chondro-
genic promoting properties. Using the same alginate solution as that used to produce the qui-
escent constructs, we introduced shear during its gelation with the same concentration of
crosslinking cations. This produced a self-supporting network of gel microparticles referred to
as alginate fluid gel.22,33 This gelation process was highly reproducible, with little variation
between batches (supplementary material, Fig. 1). Furthermore, rheological characterization
demonstrated that with repeated frequency ramps, there was a consistent shear stress. These
non-time-dependent shear-thinning properties suggest that such an alginate fluid-gel could be
delivered by intra-articular injection without modification of its structural properties.
Mechanically, alginate in its quiescent state was more elastic than fluid alginate and showed a
higher complex modulus. The loss in the elastic structure of the fluid alginate is attributed to
the presence of shear throughout the sol-gel transition, where mixing prevents a complete net-
work from forming.25,26 There were also differences in the liquid-like and frequency depen-
dent properties of the two materials. Both materials were stable at lower frequencies, with the
fluid alginate showing a shorter LVR as it can flow when stressed. Such a phenomenon arises
through the prevention of a completely gelled network, allowing polymer strands to move
freely once the required energy has been met to yield any weak inter-particle interactions or
entanglements.21,25
Following the investigation into the mechanical properties and the increased loss modulus
of fluid alginate compared to quiescent alginate, the level of entrapment provided by the two
alginate matrices was investigated. Using cell tracking, it was found that cells in fluid alginate
were able to move laterally as well as vertically through the matrix, whereas in quiescent algi-
nate, cells were confined to distinct regions. It was observed that there was increased move-
ment of chondrocytes observed after the gel had “drifted.” Therefore, this effect may be due
to fluid flow through larger pores and voids in the fluid alginate structure, which allow cells
to move laterally through the gel network. This effect would also be likely observed in an
in vivo situation due to joint motion. Further, the difference in the microstructure of the algi-
nate may introduce local differences in the stiffness of the gel matrix, resulting in changes to
cell behavior.
Despite the success of resuspending chondrocytes in alginate fluid gel, for cell viability to
be maintained, our study has found that fluid alginate was not as effective as quiescent alginate
in maintaining the chondrocyte phenotype upon culturing of constructs. This lack of effective-
ness of fluid alginate to maintain and promote the chondrogenic phenotype of primary chondro-
cytes was even observed despite culturing hydrogels in the presence of explant conditioned
growth media, which we had previously found significantly promoting the collagen type II
expression of primary chondrocytes in quiescent alginate hydrogels. As such, physical entrap-
ment provided by the quiescent alginate gel has been shown to be critical in the maintenance
of a native chondrocyte phenotype.
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CONCLUSIONS
By producing a chemically identical fluid alginate, we have shown that with the lack of
physical entrapment, passaged chondrocytes lose their ability to recover/maintain their pheno-
type. Even the introduction of growth factors released from cartilage which have a significant
increase in collagen type II expression in quiescent alginate has no effect. We have demon-
strated that maintenance of a spherical morphology alone is insufficient to recover a native col-
lagen type II phenotype in passaged adult human chondrocytes. A certain level of geometric
confinement for the chondrocytes is also essential.
METHODS
Tissue sources and isolation of primary cells
Joint tissue was collected from OA patients undergoing elective knee replacement surgery.
Ethical approval was provided by the United Kingdom National Research Ethics Service (East of
Scotland Research Ethics Service (11/ES/1044). All patients or their families provided consent.
Full-thickness cartilage was excised from the femoral condyle and cartilage explant discs gener-
ated by cork-boring. For the isolation of primary human articular chondrocytes (hACs), cartilage
was diced using a scalpel and digested in sterile-filtered 2 mg/ml collagenase type IA (0.5–3.0
FALGPA units/mg, Sigma Aldrich, Gillingham, UK) for 3 h. Both hACs and immortalised chon-
drocytes (TC28s) were cultured at 37 "C in a humidified incubator in growth media [DMEM
(Dulbecco’s Modified Eagle’s medium) supplemented with 10% FCS (Fetal Calf Serum),
penicillin-streptomycin (100 lg/ml), 2 mM L-glutamine, and 1% non-essential amino acids,
(Sigma Aldrich, Gillingham, UK)]. For the generation of conditioned media, a cartilage disc
(diameter: 4.1 mm, depth: 2 mm) was incubated with culture media for 24 h before being applied
to cultures.
Alginate preparation
A solution of 1.5 wt. % medium viscosity alginate was prepared by the addition of dH2O
to sodium alginate (Sigma) and heating to 85 "C for 1 h whilst stirring continuously. The solu-
tion was then allowed to cool to room temperature. Fluid alginate was prepared by applying a
shear rate of 500 s!1; 10% 200 mM calcium chloride was added drop-wise, and the solution
was equilibrated over 30 min at 20 "C (AR-G2, TA Instruments, New Castle, DE, USA). All
alginate used for cell culture was autoclaved prior to use.
Encapsulation of chondrocytes in alginate
For quiescent gels, both immortal chondrocytes (TC28) and primary hACs were mixed
with 1.5 wt. % alginate to a concentration of 1 $ 106 cells/ml and seeded into the wells of a
96-well plate containing 0.2 M CaCl2 with or without the presence of cartilage explant tissue.
The quiescent gel was then incubated for 20 min at 37 "C to allow crosslinking to occur. Gels
were then rinsed twice with PBS (Phosphate-buffered saline), and 0.2 ml of chondrocyte growth
medium was added and then incubated at 37 "C for up to 30 days. Conditioned media was gen-
erated from the 48 h incubation of femoral condyle cartilage explant tissue in chondrocyte
growth media (15 6 3 g in 30 ml of media). Alginate fluid gel was mixed with 1 $ 106 hACs
and pipetted into a 96-well plate. Media were changed twice a week.
Determination of chondrocyte viability
Cell viability in the alginate scaffolds was determined using a calcein AM/ethidium
homodimer-1 LIVE/DEAD assay (Invitrogen). Calcein AM is cell-permeable and is hydrolysed
to green fluorescent calcein by interaction with intra-cellular enzymes; cell-impermeable ethi-
dium homodimer-1 binds to DNA and fluoresces red, and so, it binds to the DNA of dead/dying
cells. Alginate constructs were imaged using a Leica DM 6000B confocal microscope.
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RNA isolation and quantification
Total RNA was isolated from alginate constructs and from chondrocyte monolayer cultures
using TRIzolV
R
reagent (Life Technologies, UK). In brief, alginate constructs were homogenized
in 1 ml of TRIzol reagent using a TissueRuptor (Qiagen). Chondrocyte monolayer cultures in
6-well plates were directly lysed with 1 ml of TRIzol reagent per well. Following the addition of
TRIzol, 0.2 ml of chloroform was added and the samples were shaken vigorously for 15 s before
being centrifuged for 15 min at 12 000g for the phase separation of RNA, DNA, and protein.
The aqueous (RNA containing) phase was decanted, and RNA precipitated overnight at !20 "C
by the addition of 0.5 ml of isopropanol. Following centrifugation, the RNA pellet was washed
with ethanol, dried, and resuspended in 50 ll of RNase-free H2O. RNA concentrations and A260/
280 ratio were determined using spectrophotometry (NanoDrop 2000, ThermoScientific). RNA
was stored at !80 "C prior to analysis by qRT-PCR.
Quantitative real-time PCR
Precision OneStep SYBR Green Dye (PrimerDesign) was used with a b-actin reference
gene (PrimerDesign) for quantification of the mRNA expression of COL1A1, COL2A1, ACAN,
and SOX9 genes. The forward and reverse primer sequences were designed using Primer
Express 3 software (Applied Biosystems) and produced by LifeTechnologies or PrimerDesign
as indicated alongside primer sequences shown in supplementary material, Table I. Relative
gene expression was determined by ddCT (delta-delta-cycle threshold), normalized to b-actin.
Quantification of aggrecan proteoglycan
As a marker of aggrecan proteoglycan production, sulphated glycosaminoglycans (sGAG)
released by the scaffolds into the supernatants were measured using a 1,9-dimethylmethylene blue
(DMMB) assay.34 Supernatant samples (50ll) at 3, 7, 10, 14, 17, 21, 24, 27, and 30 days and
standards of shark chondroitin sulphate dilutions were added to 200 ll of DMMB colour reagent at
pH 3. Alginate alone served as a control to remove the effect of interference of uronic acid groups
in alginate. The absorbance was read immediately at A540 using a BioTek EL808 plate reader.
Immunohistochemical analysis
For immunohistochemistry, cellular scaffolds were cultured for two weeks before analysis.
Scaffolds were then fixed with 4% paraformaldehyde for 10 min before blocking in 0.1 M PBS
with 10% goat serum and 0.3% Triton-X-100. Aggrecan was detected using the mouse anti-
aggrecan primary antibody (1:200, ThermoFisher) and then Alexa-488 goat anti-mouse secondary
antibody (1:500, Invitrogen). Nuclei were counterstained with DAPI (1:5000, Sigma Aldrich).
Characterization of fluid and quiescent alginate
To visualize the “architecture” of the fluid gel, it was mixed at a 1:4 ratio with PEG (poly-
ethylene glycol) to provide contrast between the phases and imaged using light microscopy
(Leica DM 6000B).
Oscillatory rheology was used to determine the mechanical properties of fluid and quies-
cent alginate of the same chemistry. Discs (40 mm diameter) of quiescent alginate were pro-
duced using 0.2 M CaCl2 by the filter paper method described elsewhere.
35 Fluid alginate sam-
ples were tested using a parallel, 40 mm sandblasted geometry, while quiescent alginate
samples were prepared as 40 mm discs and tested using a ridged mesh as a gripper on flat
40 mm parallel plates on a AR-G2 Rheometer (TA Instruments, USA). A strain sweep was per-
formed to determine the linear viscoelastic range of the gels. Storage (G0) and loss (G00) moduli
were determined in a range of oscillatory frequencies (0.1–100 Hz) at 0.5% strain at 37 "C. The
complex modulus (G*) was calculated by
G% ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
G0ð Þ2 þ G00ð Þ2:
q
(1)
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The angular frequency (x) was calculated by
x ¼ 2p Hzð Þ: (2)
To determine any changes in the structure during experimental procedures, the response to
shearing as experienced by fluids moving through a pipette tip was modeled by ramping the
shear rate from 0.1–500-0.1–500-0.1 s!1 at 0.5% strain. Oscillatory stress ramps were per-
formed to determine the LVR of each alginate matrix.
Scanning electron microscopy (SEM)
1 mm thick sections of quiescent alginate and 1 mm smears of fluid alginate were snap fro-
zen in liquid nitrogen and dried under vacuum for 48 h (Mini Lablyo, Frozen in Time, Ltd.,
York, UK). They were then mounted using conductive carbon tape and gold sputter coated. The
topography was then imaged using a TM3030Plus benchtop SEM (Hitachi High Technologies,
Schaumburg, USA) at 15 kV.
Cell tracking
Cell tracking was used to determine the level of entrapment provided by the different algi-
nate matrices. Chondrocytes were seeded in fluid and quiescent alginate at 1 $ 106 cells/ml and
imaged every 5 min at 3 z-positions in each well over 20 h using a Cell-iQ and accompanying
software Cell-iQ Imagen and Cell-iQ Analyser (Chip-Man Technologies, Tampere, Finland).
Cell movement was quantified by tracking individual cells frame-by-frame using Cell-iQ
Analyser. The trajectories were mapped, and the movement in 2D was normalized from gel
drift (contraction) by tracking a reference point in each frame.
Statistical analysis
Mean values and standard error of the mean are plotted. Unpaired t-tests were performed
using Prism 7 (GraphPad software, CA, USA) with a significance of p< 0.05.
SUPPLEMENTARY MATERIAL
See supplementary material for viscosity profiles of fluid alginate as it is produced as well
as primer sequences and cell tracking videos.
ACKNOWLEDGMENTS
The authors would like to acknowledge the EPSRC Physical Sciences for Health CDT for
provision of a studentship (M. Cooke, EP/L016346/1) as well as the research nurses and patients
involved in tissue donation and collection.
1ARUK, Med. Press 222, 253 (2013).
2M. Cross, E. Smith, D. Hoy, S. Nolte, I. Ackerman, M. Fransen, L. Bridgett, S. Williams, F. Guillemin, C. L. Hill, L. L.
Laslett, G. Jones, F. Cicuttini, R. Osborne, T. Vos, R. Buchbinder, A. Woolf, and L. March, Ann. Rheum. Dis. 73, 1323
(2014).
3D. P. Tonge, M. J. Pearson, and S. W. Jones, Osteoarthrosis Cartilage 22, 609 (2014).
4M. B. Goldring and S. R. Goldring, Ann. N. Y. Acad. Sci. 1192, 230 (2010).
5H. Mistry, M. Connock, J. Pink, D. Shyangdan, C. Clar, P. Royle, R. Court, L. C. Biant, A. Metcalfe, and N. Waugh,
Health Technol. Assess. 21, 1 (2017).
6J. C. H. Leijten, N. Georgi, L. Wu, C. A. Van Blitterswijk, and M. Karperien, Tissue Eng., Part B 19, 31 (2013).
7M. Otero, M. Favero, C. Dragomir, K. E. Hachem, K. Hashimoto, D. A. Plumb, and M. B. Goldring, Methods Mol. Biol.
806, 301 (2012).
8A. L. Aulthouse, M. Beck, E. Griffey, J. Sanford, K. Arden, M. A. Machado, and W. A. Horton, In Vitro Cell. Dev. Biol.
25, 659 (1989).
9E. Schuh, S. Hofmann, K. Stok, H. Notbohm, R. M€uller, and N. Rotter, J. Biomed. Mater. Res., Part A 100, 38 (2012).
10H. Vasiliadis and J. Wasiak, Cochrane Database Syst. Rev. 2011, CD003323.
11J. J. Green and J. H. Elisseeff, Nature 540, 386 (2016).
12J. L. Drury and D. J. Mooney, Biomaterials 24, 4337 (2003).
13K. Y. Lee and D. J. Mooney, Prog. Polym. Sci. 37, 106 (2012).
016104-12 Cooke et al. APL Bioeng. 1, 016104 (2017)
14N. C. Hunt and L. M. Grover, Biotechnol. Lett. 32, 733 (2010).
15J. Sun and H. Tan, Materials 6, 1285 (2013).
16M. A. LeRoux, F. Guilak, and L. A. Setton, J. Biomed. Mater. Res. 47, 46 (1999).
17R. Mhanna, A. Kashyap, G. Palazzolo, Q. Vallmajo-Martin, J. Becher, S. Moller, M. Schnabelrauch, and M. Zenobi-
Wong, Tissue Eng., Part A 20, 1454 (2014).
18D. Bosnakovski, M. Mizuno, G. Kim, S. Takagi, M. Okumura, and T. Fujinaga, Biotechnol. Bioeng. 93, 1152 (2006).
19H. A. Awad, M. Q. Wickham, H. A. Leddy, J. M. Gimble, and F. Guilak, Biomaterials 25, 3211 (2004).
20S. Ab-Rahim, L. Selvaratnam, H. R. B. Raghavendran, and T. Kamarul, Mol. Cell. Biochem. 376, 11 (2013).
21I. Fern"andez Farr"es and I. T. Norton, Food Hydrocolloids 40, 76 (2014).
22I. Fernandez Farres, R. J. A. Moakes, and I. T. Norton, Food Hydrocolloids 42, 362 (2014).
23I. T. Norton, W. J. Frith, and S. Ablett, Food Hydrocolloids 20, 229 (2006).
24M. Guvendiren, H. D. Lu, and J. A. Burdick, Soft Matter 8, 260 (2012).
25I. Fern"andez Farr"es, M. Douaire, and I. T. Norton, Food Hydrocolloids 32, 115 (2013).
26S. B. Ross-Murphy, V. J. Morris, and E. R. Morris, Faraday Symp. Chem. Soc. 18, 115 (1983).
27J. Guo, G. W. Jourdian, and D. K. Maccallum, Connect. Tissue Res. 19, 277 (1989).
28K. T. Paige, L. G. Cima, M. J. Yaremchuk, B. L. Schloo, J. P. Vacanti, and C. A. Vacanti, Plast. Reconstr. Surg. 97, 168
(1996).
29M. M. J. Caron, P. J. Emans, M. M. E. Coolsen, L. Voss, D. A. M. Surtel, A. Cremers, L. W. van Rhijn, and T. J. M.
Welting, Osteoarthrosis Cartilage 20, 1170 (2012).
30N. G. Genes, J. A. Rowley, D. J. Mooney, and L. J. Bonassar, Arch. Biochem. Biophys. 422, 161 (2004).
31A. J. Sophia Fox, A. Bedi, and S. A. Rodeo, Sports Health 1, 461 (2009).
32C. L. Murphy and A. Sambanis, Tissue Eng. 7, 791 (2001).
33A. Gabriele, F. Sypyropoulos, and I. T. Norton, Food Hydrocolloids 23, 2054 (2009).
34R. W. Farndale, D. J. Buttle, and A. J. Barrett, Biochim. Biophys. Acta 883, 173 (1986).
35N. C. Hunt, A. M. Smith, U. Gbureck, R. M. Shelton, and L. M. Grover, Acta Biomater. 6, 3649 (2010).









© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim wileyonlinelibrary.com (1 of 6) 1605594
Suspended Manufacture of Biological Structures
Samuel R. Moxon, Megan E. Cooke, Sophie C. Cox, Martyn Snow, Lee Jeys, 
Simon W. Jones, Alan M. Smith,* and Liam M. Grover*
S. R. Moxon, Dr. A. M. Smith
Department of Pharmacy
University of Huddersfield
Queensgate, Huddersfield HD1 3DH, UK
E-mail: a.m.smith@hud.ac.uk
M. E. Cooke, Dr. S. C. Cox, Prof. M. Snow,  
Prof. L. M. Grover
School of Chemical Engineering
University of Birmingham
Edgbaston B15 2TT, UK
E-mail: l.m.grover@bham.ac.uk
M. E. Cooke, Dr. S. W. Jones
Institute of Inflammation and Ageing
MRC Musculoskeletal Ageing Centre
QE Hospital
University of Birmingham
Edgbaston B15 2WB, UK
Prof. M. Snow, Prof. L. Jeys
Royal Orthopaedic Hospital
Bristol Road, Northfield, Birmingham B31 2AP, UK
DOI: 10.1002/adma.201605594
exposed to environments that differ both mechanically and 
chemically. These environments have been shown to play a 
strong role in shaping cell phenotype.[3] For some time now 
researchers have sought to recapitulate tissue structure using 
a combination of isolated cells and polymeric hydrogels that 
have a structural resemblance to the ECM.[4] Such specimens 
have been manufactured using the process of gel-casting; this 
allows for gross geometrical control, yet provides little con-
trol over the microscale geometry and spatial and mechanical 
cues important to controlling cell behavior.[5] Additive layer 
manufacturing (ALM) offers the tantalizing possibility of cre-
ating structures with a greater level of complexity than tradi-
tional processing methods such as casting, and some degree 
of control over the distribution of cells and other important 
components throughout the structure. While the ALM of hard 
materials is relatively mature and a number of industries now 
utilize such technologies, at present the ALM of soft mate-
rials remains challenging. ALM using soft materials has been 
reported in the literature since the mid 2000s when Boland 
et al. published on the production of “nose-like” specimens 
from alginate.[6] In the years since many research groups have 
published on the manufacture of structures from soft solids 
some of which allow for the incorporation of cells.[7] Most 
recently, Hwang et al. reported the production of a cartilage-like 
structure for auricular reconstruction.[8] Notably, the majority of 
additively manufactured soft-solid structures exhibit relatively 
low complexity[9] and are typically broader at their base than 
at their peak to reduce the risk of the structure collapsing. A 
number of research groups are working on the development of 
novel polymers for ALM,[7,10] but in the most part, the struc-
tures they form with these polymers are highly simplistic, with 
a self-supporting “waffle arrangement” frequently being used to 
demonstrate process resolution.[7,9,11] Some papers report the 
use of harder materials, such as poly(caprolactone) (PCL) and 
hydroxyapatite, to support the structure[12,13] or have extruded 
materials into high viscosity liquids, for example Pluronic 
F-127 hydrogel.[13] Additionally, there have been reports of addi-
tive manufacturing using a suspending medium that consists 
of either a shear-thinning synthetic hydrogel[14] or a slurry of 
gelatin particles,[15] respectively. These elegant approaches 
resulted in structures of previously unprecedented complexity, 
but neither group managed to codeposit multiple cell types or 
could demonstrate any localized modification in mechanical 
properties of chemistry, both of which are critical to biological 
performance. Furthermore, neither of these methods is condu-
cive to the manufacture of structures that are suitable for the 
clinic, since the suspending medium would be very challenging 
to completely remove from the finished part. In this study, we 
have addressed these issues by using a self-healing particu-
late or fluid gel material, which is stable at room temperature 
and in culture conditions, as a supporting media. The strong 
In this study, we describe a novel method of suspended manu-
facture for the production of complex soft structures of closely 
defined morphology, mechanical properties, and chemistry. The 
process conditions are sufficiently mild that embedded popula-
tions of cells maintain high levels of viability and retain pheno-
type. Given the simplicity of the process, it can be used for all 
existing gel materials without special modification. The method 
of manufacturing uses a “bed” of micrometer sized gel particles 
(often referred to as fluid or sheared gels),[1] which behave in 
bulk as a viscoelastic fluid and can self-heal thereby providing 
support to the complete part.[2] The final structure is formed 
through the dispersion of a gelling material into the interstices 
between the supporting fluid gel particles. This enables rela-
tively complex structuring while providing sufficient support 
to prevent the structure collapsing under its own weight. Once 
the scaffold structure has been formed the supporting phase 
may be removed through the gentle application of shear. This 
manufacturing process allows for the use of a wide range of 
polymeric materials, including many already approved by regu-
latory bodies. Ultimately it has the potential to produce struc-
tures that could make their way into clinical trial in the relative 
short term. Here we demonstrate the power of this method by 
manufacturing anisotropic structures with spatially controlled 
mechanical and chemical properties, which support a coculture 
of viable cells. These scaffolds could be used for the production 
of osteochondral plugs for the augmentation of full-thickness 
cartilage defects.
Tissues are formed of populations of cells distributed within 
an extracellular matrix (ECM), which is structured down to 
the molecular level. Local variations in organization and bio-
chemistry mean that the encapsulated populations of cells are 
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surface interactions between gel particles 
form short-range adhesions when in close 
contact causing the paste-like material to 
thicken.[16] The interactions formed between 
the particles allow the particulate material to 
support a secondary phase of similar (or in 
some cases higher) density. This “true-gel” 
(G′ >>> G′′) particulate (Figures S1–S3, Sup-
porting Information) microstructure makes 
this system physically distinct from highly 
viscous fluids, such as commercial shower 
gels, that are formed almost exclusively by 
polymer entanglement.[17] Importantly, since 
the gel particles are discrete entities they do 
not contaminate the surface of the manu-
factured sample and can actually be formed 
from the same material as that extruded into 
the particle bed (Figure 1) likely simplifying 
the translational pathway. Using particulate 
gels as a suspending agent, supports the 
fragile construct as it is formed, in a similar 
manner to the way amniotic fluid suspends 
the developing fetus. Using an XYZ stage, 
it was possible to (with 100 µm resolution) 
deposit the hydrogel polymer in a discrete 3D 
location, the resolution of which is limited 
only by the size of the droplet from the end 
of the extruding needle and the viscosity of 
the supporting medium.
A variety of hydrogel materials may be 
used for the production of the final part and 
the supporting bed. Initial experimentation 
demonstrated that it was possible to generate 
structures using combinations of gelatin, 
gellan, collagen, hyaluronic acid, agarose, 
and alginate. As a consequence of its relative 
robustness and capacity for physical modifi-
cation using seeded hydroxyapatite,[18] gellan 
was selected for further use as the final part 
and agarose as the supporting bed. The sup-
porting bed, formed from agarose with par-
ticles in the size range 2–11 µm (Figure S4, 
Supporting Information), was of sufficient 
robustness to suspend a cross-linked gellan 
gum structure such as the helix illustrated 
in Figure 1. This helical structure was loaded 
with colloidal hydroxyapatite nanocrystals 
in order to increase radio-opacity enabling 
micro-computed tomography (CT) imaging. 
Following treatment with calcium chloride solution this helical 
structure was removed from the particle bed and was shown to 
be self-supporting (Figure 1). The shear forces applied during 
the extrusion process were not of sufficient magnitude to cause 
phase separation and were sufficiently mild that it was possible 
to maintain the viability of a population of human primary 
chondrocytes within the cultures (Figure 2). To investigate the 
influence of supporting matrix viscosity on the resolution of the 
printing method, samples were made using a controlled con-
centration of gellan gum (1.5%) and a hypodermic needle of 
internal diameter 337 µm. An increase in the viscosity of the 
supporting medium resulted in a monotonic increase in resolu-
tion in the XY dimensions, but interestingly a smaller reduction 
in resolution in the Z dimension (Figure 2). At this scale, reso-
lution is ultimately limited by droplet size, which is controlled 
by the internal dimensions, flow rate of the extruding aperture 
and other parameters of deposition, such as the viscosity of 
the extruded solutions. To further investigate factors that may 
influence resolution, structures were formed using a range of 
needle diameters and it was demonstrated that resolution was 
Adv. Mater. 2017, 1605594
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Figure 1. A–D) A schematic showing the manufacturing process for a 3D soft solid structure 
manufactured using the suspended deposition method. A) Briefly, a supporting “fluid-gel” 
matrix is created in a vessel. B) A secondary phase may then be extruded into the particle 
bed. C) The self-healing, fluid gel supports the gel structure during the cross-linking process. 
D) Once cross-linked, the object may be removed from the particle bed. E) This was mani-
pulated to fabricate a simple helix loaded with hydroxyapatite nanoparticles and imaged with 
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directly related to needle diameter, increasing up to the point 
that the hydrocolloid could no longer be extruded (Figure 2). 
The peak resolution achievable for the 1.5% gellan gum and 
the agarose supporting medium was 250 µm. Given the scale 
of the tissues to be produced for osteochondral repair and the 
need for cell viability, the needle diameter was set at 337 µm 
and extrusion rate no more than 125 µL s−1. To demonstrate the 
complexity achievable with the suspended manufacturing pro-
cess, scaffolds that mimic the structuring and cellular organiza-
tion of an osteochondral defect were manufactured. This com-
plex tissue region lies between articular cartilage and bone on 
an articulating joint surface[19] and may be severely damaged 
following trauma[20] or can deteriorate during the progression 
of osteoarthritis.[21] At present the standard of care is microfrac-
ture in the knee[22] or the transplantation of tissue that has been 
isolated from a cadaver or nonarticulating region of the joint.[22] 
Neither method has been shown to be absolutely successful 
and this has driven research into the development of a range 
of synthetic osteochondral plugs.[23] The main reason for failure 
of these synthetic grafts is through delamination at the hard–
soft tissue interface.[24] Native osteochondral tissue exhibits a 
gradual structural change from disordered mineralized collagen 
at the subchondral bone,[25] through to collagen II and glycosa-
minoglycan (GAG) - rich cartilage[26] allowing stress to be dis-
tributed across the interface without stress localization and 
delamination occurring.[26,27] The region consists of four prin-
ciple cells types, which secrete and organize their local environ-
ments.[25,26] Although a number of groups have attempted this 
in vitro[28] the processes that they have employed did not mimic 
the structuring of this complex structure at a length-scale that 
is appropriate to the size of the defects encountered clinically.
Here, the suspended manufacturing process was used to 
form composite hydrogel structures with anisotropic mechan-
ical properties mimicking the native osteochondral envi-
ronment. Femoral condyle tissue was retrieved from patients 
following knee replacement and an osteochondral defect was 
introduced using a surgical drill. Excess retrieved tissues were 
digested to release the cells from the cartilage and bone sam-
ples. The structure was scanned using micro-CT and a 3D 
model of the defect was created. This 3D model was used to 
guide the manufacture of an osteochondral implant where the 
lower surface was loaded with sol-HA, gellan, and osteoblast 
cells (Figure 3). The upper surface of the construct was manu-
factured using gellan gum alone, loaded with populations of 
chondrocytes (Figure 3). The suspended manufacturing pro-
cess allowed for the production of osteochondral structures that 
fit tightly into the defects and matched the layer thicknesses 
for the bone and cartilage components. These samples were 
then placed in culture for a period of four weeks in order to 
identify whether the cell types in the different regions of the 
defect maintained phenotype. Over the course of four weeks of 
in vitro culture the osteochondral plugs maintained their struc-
tural integrity; they could be easily handled and extracted from 
the defect without deterioration (Figure 3).
Mechanical spectra of the osteochondral constructs high-
light the successful integration of two different materials 
into a single structure (Figure 3). Constructs were sliced into 
four regions and stress sweeps were conducted on each sec-
tion to determine mechanical strength and elasticity. Samples 
were subjected to increasing stress (0.1–1000 Pa) and a range 
of mechanical properties was observed throughout the con-
struct. The weakest areas with the shortest linear viscoelastic 
Adv. Mater. 2017, 1605594
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Figure 2. Extrusion of a gellan matrix loaded with primary human chondrocytes into the “fluid-gel” structure through a 337 µm internal diameter needle 
maintained cell viability throughout the construct (left column, scale bars =  200 µm). An increase in the internal diameter of the needle resulted in 
a reduction in resolution (centre, top), as did a reduction in the viscosity of the matrix (centre, bottom). From these experiments, a fluid viscosity of 
0.75 Pa s (at 1 s−1 shear rate) and needle diameter of 337 µm was set for manufacture of an osteochondral plug. A computer model of this plug (right 
column) was generated from CT scans of a defect drilled into the tissue by a clinician. The model generated was used to inform the manufacture of a 
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region were the chondral region and the uppermost surface of 
the construct (Regions A and D). Region C exhibited signifi-
cantly higher gel strength and elasticity. This can be attributed 
to the nanocrystalline hydroxyapatite (nano-HA) interacting 
with gellan helices during gelation to create a highly homog-
enous structure exhibiting higher strength in comparison with 
unloaded gellan (Figure 3). Interestingly, the incorporation of 
HA into the gellan hydrogel resulted in a more rapid relaxa-
tion response than the gellan alone (Figure 3C). This is sig-
nificant since matrices of elastic modulus >17 kPa that exhibit 
more rapid stress relaxation encourage mineralization to a 
greater extent when compared with those with slower stress 
response.[29] Region A was comprised entirely of gellan gum 
without nano-HA, which explains the lower gel strength. It is 
likely that the nano-HA began to sediment prior to gelation due 
to its higher density compared with the gel phase (3.16 com-
pared with ≈1 g cm−3) resulting in the top of the osteogenic 
region showing a lower modulus. At the interface (Region B), 
the construct exhibited mechanical properties intermediate to 
Regions A and C providing evidence for a successful integra-
tion of the two different materials (Figure 3). Interestingly, 
the trend in mechanical properties observed in regions A–C 
shows some similarity to reported changes in modulus across 
osteochondral tissue (Figure 3). A 2012 study by Campbell 
et al. outlined indentation moduli of three osteochondral 
regions, namely subchondral bone, hyaline cartilage, and the 
osteochondral interface.[27] Subchondral bone exhibited the 
highest modulus, hyaline cartilage the lowest with calcified car-
tilage (the interface) falling between the two, albeit closer to the 
modulus of bone. Indentation moduli of tissue regions were 
orders of magnitudes greater than storage moduli of respective 
construct regions and methods used to determine both differed 
greatly. However, parallels between the two trends highlight 
the level of control exhibited over mechanical properties within 
each region of osteochondral constructs.
Polymerase chain reaction (PCR) data collected from the 
retrieved samples demonstrated that the expression of both col-
lagen type II and aggrecan (ACAN) (both markers of cartilage 
formation) was highest in the chondral region of the scaffold 
(Figure 3) and collagen type I expression was lowest at this 
point. Immunohistochemical (IHC) analysis of the samples 
demonstrated the presence of aggrecan around the encapsulated 
Adv. Mater. 2017, 1605594
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Figure 3. A) Samples manufactured using suspended manufacturing were cultured before being cut with a razor blade and mechanically characterized 
using a rheometer. B) The storage modulus of the construct reduced significantly from the core “boney” area of the structure (Regions C and D) into 
the chondral region (Regions A and B). Mechanical data reflected trends seen in native tissue with an increase in modulus from hyaline cartilage 
(Region A) through the osteochondral interface (Region B) to subchondral bone (Regions C and D).[20] This demonstrates that it is possible to not only 
define geometric but also the mechanical properties exhibited by the resulting structure. C) Stress relaxation measurements show that the addition of 
hydroxyapatite (GG +  HAp) results in a faster relaxation response than gellan gum alone (GG). D) Following 4 weeks of culture within the human tissue 
defects (n =  6), the construct was removed and cells within the cartilage (CH), interfacial (IF) and bone (OB) regions were recovered for RNA isolation 
and mRNA was analyzed by qRT-PCR. The cells in the cartilaginous section of the scaffold expressed the highest levels of coll II and aggrecan (ACAN) 
and the bone region expressed significantly more coll IA1 (mean ±  SEM). This suggests that the cells deposited into discrete regions maintained not 
only viability but also their phenotype (*: P < 0.05, τ: P =  0.0793). E) Fluorescent immunohistochemistry (IHC) (DAPI (4,6-Ddamidino-2-phenylindole) =  
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cells in this area of the scaffold (Figure 3). Remarkably, the ratio 
of collagen II to collagen I changed gradually throughout the 
structure inline with what would be expected with the native 
tissue region. This indicated that while the two sections of the 
osteochondral scaffold were well integrated, the embedded 
cell population retained their native phenotype. This is some-
thing that has proven challenging with existing technologies 
for tissue structuring. In comparison with the majority of ALM 
methods, where high temperatures, pressures, or cross-linking 
agents are a necessity, the suspended manufacture method 
allowed us to maintain viability and behavior while subtly mod-
ifying the local composition of the matrix.
In this paper, a new method was reported to manufacture 
comparatively complex soft-solid structures by extruding a 
gelling polymer into a supporting particle-based matrix. The 
method allowed the structuring of soft-solid materials such 
that they exhibited distinct chemical and physical properties 
on the microscale. It was shown that suspended manufacture 
could recapitulate the structure of the osteochondral region as 
defined by CT scanning. The printed structure maintained its 
morphology and mechanical robustness over a period of four 
weeks of culture during which the encapsulated cells retained 
their phenotype. Our findings suggest that this novel method 
of producing 3D tissue-like structures has significant promise 
for the regeneration and study of complex tissue structures and 
interfaces.
Experimental Section
Fluid Gel Formulation: Fluid gels were manufactured by cooling 
solutions of 0.5% w/w agarose from 85 to 20 °C under constant shear 
using a magnetic stirrer rotating at 700 rpm. This created a constant 
angular velocity of 74 rad s−1. Fluid gels were sterilized for cell culture 
applications by autoclaving agarose solutions prior to cooling.
Suspension of Helical Polymeric Structures: Aliquots of fluid gel 
were prepared in 6 mL Bijoux tubes. Solutions of 1.5% w/w low acyl 
gellan mixed with 10% nanocrystalline hydroxyapatite/HA at 60 °C 
(formulated by a precipitation method)[30] were extruded into fluid gel 
samples through a hypodermic needle with a 337 µm inner diameter 
using a 5 mL syringe. During extrusion, the syringe was manipulated 
precisely with respect to geometric position to enable the generation 
of the helix. The suspensions were then left at room temperature for 
40 min to enable gelation to occur. Prior to extraction, samples were 
observed using micro-CT (Bruker Skyscan 1172—Bruker, Belgium) and 
reconstructed data were visualized in 3D using CTVox software (Bruker). 
Helices were then extracted and excess fluid gel was washed away with 
deionized water.
Tuning Resolution of Suspended Constructs: Low acyl gellan gum 
solutions of varying viscosity (as controlled by polymer concentration) 
were extruded into separate aliquots of fluid gel (contained in petri 
dishes of 60 mm diameter and 15 mm depth). Gelation was triggered 
by temperature and ionic interaction via injection of 200 ×  10−3 M 
CaCl2 around constructs at 20 °C. After 30 min, gelled structures were 
extracted and the resolution of each construct was measured.
Evaluation of Cell Culture Applications: Osteochondral tissue was 
donated by patients undergoing elective knee replacement surgery. 
This study was approved by the United Kingdom National Ethics 
Research Committee (Hertfordshire Research Ethics Committee 12/
EE/0136). Articular cartilage was removed from human femoral condyle 
tissue before mincing and digestion by 2 mg mL−1 collagenase for 
4 h under agitation at 37 °C for release of chondrocytes. Bone chips 
(4–5 mm3) from subchondral trabecular bone were cultured for release 
of osteoblasts. Both cell types were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum, 
1% L-glutamine, 1% PenStrep, and 1% nonessential amino acids. 
At passage 1, cells were trypsinized, counted, and resuspended at a 
density of 3 ×  106 cells mL−1 before being mixed with sterile 1.5% low 
acyl gellan gum. Cell-laden gellan gum was extruded into sterile agarose 
fluid gel to create linear constructs. Gelation at 20 °C was triggered with 
200 ×  10−3 M CaCl2 and excess calcium ions were washed away after 
30 min using Dulbecco’s phosphate buffered saline (PBS). Cell-loaded 
constructs were cultured at 37 °C/5% CO2 in culture media (as above). 
Cell viability was visualized using Calcein-acetoxymethyl (AM) and 
ethidium homodimer-1 fluorescent dyes.
Defect Formation and Reconstruction: Defects were introduced into 
femoral condyle tissue following surgery using an orthopedic drill. The 
resulting tissue was imaged using microCT (Bruker Skyscan 1172) and 
reconstructed data were viewed using CTVox software (Bruker). The 
defect was then measured for reconstruction of the defect space in 
Simpleware (Synopsys, UK).
Implant Fabrication and Culture: Prior to implant fabrication cells 
were isolated and cultured as above. Primary human osteoblasts and 
chondrocytes were trypsinized, counted, and resuspended at a density 
of 1 ×  106 cells mL−1. Osteoblasts were loaded into 1.5% low acyl gellan 
mixed with 5% nano-HA while chondrocytes were mixed with 1.5% 
gellan. Guided by dimensions obtained from defect reconstruction, 
single implants were fabricated containing a layer of chondrocyte-
loaded gellan and a thicker layer of osteoblast-loaded gellan/HA via 
extrusion into sterile agarose fluid gel. Gelation at 20 °C was triggered 
with injection of 200 ×  10−3 M CaCl2 around each suspended structure 
and constructs were extracted after 30 min. Excess fluid gel was washed 
away and constructs were implanted into tissue defects. The construct-
filled defects were then cultured as above in a humidified incubator at 
37 °C, 5% CO2 for 30 d (n =  6).
Determination of Collagen 1, Collagen 2, and Aggrecan (ACAN) 
Expression: Following 30 d of culture, constructs were removed from 
the tissue defects and separated into cartilage, interface, and bone 
regions for gene expression analysis. RNA was isolated using TRIZol 
reagent (Life Technologies, UK) and the manufacturer’s instructions 
were followed. RNA was quantified using photospectrometry (NanoDrop 
2000, NanoDrop Technologies). Quantitative-realtime polymerase chain 
reaction (Q-RTPCR) was performed using a Lightcycler 480 (Roche). 
The expression of collagen type I, type II, and aggrecan (ACAN) were 
measured and normalized to 18S expression. Validated TaqMan probes 
were purchased from Life Technologies. Gene expression was quantified 
using the Pfaffl method.[31]
Fluorescent Immunohistochemistry: Constructs were fixed with 
4% paraformaldehyde before blocking in vehicle (10% goat serum, 
0.1 M PBS, 0.3% Triton-X-100). For aggrecan, cells were incubated with 
mouse antiaggrecan primary antibody (1:100, ThermoFisher) and then 
Alexa 488 goat antimouse secondary antibody (1:500, Invitrogen). 
Nuclei were stained with 4,6-Diamddino-2-phenylindole (DAPI) (1:5000, 
Sigma-Aldrich) and constructs were imaged using a Leica DM 6000B 
microscope.
Mechanical Spectra of Implants: Layered constructs were sliced 
laterally into four separate regions (see Figure 3—mechanical spectra 
figure). Stress sweeps were conducted on each region using a Bohlin 
Gemini rheometer (Malvern, UK) with 25 mm serrated parallel plate 
geometry. Elastic and viscous moduli (G′ and G′′, respectively) were 
analyzed in response to increasing stress from 1 to 100 Pa at a constant 
temperature of 37 °C. For stress relaxation, gellan gum and gellan 
gum/hydroxyapatite constructs (height 8 mm, diameter 14 mm) were 
displaced 2 mm and held for 300 s while load was recorded (Bose 
ElectroForce 5500).
Rheological Measurements: All rheological measurements were 
performed on a Bohlin Gemini rheometer (Malvern, UK) using a 55 mm 
2° cone and plate geometry at an isothermal temperature of 37 °C which 
was maintained by a Peltier controlled lower plate.
Stress Sweeps: Samples of 0.5% agarose fluid gels were prepared and 
loaded onto the bottom plate of the rheometer. The samples were then 
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subjected to a shear stress range of 0.1–100 Pa at a constant oscillatory 
frequency of 10 Rad s−1. Elastic and viscous moduli were measured in 
response to increasing shear stress. Results were analyzed to determine 
the linear viscoelastic region.
Frequency Sweeps: Elastic and viscous moduli of 0.5% agarose fluid 
gels were analyzed in response to increasing oscillatory frequencies 
from 0.1 to 10 Rad s−1 at a constant strain of 0.05%.
Shear Sweeps: Shear ramps were performed at 37 °C on 0.5% agarose 
fluid gel samples. Shear rate was increased from 0.001 to 100 s−1 over 
a 10 min period and dynamic viscosity in response to increasing shear 
rate was subsequently analyzed.
Particle Size Distribution: Fluid gel samples were loaded onto glass 
slides and allowed to dry under a coverslip for 10 min. Samples were 
then visualized on Keyence VHX 2000 digital microscope (Keyence, UK). 
Particle sizes were analyzed with VHX 2000 communication software. 
Particle size distribution was evaluated using images of fluid gel 
particles within an area of 135 µm ×  120 µm. Images were divided into 
12 grids of 11.25 µm ×  10 µm. Within each grid, the number of particles 
was recorded and divided into categories based on size. A total of 96 
grids and ≈2300 particles were counted. Particle size distribution was 
subsequently determined by comparing the number of particles within 
each size range and calculating cumulative undersize.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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levels of pro-inflammatory cytokines, MMPs and chemokines which have catabolic func-
tions and degrade cartilage [217]. The final process in OA chondrocytes is cell death;
increased cell numbers and insu cient levels of nutrients in the chondron causes cell
necrosis [5].
1.4.2 Bone in OA
There are changes to subchondral cortical and trabecular bone as well as formation of
bony spurs (osteophytes) in OA, all of which are specific to the stage of OA. Increased
loading leads to an increase in bone turnover as stated previously. In OA, there is region-
specific thickening of the subchondral cortical and trabecular bone as seen in Figure 1.7
[59, 111]. There is also thinning of the epiphyseal trabecular bone which is likely due to




Figure 1.7: Reconstructed µCT image of an OA tibial plateau (sagittal plane) showing
thickening of the subchondral cortical bone (SCB) where cartilage (C) is thinning or
completed degenerated. The subchondral trabecular bone (STB) architecture is also
irregularly thickened.
.
Excessive loading that occurs when cartilage is completely degraded can lead to
bone marrow lesions and bone cysts. These defects in the bone have been associated with
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Figure 1.8: Schematic representation of inflammatory processes in OA progression,
adapted from van den Bosch [217].
.
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Figure 1.17: Schematic of polymer networks following A) quiescent gelation and B)
sheared gelation to produce a fluid gel, from Cooke et al. [26].
have been shown to infer di↵ering mechanical properties, particularly in the solid-like
behaviour of the gel [42]. In this instance, the fluid gel produced with a pin stirrer, with
a ‘hairy particle’ morphology (Figure 1.18B) showed a higher yield stress (defined as a
5% deviation from the LVR) than the one produced in a rheometer (Figure 1.18A) [147].
This is likely due to stronger interaction between the extensions of the hairy particles
compared to the more spherical ones. Tuning these parameters can give rise to unique
rheological properties for the potential delivery of therapeutics, cells and other material.
Figure 1.18: Morphology of agar fluid gel particles produced either in a) a rheometer or
b) a pin stirrer; reproduced from [42].
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Figure 1.19: Considerations for printing technique; reproduced from Malda et al. [120].
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Figure 1.20: A consideration of the biofabrication window regarding hydrogel sti↵ness
and geometry complexity. Softer gels which allow for cell migration and o↵er high cyto-
compatibility are of too low viscosity for traditional techniques and so novel techniques
are required to overcome this limitation. Reproduced from Malda et al. [120].
is no longer required as the cell-seeded hydrogel is printed directly [11]. This is becoming
a widely used technique and has led to the development of many novel hydrogels to
enable direct extrusion. Methacrylated gelatin (GelMA) is a commonly used bioink for
direct printing of structures for cartilage tissue engineering and has been modified with
HA, PEG, PEGDA and graphene oxide to enhance its print properties [144, 195, 244].
Another material that has been modified for printability is hyaluronic acid. Another
application of methacrylation of established hydrogels for tissue engineering was achieved
by Burdick’s group; using methacrylated (and further modified) hyaluronic acid, they
were able to produce multi-layer constructs by direct bioplotting [153]. They developed
a system to ‘in-situ’ crosslink these formulations such that they gelled upon arrival on
the collector so there was very well controlled deposition of fibres to produce a lattice
structure [154].
Many hydrocolloid solutions commonly utilised in 3D cell culture by casting into
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peak stress of 1.7 MPa which is similar to the estimated physiological peak stress during
walking [241]. Before applying a frequency sweep, each specimen was preloaded to 3 N to
avoid initial slipping and subjected to two preconditioning cycles. 1500 and 3000 cycles
at 25 and 50 Hz respectively were applied, with 60 s between them, to achieve a dynamic
‘steady-state’ which has been stated to occur after around 1200 to 4500 cycles for ex vivo
cartilage [55, 125, 220]. Following preconditioning, eight di↵erent physiologically-relevant
sinusoidal frequencies (1, 8, 10, 12, 29, 49, 71 and 88 Hz) were applied to each cartilage
specimen in order of increasing frequency [55].
Figure 2.2: Mechanical testing set up for cartilage. Left: Aluminium compression platen
mounted for DMA tests. Right: Sharp needle attached for thickness measurements.
Specimen thickness
The thickness of each cartilage specimen was measured, for conversion of DMA sti↵ness
data to moduli, using a needle thickness test. A sharp needle was attached to the ma-
chine’s displacement transducer (1 µm resolution, Figure 2.2 right) and the needle was
pushed through the full thickness of the cartilage specimen. The displacement of the
needle from initial contact with the cartilage (Figure 2.3 (a)) to contact with the base
plate (Figure 2.3 (c)) was calculated as the cartilage thickness.
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3.2 Methods
Tissue isolation and preparation
Cartilage explants were isolated from the lateral aspect of the femoral condyle of both OA
and age matched post-mortem donors with no history of joint disease, as indicated in Fig-
ure 3.1. Cartilage in this region was macroscopically undamaged compared to the medial
aspect of the joint, where cartilage had been degraded su ciently that the subchondral
bone was exposed (Figure 3.2). As the synovial fluid fills the joint space, however, the
chemical and inflammatory environment is the same across both joint aspects. Tissue
from post-mortem subjects is referred to as ‘healthy’ and tissue from joint replacement is
referred to as ‘OA’; patient data is presented in Table 3.1.
Figure 3.2: Femoral condyles as received in the laboratory from an OA patient following
TKR surgery. The dashed region indicates where cartilage explants were taken for this
study.
Table 3.1: Age and genders of the 20 patients whose cartilage was studied, n(explants)
corresponds to specimens used for DMA.
Tissue n (explants) Age Gender Thickness (mm)
Healthy 6 (22) 76 (53-87) M=3 1.465 ± 0.240
OA 14 (37) 71 (56-81) M=10 1.463 ± 0.206
DMA and thickness testing
Cylindrical cartilage explants were hydrated for 30 min in Ringer’s solution before DMA














































Figure 3.5: Thermogravimetric analysis of OA (grey) and healthy (black) cartilage be-
tween (A) 20-250￿. Dashed line indicates kinetics of mass change (DTG). Inset (B) shows
the end of the water loss region, n=4.
direction of collagen fibril alignment in this region, but the surface was not macroscopi-
cally ruptured as seen in the OA samples. The OA cartilage had severe damage to the
articulating surface post-DMA, while the middle and deep regions retained their structure.
Figure 3.6B shows the relative quantification of sulphur distribution across the sections.
Healthy and OA sections had similar sulphur levels in the deep and middle zones, but
the OA samples had lower levels in the superficial zone. Quantification of the post-DMA
samples shows that in both OA and healthy samples, mechanical testing reduced the
sulphur content, which is likely due to changes in aggrecan proteoglycan organisation.
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Figure 3.7: µXRF mapping of sulphur, calcium and phosphorus showing evidence of Ca
and P localisation in mineral deposits in the middle and superficial regions of OA cartilage.
Figure 3.8: Representative alcian blue staining of 10 µm thick cartilage sections from





























Figure 3.9: Surface roughness of healthy and OA cartilage samples with or without DMA
testing as measured by WLI; n=3, * p<0.05.
3.4 Discussion
This study aimed to understand the di↵erences in frequency-dependent viscoelastic prop-
erties of isolated healthy and OA human articular cartilage and to compare these to the
physicochemical changes seen. Tissue was excised from the lateral aspect of the OA joint,
which is known to be less exposed to mechanical stresses than the medial aspect, and
thus was used to represent cartilage which was not excessively mechanically loaded but
was exposed to the same chemical environment.
The first component of this study determined the viscoelastic properties of healthy
and OA human cartilage. The logarithmic frequency-dependent behaviour in both the
storage and loss modulus was similar to previous findings in human and bovine cartilage
[106, 161, 212]. The significant reduction in storage modulus across a range of frequencies
in OA specimens is likely to be indicative of disruption to the matrix structure as a
result of OA cytokines, MMPs and altered joint loading. The solid matrix components of
cartilage, Col II and the aggrecan-rich proteoglycan network, are primarily responsible for
the compressive sti↵ness of cartilage and was shown to be reduced in OA. This di↵erence
was statistically significant at all but the highest frequency, 88 Hz (P=0.0581), which has
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Formulation of a deliverable fluid alginate
An alginate fluid gel was produced by drop-wise addition of CaCl2 to sodium alginate
solution under shear. The forming of the fluid gel is shown in Figure 4.5A, where the
addition of the divalent cation caused a sharp increase in the viscosity of the alginate solu-
tion. The viscosity continued to increase until around 6 minutes after which the viscosity
dropped slightly and then equilibrated. To ensure that the fluid alginate was deliverable
through a needle or cannula, the shear rate was ramped and recovered cyclically between
0.1-500 s 1. There was only evidence of a very small hysteresis loop in Figure 4.5B, in-
dicating that this fluid gel will be stable during manipulation and handling. Figure 4.5C
shows the di↵erent forms that alginate was produced in. As can be seen on the right
hand side of Figure 4.5C, the fluid gel was able to flow like a liquid under shear to then
rest as a solid-like material in the absence of shear. The presence of bubbles in the fluid
gel shows how the network of entangled polymer chains can reorder around structures.
Figure 4.5: Formulation of fluid alginate. A) Viscosity profile during the cross-linking of
alginate fluid gels (n=3). B) Change in shear stress with shear rate over ramps of shear
rate from 0.1-500-0.1-500 1, sol (left), quiescent (middle) and fluid (right) alginate.
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The interesting mechanical properties of fluid gels are partly due to their particu-
late architectures with short range interactions and entanglements. Figure 4.6A shows
the typical architecture of fluid gel fragments connected by ribbon-like structures. Chon-
drocytes were then seeded between fluid alginate particles and the morphology of all cells
was spherical, showing little interaction with the alginate particles. Further there were
high levels of cell viability in these cultures (Figure 4.6B and 4.6C).
Figure 4.6: Imaging of fluid alginate and seeded chondrocytes. A) Fluid gel architecture
(SB: 200 µm), B) fluid gel with chondrocytes showing interaction with alginate fragments
and ribbons SB: 100 µm), C) z-stack of chondrocytes in fluid alginate 4 days after seeding,
SB: 100 µm
Mechanical characterisation of fluid and quiescent alginate
Dynamic small deformation rheology was performed to determine the viscoelastic prop-
erties of both the quiescent and fluid gel systems. Firstly, by applying an increas-
ing oscillatory stress, the LVR of each alginate matrix was determined (Figure 4.7A).
The LVR of the fluid gel was shorter than that of the quiescent gel, highlighting the
ability of the fluid network to flow under stress. The frequency dependent behaviour
of the materials was then probed. The presence of weak interactions and entangle-
ments were confirmed through linear rheology (Figure 4.7B), with the sheared alginate
showing solid-like behaviours dependent on frequency, typical of weak gels. Interest-
ingly, the quiescent gel showed a similar mechanical spectrum (at higher G values) infer-
ring structures which mirror each other, complementing data obtained via microscopy
shown in Figure 4.8C. Fluid alginate (grey) showed strong shear thinning behaviour
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Figure 4.8: SEM images of thin sections of fluid (A, C, E) and quiescent (B, D, F) alginate
following freeze drying.
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The e↵ect of alginate fluid gel on the phenotype of primary articular chon-
drocytes
To compare the e cacy of alginate fluid gel with quiescent alginate in recovering and
supporting a chondrogenic phenotype, primary hACs were cultured in either alginate
fluid gel or in quiescent alginate for a period of 7 days. Following 7 days of culture Col
II and aggrecan expression were higher in the quiescent than fluid alginate and Sox9
expression was significantly higher in the quiescent alginate (Figure 4.11).
Figure 4.9: Tracking of chondrocytes in (A) fluid and (B) quiescent alginate over 14
hours. Movement of cells is demonstrated by coloured circles. Full videos are available at
https://tinyurl.com/yctb9eqm, Videos 1 and 2.
Driving chondrogenic phenotype of primary chondrocytes encapsulated in al-
ginate
Due to the proximity of native cartilage tissue during the ACI repair of cartilage defects,
ex vivo cartilage tissue and cartilage conditioned media were studied to determine their
e↵ect on the e cacy of using fluid and quiescent alginate as chondrocyte delivery matrices.
By adding a piece of explanted cartilage tissue, (Figure 4.12A) there was an increase in
the expression of COL2A1 in quiescent alginate following 14 days of culture (Figure 4.12).
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The e↵ect of the physical presence of cartilage tissue was shown to be secondary to the
factors released from it (Figure 4.12B), since conditioned cartilage explant media resulted
in a greater increase (P=0.0376) in Col II expression than the cartilage tissue itself. This
suggests that in the in vivo environment, alginate encapsulation of hACs will be even more
e cacious in promoting and maintaining the chondrogenic phenotype due to the secretion
of endogenous anabolic factors from the surrounding cartilage matrix. This condition was
then investigated to determine if it could be used to drive the native alginate phenotype
in fluid alginate culture. However, when comparing conditioned and basal media, there
was no significant di↵erence between the conditions (P=0.3126, Figure 4.12C); this further






















































Figure 4.12: A) Experimental set-up for explant (left) and blank/conditioned media (CM)
(right). Relative Col II expression in B) quiescent and C) fluid alginate when cultured
with basal media (blank), a cartilage explant or conditioned media, n=3.
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5.3 Results
Characterisation of the agarose fluid bed
Agarose fluid gel was produced by introducing shear as the hydrocolloid solution was
cooled. This resulted in the formation of an entangled microparticulate gel network as
can be seen in Figure 5.2 using phase contrast microscopy. Individual tadpole-shaped
particles were formed (as indicated by arrow in Figure 5.2A) which then appeared to
interact from the head-regions to form larger aggregate particles of between 150-200 µm
in diameter. The shape of the particles prior to agglomeration was likely due to the way
that shear was applied during gelation. The hypothesised production of these particles is
shown in Figure 5.2D. The high shear in the column above the stirrer (region marked (1)
within dashed lines) may cause the formation of elongated gel particles and the toroidal
motion of the bulk gel in 3D forces these individual particles into regions of lower shear.
This would allow for the agglomeration and entanglement of these particles. In a bulk,
Figure 5.2: Phase contrast imaging of fluid agarose particles showing A) individual units
indicated by arrow B) characteristic ‘hairy’ aggregates and C) interaction of aggregates.
D) Schematic hypothesis of formation of individual particles and aggregates at high (1)
and low (2) shear regions respectively. SB=150 µm
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as seen in Figure 5.2C, the aggregates interact and entangle by the tails which project
from the core. These weak entanglements are likely responsible for the unique mechanical
properties of fluid gels.
Rheological investigations were performed to investigate the properties of agarose
fluid gel under shear. Firstly a stress sweep was performed; the LVR was found to be
fairly short with a cross-over between G’ and G” at 32 Pa. A frequency sweep was then
performed at 1% strain which showed a higher G’ than G” (tan  = 0.17±0.013), and slight
frequency dependence indicating weak gel, or structured liquid, behaviour (Figure 5.3 A,
B). The shear rate was alternated between 0.1 and 100 s 1 to investigate the recovery
of viscosity. As expected, the fluid gel was highly shear thinning and the recovery of
viscosity was very fast (Figure 5.3C). Finally, a high shear rate (100 s 1) was applied and
then removed to determine the recovery of elasticity in the agarose matrix. Figure 5.3D
shows that there was a rapid increase in shear storage modulus immediately following
shearing, although the recovery to the original elasticity takes longer than 30 s.



























































0.1 s-1 0.1 s-1 0.1 s-1
100 s-1100 s-1
Figure 5.3: Rheological characterisation of 0.5 w/v% agarose fluid gel A) Stress sweep
from 0.1-100 Pa B) Frequency sweep from 0.1-100 Hz at 0.1% strain C) Recovery of
viscosity between shear rates of 0.1 and 100 s 1 D) Recovery of elasticity at 1 Hz and 0.5
% strain following a 60 s peak hold at 100 s 1. Data plotted are mean ±SD, (n=3).
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Suspended printing resolution and di↵usion limits
Printing into a particulate fluid system restricted the resolution of print geometries to
features that were larger than the interstices between gel particles. By printing a dye
with a similar viscosity to water, the movement of material through the continuous phase
into the interstices between fluid gel particles was visualised (Figure 5.4A-F). The achieved
resolution decreased as the inner diameter of the needle increased (and Birmingham gauge
number decreased) (Figure 5.4, R2 = 0.9846). There was also larger variability of the
printed wall width when a larger needle was used.
Figure 5.4: Resolution capabilities of 0.5 w/v% fluid agarose print bed with increasing
needle diameter (decreasing gauge) A-F. SB: 5 mm; data are presented as mean ± SD,
n=18.
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Figure 5.5: Di↵usion of low viscosity dyes of varying molecular weight across a 2mm gap
following printing. A) Di↵usion data over time, B and C) Optical images of di↵usion over
120 min in B) Alcian Blue solution of 1299 g.mol 1 and C) Fast Green FCF solution of
808 g.mol 1. SB: 5 mm, bottom right = time (min); data are presented as mean ± SD,
n=9.
Further, whilst low viscosity solutions could be printed and supported, there was
a limitation of di↵usion through the particulate gel matrix. This resulted in a finite
crosslinking time before printed features were lost. Figure 5.5 shows the time-dependent
di↵usion of dye solutions of di↵erent molecular weight (Mw) across 2 mm gaps. The
di↵usion of the dye as it filled the gap was imaged over 2 h as shown in Figures 5.5 B and
C. The dye with a lower Mw (Fast Green FCF, Figure 5.5C) showed significantly faster
di↵usion than the higher Mw dye (Alcian Blue, Figure 5.5B)) (P=0.0063).
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Bioprinting of low viscosity solutions into complex geometries
To demonstrate that this technique allows for freeform fabrication, a number of structures
were printed. Printing of helical structures with overhangs showed the capability of the
agarose fluid bed to support a suspended low viscosity gel prior to crosslinking (Figure
5.6D and video 3 (1)). In more practical applications, the printing of tubular structures
and perfusable bifurcations were also possible using this technique (Figure 5.6).
Figure 5.6: Examples of geometries that can be printed from 1% w/v alginate (with food
dye for visualisation) using suspended manufacture including hollow (A,B) and hollow
bifurcating (C) structures. D) is a snapshot of Video 3, showing the printing of a helical
structure with overhangs without the need for additional support structures.
Bioprinting of bi-layered constructs and subsequent characterisation
To produce constructs that model the OCU, mineralised and non-mineralised regions were
required. As such, HAp was combined with gellan gum and printed into gellan/gellan-
1
Video available at https://tinyurl.com/yctb9eqm
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mineral constructs with continuous interfaces. This was observed visually in Figure 5.7A,
as the addition of mineral increased the opacity of the gel construct. Mineral is highly
attenuating so its distribution in the whole construct was investigated using µCT as
in Figure 5.7B. The interaction of HAp with the gellan polymer network can be seen
in Figure 5.7 C, as it coated the polymer throughout in individual particles but also
formed aggregates, as indicated by the arrow. Finally, inclusion of HAp resulted in faster
relaxation behaviour following loading to 20% strain (Figure 5.7D).
Figure 5.7: Introduction of mineral for production of bi-layered constructs. A)
Gellan/Gellan-HAp construct. B) µCT reconstruction of a bi-layered construct. C) SEM
of HAp integrated into gellan structure, arrow indicates aggregated HAp. D) Stress re-
laxation behaviour of gellan (GG) and GG-HAp constructs.
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Characterisation of embedded printed cell populations
Human osteoblasts and chondrocytes were isolated and cultured prior to printing into a
bi-layered construct. The printing process showed very good cell viability (Figure 5.8)
with very few dead cells. qRT-PCR was used to determine the stability of cell phenotype
following printing and 28 day culture of osteochondral plugs. The retrieved constructs
were sectioned as shown in Figure 5.9A prior to homogenisation for analysis. Figure 5.9
shows that Col II and aggrecan expression remained highest in the cartilage-like region
of the constructs and lowest in the bone-like region. Col I characterisation showed the
opposite, with the highest expression in the bone-like region.
Figure 5.8: Viability of TC28 cells directly after printing SB: 200 µm
For the development of tissue models, it is important that the embedded cell popula-
tions maintain their ability to produce cartilage matrix and maintain functional responses
to stimulation. Production of aggrecan (ACAN) by chondrocytes following SusMan was
investigated using IHC; Figure 5.10A shows strong evidence of aggrecan in the peripheral
regions of cells and some evidence of aggrecan in the extracellular regions. The response
of chondrocytes to inflammatory stimuli in printed constructs was evaluated by measuring
the production of IL-6 as a function of IL-1  dosage. Figure 5.10B shows this response
at 4 and 24 h. In the 3D printed (SusMan) group, the peak response was delayed and
seen to occur at a higher IL-1  concentration than in the monolayer group. The increase
between 4 and 24 h in both groups was similar however.
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Figure 5.9: qRT-PCR of partitioned constructs following 28 days culture. A) Retrieved
construct after culture in an ex vivo defect B) COL1A1, C) COL2A1 and D)ACAN
expression relative to 18S. Data are shown as mean + SEM, n=3.
Figure 5.10: Functional characterisation of SusMan constructs A) Aggrecan staining in
cartilage-like region. B)IL-6 production as a result of IL-1  stimulation at varying doses
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1. Introduction
Hydrogels are extensively used in regenerative medicine 
research as a consequence of their high-water content, meaning 
that they can be placed into a biological system without com-
promising viability.[1–3] Furthermore, given that they are formed 
from large, organic molecules, there is considerable scope for 
customizing the materials through modifications in the chem-
istry of the polymer backbone (the introduction of cell adhe-
sion moieties, etc.), or by manipulating the gel cross-linking 
The development of new materials for clinical use is limited by an onerous 
regulatory framework, which means that taking a completely new material 
into the clinic can make translation economically unfeasible. One way to get 
around this issue is to structure materials that are already approved by the reg-
ulator, such that they exhibit very distinct physical properties and can be used 
in a broader range of clinical applications. Here, the focus is on the structuring 
of soft materials at multiple length scales by modifying processing condi-
tions. By applying shear to newly forming materials, it is possible to trigger 
molecular reorganization of polymer chains, such that they aggregate to form 
particles and ribbon-like structures. These structures then weakly interact at 
zero shear forming a solid-like material. The resulting self-healing network is 
of particular use for a range of different biomedical applications. How these 
materials are used to allow the delivery of therapeutic entities (cells and pro-
teins) and as a support for additive layer manufacturing of larger-scale tissue 
constructs is discussed. This technology enables the development of a range 
of novel materials and structures for tissue augmentation and regeneration.
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process.[4,5] The first application of encap-
sulation to protect mammalian cells was 
in the 1980s, to enable the delivery of 
pancreatic islets as a treatment for dia-
betes.[3] This has ultimately spawned a 
very active research field, where gels are 
often used for the delivery of cells or other 
therapeutics.[6–8] In the last ten years, gels 
have been used widely to study how cells 
are able to respond to their local environ-
ments, enabling ground-breaking work 
that not only starts to reveal how cell 
fate can be determined by tailoring stiff-
ness,[9,10] the geometry of moieties dis-
tributed around the cells,[11,12] and the 
viscoelasticity of cell attachments/envi-
ronments,[13] but can be exploited to syn-
thesize unique delivery systems.[14,15] All 
of this points to the fact that there should 
be a panapoly of novel gel-based materials 
that are making their way to clinical appli-
cation. Despite all of this progress, how-
ever, this is not the case and one of the major reasons for this 
is that new medical materials must pass a very large number of 
biological safety tests before they are used. In addition, mate-
rials to be used in clinical trials or for sale on the market must 
be supplied via a manufacturing process that is developed, vali-
dated, and operated in accordance with Good Manufacturing 
Practice (GMP). This requires engagement with appropriate 
GMP-licensed pharmaceutical/medical device manufacturing 
facilities. The use of bespoke chemistries and formulation con-
ditions can preclude the use of processing methods and equip-
ment that are standard to the pharmaceutical/medical device 
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manufacturing industry. Thus, this furthers the increasing level 
of innovation required to develop a finished product. In many 
cases, this means that it is not economically viable to move these 
materials to the point of clinical trial and so clinical researchers 
tend to stick with a very small number of materials, which they 
use to deliver a multitude of therapeutic entities. In an attempt 
to take a much more rational approach to the use of hydrogels 
in clinical applications, we have pushed forward research on 
the structuring of materials that have already secured MHRA/
EMA/FDA approval so that they can exhibit distinct physical 
properties. We have done this by modifying gelation condi-
tions through the application of shear and by the absorption of 
reactive molecules into the gel structure in order to enable the 
formation of third phases within and between the gel particles. 
Although not completely void of the substantial costs required 
to deliver new therapeutic molecules, which require significant 
investment in toxicological and safety testing, the significant 
reduction gained from previously obtained data sets allows a 
more direct route to translation, which may result in higher 
degrees of adoption. Therefore, this paper summarizes the 
work that we have done in this area in the past few years and 
suggests areas for further research and development opportuni-
ties in the coming years.
2. Structuring Hydrogels by Shear—Formation  
of Fluid Gels
The diverse and controllable characteristics of gels, in par-
ticular hydrogels (water-based gels), have initiated great interest 
across a multitude of industries and applications. Within the 
field of biomedical research, many FDA/MHRA/EMA-approved 
synthetic polymers have been studied for their ability to form 
gelled networks.[16] However, more recently, there has been a 
push toward more natural biopolymers such as polysaccha-
rides and sugar-based hydrogelators[17] for both their ready 
availability and frequent similarity to the extracellular matrix 
(ECM). It is of no surprise therefore, that polysaccharide hydro-
gels have become widely used in the field of tissue engineering: 
predominately used as scaffolds, presenting a mimetic of ECM 
with the intrinsic ability to stimulate growth and the formation 
of new tissue.[18]
Their key ability to structure large volumes while creating 
an elastic system arises through the material microstructure; 
where coupling of long, structurally regular chains forms inter-
molecular junction zones that pack in a fashion comparable 
to those of solid-state materials.[19] However, to better under-
stand the origins of the macroscopic properties, it is necessary 
to consider structure–property relationships from the mole-
cular level. It is common to distinguish protein structures at 
multiple levels of organization.[20] These descriptions are also 
apt for polysaccharides: the primary structure detailing the 
sugar chain sequence, secondary structure defining geometric 
arrangement (helices and ribbons), and tertiary structure high-
lighting the 3D association of secondary structures.[21] This 
structuring across the polymer chains leads to varying levels of 
chain associations during the disorder–order transition upon 
gelation. For example, in the case of carrageenan (a galactopyra-
nose polymer), domains of linked helices (tertiary structures) 
are formed through intermolecular association, but further 
require ionic-mediation to develop a continuous gel structure 
(Figure 1ai).[22] Therefore, inevitably, the number and density 
of junctions formed in this way between polymer chains is a 
direct function of the final gel strength and elasticity.[23]
This results in an array of material behaviors varying from 
strong gels, with relatively large moduli independent across 
a large range of frequencies, indicative of self-supporting 
structures, to weak maleable gels, where weakly associated 
chains lead to high-frequency sensitive systems with com-
paratively low moduli (Figure 1b).[24] However, the reliance 
on molecular configuration to achieve certain properties is a 
major problem, since when implanted or formed in situ the 
large number of other molecules that are present in the in 
vivo milieu interfere with these processes and can make them 
unpredictable. Such unpredictability is a significant barrier to 
clinical translation.
In an effort to produce more predictable systems, microgel 
suspensions known as “fluid” or “sheared” gels are being 
employed for their unique flow behaviors,[25] engineering the 
ability to self-structure post-shearing.[26–28] This presents a much 
more dynamic scaffold, which can be prepared exogenously 
for potential injection into the body.[29,30] Patented in 1990 as a 
system of microgels for use in food and cosmetics, derived upon 
shearing throughout gelation, fluid gels are substantially less 
rigid than their quiescently formed counterparts.[30] Shearing 
during the sol–gel transition results in networks of weakly 
flocculated, discrete gel entities (Figure 1aii), whereby particle 
sizes become dependent on the applied shear, and suspension 
rheology based on particle volume fractions.[31,32] However, 
in reality, such systems are more complicated, as interactions 
between particles on a mesoscopic level (structuring between 
particles) effectively dictate the bulk rheology of the systems. 
The particulate nature of these networks engenders a level of 
self-healing following manipulation, which is a key property 
that can be exploited in a number of biomedical applications.
The differences between quiescent gels and the properties 
of the microgels formed on shearing again lie in the micro-
structural changes upon gelation. One such example is the sig-
nificantly reduced enthalpies of melting in carrageenan fluid 
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gels when compared to their quiescent form (Figure 1d). Such 
data infers a heterogeneous polymer density across the gelled 
entities, with fewer ordered helices toward the particle periph-
eries.[33] This is not true for all polysaccharides however, as agar 
systems do not show such disparities.[32] Here, rapid gelation 
kinetics result in more uniform helical domains across the par-
ticles.[34,35] This suggests a mechanistic change in the microgel 
formation, driven by competition between two major factors: gela-
tion kinetics and shear separation time/length scale (Figure 1c). 
Particle morphology also demonstrates a dependency on the 
competition between the two phenomena. In systems where 
gelation kinetics “k” greatly outweighs the time scale of separa-
tion “γ” (k > γ), rapid aggregation followed by subsequent shear 
breakdown develops large anisotropic morphologies. Whereas, 
in the counter case, k < γ, large shear forces confine growth, 
leading to more regular particles.[27] The consequential effects 
of such changes in particle morphology upon the aforemen-
tioned mesoscopic structuring have been clearly identified for 
both linear and nonlinear rheological properties. In the case 
of spherical particles, suspensions agree with Hertzian models 
resulting in elastic moduli arising through particle deforma-
tion, as systems become closely packed (Figure 1e).[25,36] Elastic 
response for anisotropic particles however, occurs at much 
lower volume fractions.[25] This is also reflected in the nonlinear 
measurements, with particles enhancing viscosities at volume 
fractions as low as Φ =  0.2.[37] In these cases, large effective 
hydrodynamic volumes associated with anisotropic morpholo-
gies allow a vast degree of continuous phase to become struc-
tured by very few particles.[37–41]
Although some of the literature highlights the differences 
between quiescent and fluid gels, projecting the design rules 
in which to engineer systems with specific intrinsic properties, 
the actual nature of the interstitial space between particles is 
yet to be adequately defined. One theory proposes that disor-
dered “hairy-like” polymers at the particle interfaces interlink 
to form a weak network between particles.[32] This may be the 
case for closely packed particles, where the interstitial layer 
is of the order of several hundred nanometers. However, an 
alternative explanation proposed here would be a combina-
tion of entropically driven structuring,[40,41] resulting in steric 
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Figure 1. a) i) Schematic showing a typical gelled network where polymers interconnect to form junction zones (highlighted using red dots). ii) Diagram 
of a fluid/sheared gel system, where anisotropic gelled particles interact to form a weak continuous network. b) Idealized mechanical spectra showing G′ 
and G′′ dependency on frequency for both a strong “quiescent” and weak “fluid” gel system. c) 3D plot depicting the effects of processing on resulting 
suspension elastic response for protein fluid-gel particles. d) Differential scanning calorimetry (DSC) curves for carrageenan fluid gels. Note the change 
in peak height for the first and second melts, showing a change in degree of ordering between the fluid gel in the first heat and quiescent gel in the second 
heat. Adapted with permission.[34] Copyright 2012, Elsevier Ltd. e) Comparison of elastic moduli for sheared and spherical microgel systems: (⬤) 0.75% 
agar sheared gel, (○) 1.75% agar sheared gel, (▾) 2% agar microgel spheres, and (△ ) 5% agar microgel spheres. Trend lines show both power and 
Hertz fits to sheared and spherical systems respectively. Adapted with permission.[25] Copyright 2000, the Royal Society of Chemistry. f) Structuring as a 
function of time for carrageenan fluid gels (FG) prepared at various shear rates: (⬤) 5 s−1, (▽ ) 100 s−1, and (⬛) 300 s−1. Reproduced with permission.[27] 
Copyright 2009, Elsevier Ltd.
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confinement of particles, and/or weak electrostatic bridging 
between microgel interfaces at smaller length scales. Such 
a theory would encompass hysteretic effects, where self- 
structuring postshearing through entropic interweaving and 
electrostatic bridging, results in the observed recovery of an 
elastic network (Figure 1f).[26–28]
3. The Delivery of Biological Therapeutics  
Using Hydrogels
Many hydrogel materials have been used for the encapsula-
tion and culture of cells in vitro, both for continued immunoi-
solation[42,43] and for the controlled delivery of biotherapeutics 
(both cells and proteins).[44–48] With the use of traditional “qui-
escently” gelled materials this can be very challenging, since 
gelation in a complex biological environment rich in ions and 
proteins can modify the kinetics of the gelation process and 
result in a material that gels unpredictably or behaves unpre-
dictably following the gelation process – something that is 
completely unacceptable in a clinical environment. Up until 
relatively recently, there was also little consideration to how 
the local environment has a strong influence on the dynamic 
mechanical properties of these materials. Alginate, for example, 
is now known to lose mechanical integrity when placed into 
a physiological environment,[49,50] due to ion exchange of the 
divalent cations that enable the formation of “egg-box” junc-
tions for monovalent ions such as sodium.[51] This causes the 
dispersion of the polymeric material and a loss of its ability to 
structure the surrounding liquid. This unpredictable behavior 
may explain why immunoisolation using polymers like algi-
nate has proven ineffective when applied clinically, unless 
other poly mers are incorporated as mechanically protective and 
permselective coatings.[42] What is also becoming very clear is 
that the materials are not “biologically inert”, but rather provide 
subtle environmental cues that strongly drive cellular behavior. 
Initially, this was thought to be principally a consequence of the 
modulus of the materials,[9,10] but more recently reports have 
suggested that this can be modified by changing the distribu-
tion of grafted adhesion moieties and the nature of the interac-
tions that may be formed with the polymer chain.[4,11,12] It has 
become clear that the level of entrapment that can be provided 
by the relatively stiff quiescently gelled matrix can have a signif-
icant influence on biological properties, including the capacity 
of cells to proliferate, maintain specific phenotypes or even 
secrete functional protein molecules as shown in Figure 2.[52–54]
3.1. Sheared/Fluid Gels as Delivery Agents
The shear processing of gels offers an additional degree of 
freedom for the production of cell and protein-delivery devices. 
From the perspective of handling, the reversible structural prop-
erties of fluid gels allow it to liquefy upon the application of 
shear, but may also be combined with biological fluids such as 
platelet-rich plasma or bone marrow aspirate and still thicken/
solidify in situ. This is often very difficult to achieve with inject-
able hydrogels that solidify through a process of cross-linking, 
in situ. As such, fluid gels have the capacity to act as delivery 
agents for a great number of different cell and protein products 
(Figure 3).
Mesenchymal stem cells alone have been proposed to have 
beneficial effects in patients suffering a multitude of patholo-
gies across body systems, including: the lungs,[55] brain,[56] mus-
culoskeletal system,[57,58] peripheral nervous system,[59] skin,[60] 
and the heart.[61] Although some have reported that direct 
injection of these cells into the affected tissues can have ben-
eficial therapeutic effects, the level of engraftment of the cells 
to the site of application typically ranges between only 1% and 
10%,[62–65] and has been proposed to be as low as 0.001%.[66] 
As a result, the number of cells that are typically used in these 
therapies tend to be very large, ultimately creating the poten-
tial for carcinogenesis and other negative outcomes. The cost 
of such a treatment is, of course, considerable and as has been 
shown with autologous chondrocyte implantation (ACI), the 
clinical outcome and patient benefit over standard of care is 
unclear.[67,68] There are a number of ways to overcome these 
issues, which include the retention of the cells at the site of the 
implant within a material or through the use of cheaper autolo-
gous therapies. These are classified as minimal interventions 
by the regulator.
We have been able to develop materials for the repair and 
regeneration of cartilage, the cornea, and the skin that can be 
delivered in a way that is amenable to eventual clinical applica-
tion. Through careful formulation, we have been able to pro-
duce materials that may be delivered using a range of different 
applicator technologies already used by clinicians, including 
cannulas/needles, sprays, and eyedroppers. Below, is a brief 
description of how we have used fluid gels to produce these 
therapeutics along with our progress in taking these to the 
point of clinical application. Furthermore, we have outlined 
major challenges that still need to be overcome in order to 
enable transition to the clinic. For each example, we have also 
outlined the clinical problems that we are attempting to address 
in order to place the technologies in context.
3.1.1. Cell Delivery for Cartilage Regeneration
Articular cartilage is a specialized avascular connective tissue 
layer covering the ends of bones that come together to form 
joints. It provides a smooth lubricated surface to minimize 
friction between the contact areas of the bones, and facilitates 
efficient load distribution through to the subchondral hard 
tissue. Chondrocytes, the sole cell type within cartilage, are 
sparsely distributed within a dense extracellular matrix that is 
mainly composed of collagen, water, proteoglycans, and glyco-
proteins. The high concentrations of hyaluronan and proteo-
glycan aggrecans allow for large volumes of aqueous medium 
to be entrapped within the matrix, and for covalent binding to 
other structural proteins, respectively, providing articular carti-
lage with its shock-absorbing properties.[69] Collagen organiza-
tion, as well as relative matrix composition, cell density, and cell 
morphology, vary as a function of depth from the articular sur-
face and act collectively to resist the range of forces experienced 
by the joint.
The avascular nature of cartilage and the low number of cells 
that are found within articular cartilage matrix result in a tissue 
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with poor regenerative capacity following damage. Articular 
cartilage is one of the most challenging tissues to engineer or 
mimic synthetically due to the complex transitions in composi-
tion and ultrastructure, which are vital to its overall mechan-
ical function. Consequently, most therapies for the repair of 
damaged cartilage involve tissue grafts or exploiting the local 
biology to facilitate new tissue formation. The current gold 
standard treatments in the repair of focal cartilage defects are 
microfracture or mosaicplasty. Microfracture involves removing 
the damaged cartilage and making a series of small holes in the 
subchondral plate causing bleeding from the marrow, and the 
formation of a clot that fills the focal defect. The aim here is to 
introduce and retain progenitor cells (present in marrow) into 
the defect site, a fraction of which have the potential to develop 
into chondrocytes and facilitate new cartilage formation. In 
mosaicplasty, small portions of cartilage are transplanted from 
nonarticulating regions of the affected joint into the carti-
lage defect site. This approach enables the engraftment of an 
already fully developed native cartilage structure. A common 
drawback with both methods is the formation of a fibrocarti-
laginous matrix as opposed to hyaline cartilage.[70,71] Fibrocarti-
lage does not exhibit the same specialized surface structure as 
hyaline cartilage. As a consequence, the new tissue is mechani-
cally inferior to the surrounding intact cartilage (particularly in 
resisting shear forces), which increases the risk of failure. A 
range of cell-based therapies, such as ACI, have been developed 
for the production of a native articular cartilage. To date, none 
of these methods have been able to surpass microfracture as the 
method of choice for orthopedic surgeons. Although there has 
been some success with the use of bone-derived mesenchymal 
stem cells for cartilage regeneration, there is a recognized need 
for culture and delivery systems that successfully maintain the 
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Figure 2. Effect of entrapment on cellular activity. a) Live/dead staining of encapsulated fibroblasts 4 d postencapsulation in 5% w/v alginate quiescent 
gel. Live cells stain green and dead cells stain red. b) Growth curves of the encapsulated 3T3 fibroblasts shown in (a), compared with nonencapsulated 
3T3s (control). The encapsulated fibroblasts remain at a constant viable cell number up to 33 d postencapsulation, rather than exhibiting the normal 
bell-shaped growth curve seen with monolayer cultured fibroblasts. c) Fibroblasts released from encapsulation in 5% w/v alginate quiescent gel display 
normal growth in monolayer culture after both 1 and 3 weeks encapsulation. Adapted with permission.[52] Copyright 2009, Elsevier Ltd. d) Relative 
transcription of Coll1a by 3T3 fibroblasts encapsulated in 2% w/v Ca–alginate quiescent hydrogel for 7 and 21 d. Expression is shown for encapsulated 
cells and those that are released and grown as monolayers for 48 h and control fibroblasts, grown as monolayers having never been encapsulated. Col1a 
transcription was found to be only approximately 25−30% lower than before encapsulation. e) Despite the relatively high Col1a transcription levels while 
encapsulated, Haematoxylin Van Gieson (HVG) staining of the samples revealed very little collagen matrix had been produced by the encapsulated cells 
even after 3 weeks. f) However, soluble collagen was detected within the alginate structures and could be released into physiological media. Overall, 
this suggested that while the alginate gel system allowed for the passage of essential collagen precursor molecules and their assembly into soluble 
collagen, it sterically hindered collagen fibrillization. Adapted with permission.[53] Copyright 2012, the American Chemical Society.
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required chondrogenic phenotype during culture expansion in 
the lab, and upon implantation – especially for maintaining 
chondrogenic phenotype during the healing process. Alginate-
based gels have been used as a biomaterial in chondrocyte cul-
ture since the 1980s as demonstrated by Guo et al. in 1989.[72] 
The general popularity of alginates in bioengineering stems 
from their good biocompatibility/tolerance with a range of tis-
sues, low cost, and ease of gelation using divalent ions (many 
of which are endogenous to the human body). However, it is 
the similarility between the ultrastructure of gelled alginates 
and that of native extracellular matrix that has made alginates 
favorable for use in research and development into chondro-
cyte culture.[51,73] The 3D structure of the gels is thought to 
help the chondrocytes exhibit more in vivo-like behavior.[74] Fur-
thermore, the ability to form 3D structures with tunable bulk 
mechanical properties, incorporate cell binding moieties, and 
allow the diffusion of soluble factors have proven to be impor-
tant features in supporting chondrogenesis and maintaining 
chondrogenic phenoptype. Thus, their regenerative potential is 
maximized.[51,75] Hwang et al. demonstrated that the porosity 
in a gel system can be tuned by the addition of gelatin micro-
beads as a means of enhancing the mass transport of oxygen, 
nutrients, secreted biomolecules, and waste products.[76] Prom-
ising human cell-based models have also been developed with 
good medium to long-term cell viability. Choi et al. successfully 
cultured human articular chondrocytes in alginate beads over 
15 d, and Loeser et al. successfully cultured human articular 
chondrocytes in alginate exposed to the chondrogenic growth 
factor insulin-like growth factor-1 and reported 95% survival 
at 21 d.[77,78]
Beyond the successful culture of chondrocytes in a lab, 
a major issue is the delivery and retention of chondrocytes 
into a focal defect using a non-invasive approach. Many have 
attempted to form in situ gelling materials that are capable of 
solidifying in the focal defect, and there are clinical products on 
the market that form a polymerized biological scaffold within 
the defect (BST-CarGel, Smith & Nephew; GelrinC, Regents 
Biomaterials; Chondron, RMS Regrow). We have demon-
strated that it is possible to use “sheared” or “fluid” gels as 
vehicles to deliver and retain populations of chondrocyte cells. 
These materials can be injected into an aqueous medium and 
will retain their mechanical integrity over a period of 21 d of 
ageing (Figure 4). Importantly, the material can be injected 
through a narrow gauge needle while maintaining the viability 
of the incorporated cell population (Figure 3). Once injected 
into a defect, unlike gel systems that are gelled in situ or before 
implantation, the cells are able to move within the structure of 
the fluid gel and can migrate down into the bottom of the tissue 
Adv. Mater. 2018, 1705013
Figure 3. a) Optical microscopic image of diluted alginate fluid gel negatively stained with blood. Red blood cells (black) become sterically localized 
by the sheared alginate gel (white). Scale bar represents 200 µm. b) Schematic diagram depicting the stabilization of PRP (platelet rich plasma) via 
fluid-gel particles for in situ cartilage repair. c) Section of a tibial plateau with defect plugged using alginate/BMAC (bone marrow aspirate concentrate) 
fluid gel using a syringe. d) Flow profile obtained for 10% blood serum in 1% alginate fluid gel. The plot shows data for both increasing and decreasing 
shear, highlighting its reversible shear thinning behavior, crucial for application via syringe. e) Frequency sweep obtained for the same sample showing 
the typical weak solid-like structure exhibited by fluid gels under static conditions.
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defect (Figure 4). However, recent work within our group has 
also suggested that the lack of physical entrapment of the cells 
can result in the dedifferentiation of the encapsulated cells into 
a fibroblastic phenotype. While this lack of physical entrapment 
may ultimately hinder the use of fluid gels for the delivery of dif-
ferentiated chondrocyte cells, we have demonstrated that fluid 
gels are effective in the delivery of other biological agents, such 
as platelet rich plasma and bone marrow aspirate concentrate, 
and their stabilization within a model joint defect. Our current 
work aims to translate this technology into a usable minimal 
intervention for cartilage augmentation (Figure 3). The ability 
of fluid gels to facilitate cell migration can actually be an advan-
tage when designing therapies for other tissue applications. In 
the case of the skin, the ability for cells to migrate through the 
surface of the material would enable a topically applied cell pop-
ulation to fully colonize the wound bed.
3.1.2. Skin—Keratinocyte Delivery to Aid Wound Closure
Skin exhibits a multilayered structure with the uppermost 
layer of the epidermis consisting of layered keratinocytes that 
differentiate from the basal lamina over a period of several 
weeks.[79] The layer below the epidermis, known as the dermis, 
consists of a population of fibroblast cells that play a role in 
secreting extracellular matrix molecules such as collagen types I 
and IV and glycosaminoglycans.[80]
Serious damage to the epidermal and dermal layers break 
this fragile interplay until healing occurs and the wound is 
closed. In the case of large and deep burns, wound healing 
without intervention can take several weeks, wherein a patient 
is likely to develop acute systemic dysfunction with high risk of 
death through systemic infection and dehydration.[81] In order 
to speed the process of conventional skin grafting, it is possible 
to grow a multilayer sheet of keratinocytes in the laboratory in 
a period of up to 3 weeks.[82–85] These cells may then be applied 
to the surface of the wound. The keratinocytes then accelerate 
the closure of the wound by secreting factors that are able to 
stimulate collagen deposition (TGF-β1) and differentiation of 
the cells in the wound bed into myofibroblasts, which are able 
to fully close the wound. Although this process was pioneered 
in the 1970s and has found use in the clinic, the cost of the 
treatment, in addition to the amount of time it takes to gen-
erate sufficient cells, limits utility.[86] Poor outcomes in terms 
Adv. Mater. 2018, 1705013
Figure 4. a) Sedminentation of cells through a fluid-gel network over 7 d. b) Mechanical stability of fluid alginate over 3 weeks (day 7: circles; day 14: 
squares; day 21: triangles; G′: closed symbols; G′′: open symbols). c) Cell tracking showing lateral movement of cells through fluid alginate. d) Quan-
tification of the cell movement in the x–y plane. e) Fluid alginate architecture showing voidage regions in the polymer network.
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of graft take, formation of bullae (blisters), poor handling 
due to fragility of sheets, and wound contraction have been 
reported. More recently, spray technologies have been used to 
deliver autologous and allogenic keratinocytes to the surface 
of wounded skin. Preconfluent cells have demonstrated utility 
in regenerating the skin and require a similar culture period 
of approximately 2–3 weeks.[87–89] Consequently, there is now 
a drive to develop allogeneic therapies from immunogenically 
privileged neonatal foreskin fibroblasts and keratinocytes.[90] 
However, a phase 3 clinical trial in nonhealing wounds was 
stopped prematurely due to low efficacy.[91] There are also prod-
ucts available that eliminate the in vitro culturing step by sepa-
rating epithelial cells from patient biopsies in the clinical set-
ting, and these cells may then be dispersed and sprayed onto 
the wound surface in a single procedure.[92,93] Although these 
technologies have been available for some time, there are as yet 
few clinical trials that show a conclusive benefit for using this 
approach.[94,95] One potential reason for this is that the cells 
themselves are delivered using a low-viscosity spraying system 
and anecdotally the level of “run-off” from the wound surface 
following spraying is high.[86] Although some products now try 
to remedy this using fibrin glue as an adjunct, the technology 
has yet to find strong traction in the clinic.[96,97] One of the 
major advantages of using a fluid gel system for the delivery of 
keratinocytes is that the material itself shear-thins considerably 
under the rapid shear forces experienced in a spraying system. 
We have utilized fluid-gel systems that are formed from a 
polysaccharide called gellan gum. Populations of cells may be 
incorporated into this system and can then be sprayed through 
a nozzle and deposited onto a surface as shown in Figure 5a–c. 
The soft solid then rapidly structures as it impacts on the 
skin, where the cells are retained on the surface, rather than 
running off, maintaining high-levels of viability. Importantly, 
the structure of the fluid gel allows cell movement within it, 
and we have shown that the viscosity of the material can be 
tailored to allow sedimentation of cells onto the upper surface 
of the tissue. In addition to being sprayed onto the surface of 
the skin, the gellan fluid gel may also be used to spread cells 
Adv. Mater. 2018, 1705013
Figure 5. Cell encapsulation and spray deposition of gellan gum fluid gel. Video of a) spray delivery with handheld spray pump of material to tilted 
gelatin substrate demonstrated poor adherence of water b) compared to gellan gum fluid gel. c) Airbrush spray delivery system was used to stand-
ardize air pressure at delivery (15 PSI) and nozzle size (0.75 mm). d) Comparison of dyed gellan fluid gel (left), quiescent gellan gel (middle) and 
sodium chloride (right) droplets to porcine skin indicates a low rate of spreading of the gellan explained by the higher viscosity and structural stability 
of the material. e) Airbrush spray delivery of dyed sodium chloride to porcine skin showed rapid run-off with pooling of material at the bottom of the 
substrate, f) whereas uniform distribution without run-off was achieved by gellan fluid-gel spray delivery. g) Fluorescence cell viability assay of human 
dermal fibroblasts (HDF) 7 d after encapsulation in gellan fluid gel (live cells green, dead cell red), cells are viable and attach to the bottom of the well 
and seem to migrate out of the gel. h) High viability of cells at day 1 following spraying of encapsulated HDFs in gellan fluid gel.
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across a surface, yet be retained in place once the spreading 
process has been completed. Figure 5d–f demonstrates how 
the material is retained on the surface of the skin. The mate-
rial is compared against sodium chloride and a gellan quies-
cent gel. When the surface of the skin was inclined, the fluid 
gel was retained on the surface of the skin in exactly the same 
way as the gellan quiescent gel. It is worth noting that in order 
to get the quiescently gelled gellan to spread and then reset on 
the surface of the skin, the material was heated to around 50 
°C before being allowed to cool, which would not have been 
conducive to cell survival. Shear structuring of the material 
was a successful way to enhance functionality without com-
promising cell viability (Figure 5g–h). The next challenge with 
this material will be to develop a manufacturing and packaging 
process that will not compromise the properties of the finished 
product. At present, the delicate structure tends to breakdown 
when exposed to doses of gamma irradiation considered low 
by industry standards. The development of non traditional 
sterilization methods may prove essential in the transit of 
these materials to the clinic. Although autoclaving is a possi-
bility without causing a significant change in the properties of 
the final product, this method is unsuitable for the delivery of 
delicate therapeutic proteins that may be required to enhance 
the regenerative capacity of the tissue.
3.1.3. Cornea—Scar Prevention
The cornea is a layered structure exhibiting very high levels 
of organization in order to both protect the inside of the eye 
and provide the majority of the eye’s refractive power.[98] The 
cornea is composed of five layers, with the anterior surface 
of the cornea consisting of epithelial cell layers that overlay a 
tough collagenous layer (Bowman’s layer), mostly consisting of 
tightly woven collagen type I meshworks. The corneal stroma is 
an optically transparent layer composed of heterotypic collagen 
type I and V fibrils of around 30 nm in diameter, embedded 
within a proteoglycan matrix.[98,99] The stroma makes up 90% 
of the overall corneal thickness and is maintained by resident 
keratinocytes.[98] The collagen fibrils are arranged in flattened 
tightly spaced bands called lamellae that traverse the diameter 
of the cornea and are superimposed over one another making 
up most of the stromal thickness.[100] Further structuring 
occurs from the interlacing of the lamellae, which is most 
prominent within the anterior and mid-stromal layers and less 
so in the posterior stroma, where they are stacked in a similar 
fashion to layers in plywood.[98] The posterior stromal region, 
particularly in the central corneal region, is more hydrated 
than the rest of the stroma and thus the corneal stroma overall 
is akin to a highly structurual and mechanical anistotropic 
hydrogel system. The predominant collagen orientation within 
the stroma also varies as a function of depth. In the anterior 
region, the collagen does not exhibit any preferred orientation, 
whereas the mid- and posterior regions demonstrate preferred 
orthogonal arrangement of collagen along the nasal-temporal 
and superinferior directions.[101] The key structural factors of 
the cornea, leading to high optical transparency, are the uni-
formity of the collagen fibril diameters and tight regulation of 
the distances between adjacent collagen fibrils.[98,99,102,103] The 
fourth layer of the cornea, Descemet’s membrane, is composed 
of a thin layer of collagen type IV and is designed to support 
the corneal endothelium layer that makes up the posterior 
surface of the cornea. When the corneal surface is damaged, 
it is typically capable of healing itself. However, in the case of 
infection (e.g., microbial keratitis), a significant inflammatory 
process is triggered, resulting in the upregulation of growth 
factors such as TGF-β1, which is a potent fibrogenic factor 
leading to disorganized deposition of collagen and extracellular 
matrix within the stroma.[104] Dysregulated collagen and ECM 
deposition prevents light transmission through the cornea 
and ultimately leads to blindness.[105] Treatment of diseases 
such as microbial keratitis may result in a corneal transplant if 
standard treatments with antibiotics and steroid fail.[106] Thera-
peutic proteins such as decorin have been shown to regulate 
the deposition of collagen by binding the inflammatory cytokine 
TGFβ-1.[107] This prevents collagen upregulation as well as 
the differentiation of keratocytes to the myofibroblastic pheno-
type that causes wound contraction and ECM deposition.[108] 
Topical delivery of therapeutic proteins/molecules to the surface 
of the eye has previously been attempted, however with limited 
success.[109–112] Gellan fluid-gel based eyedrops allow for the ini-
tial retention and then tailored release of the therapeutic agents 
onto the surface of the eye over a period of hours, as opposed 
to seconds/minutes as experienced with the majority of eye-
drops (Figure 6a–c).[113] Since gellan is optically transparent, a 
patient’s vision would not be compromised by the gellan when 
placed on the eye. During blinking, the eyelid sweeps over 
and applies shear to the surface of the gellan eyedrop, causing 
layers of the material to be removed. The eyedrop is cleared 
from the surface of the eye over a period of around 2 h. This 
technology has been exploited to deliver a sustained dose of 
decorin to the surface of the eye, which we have demonstrated 
facilitates reepithelialization of the eye surface (Figure 6d,e), 
both ex vivo in an organ culture model of corneal abrasion and 
when challenged in an in vivo corneal abrasion model. In addi-
tion to delivering the molecule to the surface of the eye over an 
extended period of time, we believe that the eyedrop will pro-
vide some relief to patients with this very painful condition, by 
lubricating the surface. Indeed, it has previously been reported 
that fluid gels, if formulated correctly, can be used as an ade-
quate lubricant for surfaces.[114]
4. Bioprinting
In addition to enabling the encapsulation of cells and pro-
teins for in situ delivery, the “self-healing” structure of fluid 
gels means they have found application as supports for addi-
tive layer manufacturing (ALM) of soft material structures, 
with complexity that is far beyond what has previously been 
reported. For many years, researchers have sought to replicate 
tissue structure and composition by using a combination of 
isolated cells and polymeric hydrogels that have a structural 
resemblance to ECM, to create an implantable living con-
struct.[115] Most constructs have been fabricated using a gel 
casting process that provides little control over the microscale 
geometry of the deposited material, or the local mechanical 
properties so important to controlling cell fate. Innovation in 
Adv. Mater. 2018, 1705013
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this area has been driven largely by the desire to develop ther-
apies that come close to offering the same key advantages as 
auto- and allografts, in that they are structurally and biologically 
the same as the surrounding tissue, while moving away from 
harvesting graft material itself. This is because the grafts are 
only suitable for relatively small defects and the graft approach 
in general is unlikely to be able to meet future clinical demand.
3D bioprinting using ALM has become a useful approach 
for creating structures with a greater level of complexity than 
traditional processing methods, such as casting, with some 
degree of control over the distribution of biological material 
throughout the structure.[116] While ALM of hard materials is 
relatively mature and adopted by a number of industries, ALM 
of soft mateials remains challenging. One of the major chal-
lenges for 3D bioprinting is the lack of suitable materials that 
are both able to replicate tissue material behavior and com-
patible with current 3D printing technologies. The advantage 
of biopolymer materials for tissue engineering applications is 
their similarity to native ECM. However, controlling their phys-
ical properties to be optimal for both the tissue engineering 
application and the mechanics of the printing process is more 
difficult than of synthetic materials. Biopolymers used for 
tissue engineering tend to have relatively low viscosities in the 
pregelled state that facilitates mixing with cells. Furthermore, 
many of these materials exhibit pseudoplastic (shear thinning) 
flow behavior that also can be advantageous for extrusion, when 
fabricating scaffolds. Unfortunately, low-viscosity materials can 
be problematic when 3D bioprinting, as the printed structure 
can collapse and lose its shape before solidification can be 
initiated.[117] Another problem when 3D printing biopolymer 
hydrogels is the inability to integrate multiple layers of material 
once gelled, preventing the production of integrated gels with 
regional variations in mechanical behavior. To overcome these 
problems, researchers often incorporate highly viscous mate-
rials to maintain a 3D shape after deposition,[117–119] which is 
not ideal as highly viscous materials can impede homogeneous 
cell mixing and often require increased extrusion pressure in 
order to print. This can lead to reduced cell viability as a result 
of the shear stresses inflicted on cells and has therefore limited 
their use in 3D bioprinting.[120]
We recently developed a technique that overcomes some of 
the issues associated with additive layer manufacturing when 
using low-viscosity materials, allowing them to be used as a 
bioink to create relatively complex soft-solid structures.[116] 
This was achieved by extruding a gelling biopolymer solution 
into a self-healing fluid-gel matrix, which suspends the fragile 
printed construct in the liquid state to prevent flow and thus 
retaining the deposited morphology. Additionally, as the printed 
construct remained in the liquid state, it was possible to build 
the construct layer by layer and interface two different materials 
Adv. Mater. 2018, 1705013
Figure 6. Optical coherance tomography (OCT) images illustrating the flow and clearance rate of fluid-gel eyedrops: a) when compared to PBS drops. 
b) On the surface of intact rat eyes over a 2-h period, fluid gel remained on the surface of the eye for nearly 60 min and some residue was noticed at 
120 min. The PBS drop however cleared within 60 min. Fluid-gel thickens on the surface of freshly enucleated pig eyes, indicated by the black arrow. 
c) Eyes treated over 4 d with fluid gels containing decorin demonstrated significant reepithelialization in ex vivo organ culture models e) when com-
pared to d) fluid gels without decorin.
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with dissimilar mechanical properties, creating a structure with 
distinct regions of anisotropic physical behavior. To demon-
strate the potential for clinical application of the technique, we 
created a structure that recapitulated the osteochondral region 
as directed by microcomputed tomography (CT) imaging.[116]
Native osteochondral tissue has a gradually changing micro-
structure that extends from disordered mineralized collagen in 
subchondral bone[121] to cartilage, across which there are dis-
tinct variations in the relative concentrations of noncollagenous 
proteins, and orientation of collagen fibers as a function of 
depth.[122] This graded structure allows applied stress to be dis-
tributed across the interface without specific stress localization, 
helping to prevent delamination from occurring.[123] In our 
work, femoral condyle tissue was donated from patients fol-
lowing total knee replacement surgery and a full-thickness 
osteochondral defect was introduced using a surgical drill. The 
tissue containing the defect was scanned using micro-CT to 
generate a 3D model. Chondrocytes and osteoblasts were iso-
lated from the tissue samples and, following primary cell cul-
ture, were added to 1.5% gellan and 1.5% gellan mixed with 
5% nanohydroxyapatite (HA), respectively. Using the 3D model 
as a guide for accurate dimensions, an osteochondral implant 
was manufactured with the lower layer loaded with gellan, HA, 
and osteoblast cells, while the upper layer of the construct was 
manufactured using gellan gum loaded with chondrocytes. The 
manufactured cell-laden construct was then implanted into the 
defect of the ex vivo femoral condyle. After 4 weeks in culture, 
the construct maintained morphology and the encapsulated 
cells retained their phenotype within the distinct layers of the 
manufactured structure.
Our suspended additive layer manufacturing process has 
since been integrated into a commercially available extrusion-
based 3D bioprinter (Cellink, Sweden), adding the ability to 
manufacture more geometrically intricate structures. To dem-
onstrate the ability to retain the structural integrity of printed 
low-viscosity materials, an S-hook shaped construct was printed 
from a G-code file using 1% w/w gellan gum (Figure 7a). When 
printed onto a planar surface, the structure collapsed as the 
material began to flow under gravitational force (Figure 7b). 
However, when printed into a fluid-gel bed (prepared from 
0.5% agarose), the structure retained the S-hook shape, clearly 
demonstrating protective support afforded by the surrounding 
fluid gel on the printed construct (Figure 7c). We then dem-
onstrated the ability of the process to manufacture graded 
interfaces between soft-solid structures over relatively large 
length scales. Our model for this was printing conjoined dou-
blet and triplet cuboids from single cuboid units measuring 
10 mm × 10 mm × 5 mm, using gellan gum and gellan gum 
containing an orange dye (Figure 7d–f). Once the first cuboid 
was printed and remained in the liquid state, a second cuboid 
was printed with a 1 mm overlap with the first cuboid in the 
lateral plane to create an interfacial region. Once printed, the 
structures were crosslinked in situ using 100 × 10−3 M CaCl2 
for 30 min, and recovered as a single structure from the sus-
pending particulate gel by gently washing with distilled water. 
This technique could potentially be used to model diffusion 
of molecules from one gel system to another, or fabricate dis-
crete molecular reservoirs within a larger structure. Finally, we 
explored the potential to integrate different materials each with 
different gelation mechanisms using suspended bioprinting. 
Figure 7g–i shows the manufacture of cylindrical constructs 
consisting of a layer of gellan gum and a layer of type 1 collagen 
(PureCol EZ Gel, Advanced BioMatrix, USA), each layer with 
dimensions of 5 mm × 5 mm × 2.5 mm. In this example, the 
fluid gel base was maintained at 37 °C while the gellan cylinder 
was deposited first and left in the liquid state. The collagen was 
then deposited at 20 °C and left for 60 min to allow thermal 
gelation to occur, as the collagen equilibrated to 37 °C tempera-
ture of the supporting particulate bed. To initiate gelation of the 
gellan cylinder, 100 × 10−3 M CaCl2 was added to the construct 
and left to gel for a further 30 min. Once fully crosslinked, 
the construct could be removed as one piece (Figure 7h). The 
finished construct exhibited a clear interfacial region between 
the two layers, which could not be physically separated, thus 
suggesting the formation of an interpenetrating polymerized 
network across the interface (Figure 7i). The order in which the 
different materials are gelled during fabrication of a construct 
can strongly influence the stability of the interface between them. 
Successful integration of collagen and gellan layers required the 
gelation of the collagen layer before gelation of the gellan layer. 
This is attributed to a mechanism reported by Gillette et al. 
when attempting to integrate collagen into crosslinked alginate, 
whereby the small pore size of the gelled alginate inhibited 
the formation of a network of collagen fibers within the algi-
nate structure.[124]
In summary, the easily removable physical support offered 
by the fluid gel bed enables the deposition of biological mate-
rials in the liquid phase in 3D, with complex geometries and 
interfaces, before solidifying into a single construct with graded 
mechanical, chemical, and structural properties. This approach 
effectively decouples the viscosity of the starting material from 
the desired mechanical properties of the final printed construct. 
Biopolymers can be prepared at the relatively low viscosities 
required for low-pressure extrusion-based bioprinting, with the 
final mechanical properties engineered into the materials by 
gelation postextrustion.
Suspended bioprinting is, therefore, an enabler for a range 
of soft-solid materials, for which their full potential in tissue 
engineering is well established but not fully realized to date, to 
be used in the ALM of implantable biological constructs.
5. Conclusions and Outlook
Soft-solid materials have long been used as basic building 
blocks in the fields of tissue engineering and regenerative 
medicine, with certain materials having found use as wound 
dressings, eyedrops, and for the immunoisolation of cells. 
Despite extraordinary amounts of innovation around the 
manipulation of chemistry and local mechanics, which has 
significantly improved our understanding of how local envi-
ronments can influence cell behavior, relatively few new 
so-called “smart materials” have made the transition to full 
clinical use. One of the reasons for this relative lack of pro-
gress is that the costs of taking new compositions to the clinic, 
through toxicity testing and characterization, is so high as to 
make it uneconomical. We have focused a large amount of 
research on modifying material structures by making changes 
Adv. Mater. 2018, 1705013
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to processing conditions, without modifying composition. In 
the case of hydrogels, this has allowed us to take existing reg-
ulator-approved materials, and process them in a manner that 
allows us to produce structures that exhibit very distinct proper-
ties from the conventionally processed materials. Of particular 
use is the capacity of these materials to self-heal following the 
application of mechanical shear. This means that the materials 
are able to be delivered through a narrow aperture, which gen-
erates local shear and liquefies the material sufficiently that it 
may be deposited over a surface, where it solidifies. This has 
allowed us to produce eyedrops, cell spraying devices, and 
injectable delivery devices. Importantly, these materials are 
ready for translation to the clinic having undergone less cum-
bersome toxicity testing than for a completely new material. We 
have also used the self healing capacity of these materials to 
provide support in a new method for the additive layer manu-
facturing of cell containing soft-solids. This method differs to 
other soft-solid additive layer manufacturing methods, in that 
both the support phase and the cell-bearing phase can exhibit 
exactly the same composition. When the part has been removed 
from the print-bed, the support material can be dispersed by 
the application of gentle shear. This enables us to produce com-
plex structures with a supporting medium without the worry of 
contaminating the implant surface.
These systems are still far from being exploited to their 
full potential and also still need considerable refinement 
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Figure 7. Suspended bioprinting of various biopolymer structures. a,b) G-code image for an S-shape hook with dimensions of 25 mm × 40 mm × 2.5 mm 
was printed using 1% w/w gellan gum onto a planar surface and imaged at the end of the printing process. c) The same structure printed into a 0.5% 
w/w agarose particulate gel bed. The construct printed onto the planar surface lost all structural integrity, collapsing under its own weight and flowed 
across the surface, resulting in a distorted structure. The construct printed within the particulate bed retained accurate dimensional conformation. 
d–f) Design and manufacture of multilayered constructs using suspended bioprinting. d) G-code file of a 10 mm × 10 mm × 5 mm cuboid. Two cuboids 
integrated using suspended bioprinting process; one contained a dye highlighting the ability to interface two separate biopolymer structures e) and 
another incorporating a double interface of gellan/dyed gellan/gellan to illustrate the potential for creating compositional gradients. g–i) Suspended 
bioprinting of a composite hydrogel cylindrical structure. g) G-code image of the single cylindrical structure with dimensions of 10 mm × 10 mm × 5 mm. 
h) Composite structure prepared from 1.5% gellan with 0.5% type 1 collagen using the suspended bioprinting process. i) A microscopic image of the 
interfacial region between the two dissimilar materials. These example constructs illustrate the potential of this approach to 3D bioprinting to manu-
facture biopolymer constructs with distinct anisotropic chemical and mechanical properties.
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before eventually finding widespread use across medical 
fields. The polymeric gels are very difficult to sterilize using 
standard methods, and at present require non-cost effective 
low-throughput processes that allow for sterile-filling. Future 
innovations and collaborative work with the regulators should 
seek to develop new, more gentle sterilization methods, that are 
not likely to cause destruction of the polymeric material from 
which the structure is formed. Gamma irridation, ethylene 
oxide, and high temperatures are all very useful for sterilizing 
metallic materials, but impart enough energy into hydrated 
polymer systems to cause significant breakdown, and there-
fore significantly modify the properties exhibited by the mate-
rials. The use of alternative light sources (UV and blue light) 
and supercritical processing technologies may well provide the 
answer to this significant problem, but need to be validated and 
widely accepted by regulators worldwide.
We have also only just begun to explore the potential of 
these materials for delivering complex, composite struc-
tures. The incorporation of secondary materials into the fluid 
gel, which are capable of inducing osteogenesis in codistrib-
uted bone marrow aspirate and other sources of cell popu-
lations, has significant potential for shaping the local cel-
lular environment in vivo, thereby enabling superior tissue 
regeneration (Figure 8a). Indeed, providing the reactants to 
generate a third phase between the polymeric components 
of the gel, enabling hardening into a comparatively stiff 
structure has already been achieved with some success 
(Figure 8b,c).[125]
Figure 8. Fluid-gel materials may be loaded with osteogenic ceramics materials and extruded through a syringe, before they thicken upon a surface. a) The 
ceramic particles remain evenly distributed throughout the process. b,c) It is also possible to deliver the precursors of bone mineral formation within 
gel materials such that they harden in situ to form a relatively stiff composite matrix, but remain liquid prior to administration. This flexibility enables 
the tailoring of local environments to create more regenerative localized conditions. b,c) Reproduced with permission.[125] Copyright 2018, Wiley-VCH. 
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exposed to environments that differ both mechanically and 
chemically. These environments have been shown to play a 
strong role in shaping cell phenotype.[3] For some time now 
researchers have sought to recapitulate tissue structure using 
a combination of isolated cells and polymeric hydrogels that 
have a structural resemblance to the ECM.[4] Such specimens 
have been manufactured using the process of gel-casting; this 
allows for gross geometrical control, yet provides little con-
trol over the microscale geometry and spatial and mechanical 
cues important to controlling cell behavior.[5] Additive layer 
manufacturing (ALM) offers the tantalizing possibility of cre-
ating structures with a greater level of complexity than tradi-
tional processing methods such as casting, and some degree 
of control over the distribution of cells and other important 
components throughout the structure. While the ALM of hard 
materials is relatively mature and a number of industries now 
utilize such technologies, at present the ALM of soft mate-
rials remains challenging. ALM using soft materials has been 
reported in the literature since the mid 2000s when Boland 
et al. published on the production of “nose-like” specimens 
from alginate.[6] In the years since many research groups have 
published on the manufacture of structures from soft solids 
some of which allow for the incorporation of cells.[7] Most 
recently, Hwang et al. reported the production of a cartilage-like 
structure for auricular reconstruction.[8] Notably, the majority of 
additively manufactured soft-solid structures exhibit relatively 
low complexity[9] and are typically broader at their base than 
at their peak to reduce the risk of the structure collapsing. A 
number of research groups are working on the development of 
novel polymers for ALM,[7,10] but in the most part, the struc-
tures they form with these polymers are highly simplistic, with 
a self-supporting “waffle arrangement” frequently being used to 
demonstrate process resolution.[7,9,11] Some papers report the 
use of harder materials, such as poly(caprolactone) (PCL) and 
hydroxyapatite, to support the structure[12,13] or have extruded 
materials into high viscosity liquids, for example Pluronic 
F-127 hydrogel.[13] Additionally, there have been reports of addi-
tive manufacturing using a suspending medium that consists 
of either a shear-thinning synthetic hydrogel[14] or a slurry of 
gelatin particles,[15] respectively. These elegant approaches 
resulted in structures of previously unprecedented complexity, 
but neither group managed to codeposit multiple cell types or 
could demonstrate any localized modification in mechanical 
properties of chemistry, both of which are critical to biological 
performance. Furthermore, neither of these methods is condu-
cive to the manufacture of structures that are suitable for the 
clinic, since the suspending medium would be very challenging 
to completely remove from the finished part. In this study, we 
have addressed these issues by using a self-healing particu-
late or fluid gel material, which is stable at room temperature 
and in culture conditions, as a supporting media. The strong 
In this study, we describe a novel method of suspended manu-
facture for the production of complex soft structures of closely 
defined morphology, mechanical properties, and chemistry. The 
process conditions are sufficiently mild that embedded popula-
tions of cells maintain high levels of viability and retain pheno-
type. Given the simplicity of the process, it can be used for all 
existing gel materials without special modification. The method 
of manufacturing uses a “bed” of micrometer sized gel particles 
(often referred to as fluid or sheared gels),[1] which behave in 
bulk as a viscoelastic fluid and can self-heal thereby providing 
support to the complete part.[2] The final structure is formed 
through the dispersion of a gelling material into the interstices 
between the supporting fluid gel particles. This enables rela-
tively complex structuring while providing sufficient support 
to prevent the structure collapsing under its own weight. Once 
the scaffold structure has been formed the supporting phase 
may be removed through the gentle application of shear. This 
manufacturing process allows for the use of a wide range of 
polymeric materials, including many already approved by regu-
latory bodies. Ultimately it has the potential to produce struc-
tures that could make their way into clinical trial in the relative 
short term. Here we demonstrate the power of this method by 
manufacturing anisotropic structures with spatially controlled 
mechanical and chemical properties, which support a coculture 
of viable cells. These scaffolds could be used for the production 
of osteochondral plugs for the augmentation of full-thickness 
cartilage defects.
Tissues are formed of populations of cells distributed within 
an extracellular matrix (ECM), which is structured down to 
the molecular level. Local variations in organization and bio-
chemistry mean that the encapsulated populations of cells are 
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surface interactions between gel particles 
form short-range adhesions when in close 
contact causing the paste-like material to 
thicken.[16] The interactions formed between 
the particles allow the particulate material to 
support a secondary phase of similar (or in 
some cases higher) density. This “true-gel” 
(G′ >>> G′′) particulate (Figures S1–S3, Sup-
porting Information) microstructure makes 
this system physically distinct from highly 
viscous fluids, such as commercial shower 
gels, that are formed almost exclusively by 
polymer entanglement.[17] Importantly, since 
the gel particles are discrete entities they do 
not contaminate the surface of the manu-
factured sample and can actually be formed 
from the same material as that extruded into 
the particle bed (Figure 1) likely simplifying 
the translational pathway. Using particulate 
gels as a suspending agent, supports the 
fragile construct as it is formed, in a similar 
manner to the way amniotic fluid suspends 
the developing fetus. Using an XYZ stage, 
it was possible to (with 100 µm resolution) 
deposit the hydrogel polymer in a discrete 3D 
location, the resolution of which is limited 
only by the size of the droplet from the end 
of the extruding needle and the viscosity of 
the supporting medium.
A variety of hydrogel materials may be 
used for the production of the final part and 
the supporting bed. Initial experimentation 
demonstrated that it was possible to generate 
structures using combinations of gelatin, 
gellan, collagen, hyaluronic acid, agarose, 
and alginate. As a consequence of its relative 
robustness and capacity for physical modifi-
cation using seeded hydroxyapatite,[18] gellan 
was selected for further use as the final part 
and agarose as the supporting bed. The sup-
porting bed, formed from agarose with par-
ticles in the size range 2–11 µm (Figure S4, 
Supporting Information), was of sufficient 
robustness to suspend a cross-linked gellan 
gum structure such as the helix illustrated 
in Figure 1. This helical structure was loaded 
with colloidal hydroxyapatite nanocrystals 
in order to increase radio-opacity enabling 
micro-computed tomography (CT) imaging. 
Following treatment with calcium chloride solution this helical 
structure was removed from the particle bed and was shown to 
be self-supporting (Figure 1). The shear forces applied during 
the extrusion process were not of sufficient magnitude to cause 
phase separation and were sufficiently mild that it was possible 
to maintain the viability of a population of human primary 
chondrocytes within the cultures (Figure 2). To investigate the 
influence of supporting matrix viscosity on the resolution of the 
printing method, samples were made using a controlled con-
centration of gellan gum (1.5%) and a hypodermic needle of 
internal diameter 337 µm. An increase in the viscosity of the 
supporting medium resulted in a monotonic increase in resolu-
tion in the XY dimensions, but interestingly a smaller reduction 
in resolution in the Z dimension (Figure 2). At this scale, reso-
lution is ultimately limited by droplet size, which is controlled 
by the internal dimensions, flow rate of the extruding aperture 
and other parameters of deposition, such as the viscosity of 
the extruded solutions. To further investigate factors that may 
influence resolution, structures were formed using a range of 
needle diameters and it was demonstrated that resolution was 
Adv. Mater. 2017, 1605594
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Figure 1. A–D) A schematic showing the manufacturing process for a 3D soft solid structure 
manufactured using the suspended deposition method. A) Briefly, a supporting “fluid-gel” 
matrix is created in a vessel. B) A secondary phase may then be extruded into the particle 
bed. C) The self-healing, fluid gel supports the gel structure during the cross-linking process. 
D) Once cross-linked, the object may be removed from the particle bed. E) This was mani-
pulated to fabricate a simple helix loaded with hydroxyapatite nanoparticles and imaged with 
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directly related to needle diameter, increasing up to the point 
that the hydrocolloid could no longer be extruded (Figure 2). 
The peak resolution achievable for the 1.5% gellan gum and 
the agarose supporting medium was 250 µm. Given the scale 
of the tissues to be produced for osteochondral repair and the 
need for cell viability, the needle diameter was set at 337 µm 
and extrusion rate no more than 125 µL s−1. To demonstrate the 
complexity achievable with the suspended manufacturing pro-
cess, scaffolds that mimic the structuring and cellular organiza-
tion of an osteochondral defect were manufactured. This com-
plex tissue region lies between articular cartilage and bone on 
an articulating joint surface[19] and may be severely damaged 
following trauma[20] or can deteriorate during the progression 
of osteoarthritis.[21] At present the standard of care is microfrac-
ture in the knee[22] or the transplantation of tissue that has been 
isolated from a cadaver or nonarticulating region of the joint.[22] 
Neither method has been shown to be absolutely successful 
and this has driven research into the development of a range 
of synthetic osteochondral plugs.[23] The main reason for failure 
of these synthetic grafts is through delamination at the hard–
soft tissue interface.[24] Native osteochondral tissue exhibits a 
gradual structural change from disordered mineralized collagen 
at the subchondral bone,[25] through to collagen II and glycosa-
minoglycan (GAG) - rich cartilage[26] allowing stress to be dis-
tributed across the interface without stress localization and 
delamination occurring.[26,27] The region consists of four prin-
ciple cells types, which secrete and organize their local environ-
ments.[25,26] Although a number of groups have attempted this 
in vitro[28] the processes that they have employed did not mimic 
the structuring of this complex structure at a length-scale that 
is appropriate to the size of the defects encountered clinically.
Here, the suspended manufacturing process was used to 
form composite hydrogel structures with anisotropic mechan-
ical properties mimicking the native osteochondral envi-
ronment. Femoral condyle tissue was retrieved from patients 
following knee replacement and an osteochondral defect was 
introduced using a surgical drill. Excess retrieved tissues were 
digested to release the cells from the cartilage and bone sam-
ples. The structure was scanned using micro-CT and a 3D 
model of the defect was created. This 3D model was used to 
guide the manufacture of an osteochondral implant where the 
lower surface was loaded with sol-HA, gellan, and osteoblast 
cells (Figure 3). The upper surface of the construct was manu-
factured using gellan gum alone, loaded with populations of 
chondrocytes (Figure 3). The suspended manufacturing pro-
cess allowed for the production of osteochondral structures that 
fit tightly into the defects and matched the layer thicknesses 
for the bone and cartilage components. These samples were 
then placed in culture for a period of four weeks in order to 
identify whether the cell types in the different regions of the 
defect maintained phenotype. Over the course of four weeks of 
in vitro culture the osteochondral plugs maintained their struc-
tural integrity; they could be easily handled and extracted from 
the defect without deterioration (Figure 3).
Mechanical spectra of the osteochondral constructs high-
light the successful integration of two different materials 
into a single structure (Figure 3). Constructs were sliced into 
four regions and stress sweeps were conducted on each sec-
tion to determine mechanical strength and elasticity. Samples 
were subjected to increasing stress (0.1–1000 Pa) and a range 
of mechanical properties was observed throughout the con-
struct. The weakest areas with the shortest linear viscoelastic 
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Figure 2. Extrusion of a gellan matrix loaded with primary human chondrocytes into the “fluid-gel” structure through a 337 µm internal diameter needle 
maintained cell viability throughout the construct (left column, scale bars =  200 µm). An increase in the internal diameter of the needle resulted in 
a reduction in resolution (centre, top), as did a reduction in the viscosity of the matrix (centre, bottom). From these experiments, a fluid viscosity of 
0.75 Pa s (at 1 s−1 shear rate) and needle diameter of 337 µm was set for manufacture of an osteochondral plug. A computer model of this plug (right 
column) was generated from CT scans of a defect drilled into the tissue by a clinician. The model generated was used to inform the manufacture of a 
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region were the chondral region and the uppermost surface of 
the construct (Regions A and D). Region C exhibited signifi-
cantly higher gel strength and elasticity. This can be attributed 
to the nanocrystalline hydroxyapatite (nano-HA) interacting 
with gellan helices during gelation to create a highly homog-
enous structure exhibiting higher strength in comparison with 
unloaded gellan (Figure 3). Interestingly, the incorporation of 
HA into the gellan hydrogel resulted in a more rapid relaxa-
tion response than the gellan alone (Figure 3C). This is sig-
nificant since matrices of elastic modulus >17 kPa that exhibit 
more rapid stress relaxation encourage mineralization to a 
greater extent when compared with those with slower stress 
response.[29] Region A was comprised entirely of gellan gum 
without nano-HA, which explains the lower gel strength. It is 
likely that the nano-HA began to sediment prior to gelation due 
to its higher density compared with the gel phase (3.16 com-
pared with ≈1 g cm−3) resulting in the top of the osteogenic 
region showing a lower modulus. At the interface (Region B), 
the construct exhibited mechanical properties intermediate to 
Regions A and C providing evidence for a successful integra-
tion of the two different materials (Figure 3). Interestingly, 
the trend in mechanical properties observed in regions A–C 
shows some similarity to reported changes in modulus across 
osteochondral tissue (Figure 3). A 2012 study by Campbell 
et al. outlined indentation moduli of three osteochondral 
regions, namely subchondral bone, hyaline cartilage, and the 
osteochondral interface.[27] Subchondral bone exhibited the 
highest modulus, hyaline cartilage the lowest with calcified car-
tilage (the interface) falling between the two, albeit closer to the 
modulus of bone. Indentation moduli of tissue regions were 
orders of magnitudes greater than storage moduli of respective 
construct regions and methods used to determine both differed 
greatly. However, parallels between the two trends highlight 
the level of control exhibited over mechanical properties within 
each region of osteochondral constructs.
Polymerase chain reaction (PCR) data collected from the 
retrieved samples demonstrated that the expression of both col-
lagen type II and aggrecan (ACAN) (both markers of cartilage 
formation) was highest in the chondral region of the scaffold 
(Figure 3) and collagen type I expression was lowest at this 
point. Immunohistochemical (IHC) analysis of the samples 
demonstrated the presence of aggrecan around the encapsulated 
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Figure 3. A) Samples manufactured using suspended manufacturing were cultured before being cut with a razor blade and mechanically characterized 
using a rheometer. B) The storage modulus of the construct reduced significantly from the core “boney” area of the structure (Regions C and D) into 
the chondral region (Regions A and B). Mechanical data reflected trends seen in native tissue with an increase in modulus from hyaline cartilage 
(Region A) through the osteochondral interface (Region B) to subchondral bone (Regions C and D).[20] This demonstrates that it is possible to not only 
define geometric but also the mechanical properties exhibited by the resulting structure. C) Stress relaxation measurements show that the addition of 
hydroxyapatite (GG +  HAp) results in a faster relaxation response than gellan gum alone (GG). D) Following 4 weeks of culture within the human tissue 
defects (n =  6), the construct was removed and cells within the cartilage (CH), interfacial (IF) and bone (OB) regions were recovered for RNA isolation 
and mRNA was analyzed by qRT-PCR. The cells in the cartilaginous section of the scaffold expressed the highest levels of coll II and aggrecan (ACAN) 
and the bone region expressed significantly more coll IA1 (mean ±  SEM). This suggests that the cells deposited into discrete regions maintained not 
only viability but also their phenotype (*: P < 0.05, τ: P =  0.0793). E) Fluorescent immunohistochemistry (IHC) (DAPI (4,6-Ddamidino-2-phenylindole) =  
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cells in this area of the scaffold (Figure 3). Remarkably, the ratio 
of collagen II to collagen I changed gradually throughout the 
structure inline with what would be expected with the native 
tissue region. This indicated that while the two sections of the 
osteochondral scaffold were well integrated, the embedded 
cell population retained their native phenotype. This is some-
thing that has proven challenging with existing technologies 
for tissue structuring. In comparison with the majority of ALM 
methods, where high temperatures, pressures, or cross-linking 
agents are a necessity, the suspended manufacture method 
allowed us to maintain viability and behavior while subtly mod-
ifying the local composition of the matrix.
In this paper, a new method was reported to manufacture 
comparatively complex soft-solid structures by extruding a 
gelling polymer into a supporting particle-based matrix. The 
method allowed the structuring of soft-solid materials such 
that they exhibited distinct chemical and physical properties 
on the microscale. It was shown that suspended manufacture 
could recapitulate the structure of the osteochondral region as 
defined by CT scanning. The printed structure maintained its 
morphology and mechanical robustness over a period of four 
weeks of culture during which the encapsulated cells retained 
their phenotype. Our findings suggest that this novel method 
of producing 3D tissue-like structures has significant promise 
for the regeneration and study of complex tissue structures and 
interfaces.
Experimental Section
Fluid Gel Formulation: Fluid gels were manufactured by cooling 
solutions of 0.5% w/w agarose from 85 to 20 °C under constant shear 
using a magnetic stirrer rotating at 700 rpm. This created a constant 
angular velocity of 74 rad s−1. Fluid gels were sterilized for cell culture 
applications by autoclaving agarose solutions prior to cooling.
Suspension of Helical Polymeric Structures: Aliquots of fluid gel 
were prepared in 6 mL Bijoux tubes. Solutions of 1.5% w/w low acyl 
gellan mixed with 10% nanocrystalline hydroxyapatite/HA at 60 °C 
(formulated by a precipitation method)[30] were extruded into fluid gel 
samples through a hypodermic needle with a 337 µm inner diameter 
using a 5 mL syringe. During extrusion, the syringe was manipulated 
precisely with respect to geometric position to enable the generation 
of the helix. The suspensions were then left at room temperature for 
40 min to enable gelation to occur. Prior to extraction, samples were 
observed using micro-CT (Bruker Skyscan 1172—Bruker, Belgium) and 
reconstructed data were visualized in 3D using CTVox software (Bruker). 
Helices were then extracted and excess fluid gel was washed away with 
deionized water.
Tuning Resolution of Suspended Constructs: Low acyl gellan gum 
solutions of varying viscosity (as controlled by polymer concentration) 
were extruded into separate aliquots of fluid gel (contained in petri 
dishes of 60 mm diameter and 15 mm depth). Gelation was triggered 
by temperature and ionic interaction via injection of 200 ×  10−3 M 
CaCl2 around constructs at 20 °C. After 30 min, gelled structures were 
extracted and the resolution of each construct was measured.
Evaluation of Cell Culture Applications: Osteochondral tissue was 
donated by patients undergoing elective knee replacement surgery. 
This study was approved by the United Kingdom National Ethics 
Research Committee (Hertfordshire Research Ethics Committee 12/
EE/0136). Articular cartilage was removed from human femoral condyle 
tissue before mincing and digestion by 2 mg mL−1 collagenase for 
4 h under agitation at 37 °C for release of chondrocytes. Bone chips 
(4–5 mm3) from subchondral trabecular bone were cultured for release 
of osteoblasts. Both cell types were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum, 
1% L-glutamine, 1% PenStrep, and 1% nonessential amino acids. 
At passage 1, cells were trypsinized, counted, and resuspended at a 
density of 3 ×  106 cells mL−1 before being mixed with sterile 1.5% low 
acyl gellan gum. Cell-laden gellan gum was extruded into sterile agarose 
fluid gel to create linear constructs. Gelation at 20 °C was triggered with 
200 ×  10−3 M CaCl2 and excess calcium ions were washed away after 
30 min using Dulbecco’s phosphate buffered saline (PBS). Cell-loaded 
constructs were cultured at 37 °C/5% CO2 in culture media (as above). 
Cell viability was visualized using Calcein-acetoxymethyl (AM) and 
ethidium homodimer-1 fluorescent dyes.
Defect Formation and Reconstruction: Defects were introduced into 
femoral condyle tissue following surgery using an orthopedic drill. The 
resulting tissue was imaged using microCT (Bruker Skyscan 1172) and 
reconstructed data were viewed using CTVox software (Bruker). The 
defect was then measured for reconstruction of the defect space in 
Simpleware (Synopsys, UK).
Implant Fabrication and Culture: Prior to implant fabrication cells 
were isolated and cultured as above. Primary human osteoblasts and 
chondrocytes were trypsinized, counted, and resuspended at a density 
of 1 ×  106 cells mL−1. Osteoblasts were loaded into 1.5% low acyl gellan 
mixed with 5% nano-HA while chondrocytes were mixed with 1.5% 
gellan. Guided by dimensions obtained from defect reconstruction, 
single implants were fabricated containing a layer of chondrocyte-
loaded gellan and a thicker layer of osteoblast-loaded gellan/HA via 
extrusion into sterile agarose fluid gel. Gelation at 20 °C was triggered 
with injection of 200 ×  10−3 M CaCl2 around each suspended structure 
and constructs were extracted after 30 min. Excess fluid gel was washed 
away and constructs were implanted into tissue defects. The construct-
filled defects were then cultured as above in a humidified incubator at 
37 °C, 5% CO2 for 30 d (n =  6).
Determination of Collagen 1, Collagen 2, and Aggrecan (ACAN) 
Expression: Following 30 d of culture, constructs were removed from 
the tissue defects and separated into cartilage, interface, and bone 
regions for gene expression analysis. RNA was isolated using TRIZol 
reagent (Life Technologies, UK) and the manufacturer’s instructions 
were followed. RNA was quantified using photospectrometry (NanoDrop 
2000, NanoDrop Technologies). Quantitative-realtime polymerase chain 
reaction (Q-RTPCR) was performed using a Lightcycler 480 (Roche). 
The expression of collagen type I, type II, and aggrecan (ACAN) were 
measured and normalized to 18S expression. Validated TaqMan probes 
were purchased from Life Technologies. Gene expression was quantified 
using the Pfaffl method.[31]
Fluorescent Immunohistochemistry: Constructs were fixed with 
4% paraformaldehyde before blocking in vehicle (10% goat serum, 
0.1 M PBS, 0.3% Triton-X-100). For aggrecan, cells were incubated with 
mouse antiaggrecan primary antibody (1:100, ThermoFisher) and then 
Alexa 488 goat antimouse secondary antibody (1:500, Invitrogen). 
Nuclei were stained with 4,6-Diamddino-2-phenylindole (DAPI) (1:5000, 
Sigma-Aldrich) and constructs were imaged using a Leica DM 6000B 
microscope.
Mechanical Spectra of Implants: Layered constructs were sliced 
laterally into four separate regions (see Figure 3—mechanical spectra 
figure). Stress sweeps were conducted on each region using a Bohlin 
Gemini rheometer (Malvern, UK) with 25 mm serrated parallel plate 
geometry. Elastic and viscous moduli (G′ and G′′, respectively) were 
analyzed in response to increasing stress from 1 to 100 Pa at a constant 
temperature of 37 °C. For stress relaxation, gellan gum and gellan 
gum/hydroxyapatite constructs (height 8 mm, diameter 14 mm) were 
displaced 2 mm and held for 300 s while load was recorded (Bose 
ElectroForce 5500).
Rheological Measurements: All rheological measurements were 
performed on a Bohlin Gemini rheometer (Malvern, UK) using a 55 mm 
2° cone and plate geometry at an isothermal temperature of 37 °C which 
was maintained by a Peltier controlled lower plate.
Stress Sweeps: Samples of 0.5% agarose fluid gels were prepared and 
loaded onto the bottom plate of the rheometer. The samples were then 
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subjected to a shear stress range of 0.1–100 Pa at a constant oscillatory 
frequency of 10 Rad s−1. Elastic and viscous moduli were measured in 
response to increasing shear stress. Results were analyzed to determine 
the linear viscoelastic region.
Frequency Sweeps: Elastic and viscous moduli of 0.5% agarose fluid 
gels were analyzed in response to increasing oscillatory frequencies 
from 0.1 to 10 Rad s−1 at a constant strain of 0.05%.
Shear Sweeps: Shear ramps were performed at 37 °C on 0.5% agarose 
fluid gel samples. Shear rate was increased from 0.001 to 100 s−1 over 
a 10 min period and dynamic viscosity in response to increasing shear 
rate was subsequently analyzed.
Particle Size Distribution: Fluid gel samples were loaded onto glass 
slides and allowed to dry under a coverslip for 10 min. Samples were 
then visualized on Keyence VHX 2000 digital microscope (Keyence, UK). 
Particle sizes were analyzed with VHX 2000 communication software. 
Particle size distribution was evaluated using images of fluid gel 
particles within an area of 135 µm ×  120 µm. Images were divided into 
12 grids of 11.25 µm ×  10 µm. Within each grid, the number of particles 
was recorded and divided into categories based on size. A total of 96 
grids and ≈2300 particles were counted. Particle size distribution was 
subsequently determined by comparing the number of particles within 
each size range and calculating cumulative undersize.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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